Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),-0.7228555666835237,-2.369205951730821,0.0,0.0,0.0,14/30,10.96%,GRIK2;GRID2;GRIA4;GABRB1;GRIA1;GRIN2A;GRIN2B;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,ligand-gated channel activity (GO:0022834),-0.7228624108683614,-2.320689275893969,0.0,0.0,0.0,14/29,10.96%,GRIK2;GRID2;GRIA4;GABRB1;GRIA1;GRIN2A;GRIN2B;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,glutamate receptor activity (GO:0008066),-0.789511377956308,-2.262745822851232,0.0,0.0,0.0,12/19,10.96%,GRM7;GRIK2;GRID2;GRIA4;GRM8;GRM5;GRIA1;GRM1;GRIA2;GRIK4;GRIN2D;GRIK1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.674794274282364,-2.2124609726994606,0.0,0.0,0.0,16/29,12.92%,GRIK2;GRID2;GRIA4;GABRB1;GRIA2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;GRIN2D;GABRB3;GRIK1;GLRA2;GABRA5
prerank,microtubule minus-end binding (GO:0051011),0.7960342882851801,2.030551364624124,0.0,0.03513391246003467,0.031,6/13,7.65%,CAMSAP1;NUMA1;TUBGCP5;MACF1;HAUS7;CAMSAP2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7336023012889779,-1.9956760420256774,0.0,0.016302674652308644,0.07,11/17,10.96%,GRIK2;GRIA4;GRIA1;GRIN2A;GRIN2B;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;GRIK1
prerank,cAMP binding (GO:0030552),-0.7817998753269186,-1.924979720607587,0.0,0.037661242076535796,0.185,7/11,13.67%,PDE4B;PDE4D;HCN1;RAPGEF2;PDE10A;PDE4A;PDE2A
prerank,cyclic nucleotide binding (GO:0030551),-0.6421902774489793,-1.9211409161819792,0.0,0.03331287948844262,0.19,9/21,13.67%,PDE4B;PDE4D;HCN1;PDE11A;RAPGEF2;KCNH1;PDE10A;PDE4A;PDE2A
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5772403221557281,-1.8568051264617444,0.0024330900243309003,0.06590717363393764,0.374,11/28,12.92%,GRIK2;GRID2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;CHRNA4;GRIK1;GABRA5
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.647314725916121,-1.849498730350163,0.002288329519450801,0.06339929031453362,0.396,11/19,16.06%,GRIK2;GRID2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;GRIK1;GABRA5;GRIK3
prerank,R-SMAD binding (GO:0070412),0.6524926220543208,1.810183104188207,0.00375234521575985,0.4103836163734605,0.501,8/18,9.34%,LDLRAD4;SMAD3;PMEPA1;DDX5;SMURF1;PAX6;RANBP3;JUN
prerank,glycine binding (GO:0016594),-0.7177579849989846,-1.8043113644229505,0.0019880715705765406,0.09327606256763933,0.564,7/11,17.08%,GRIN2B;GLRA1;GRIN3A;SRR;GLRA2;GNMT;GLDC
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6646891913264611,-1.8031921081025843,0.0,0.08554683131706262,0.567,7/15,7.32%,HS6ST3;HS3ST5;NDST4;HS3ST2;HS6ST2;HS3ST4;HS3ST1
prerank,I-SMAD binding (GO:0070411),0.7138596622392293,1.7994821529315448,0.001984126984126984,0.30774704802956293,0.546,5/13,2.53%,TGFBR1;SMAD3;SMAD7;SMURF1;TGFB1I1
prerank,syntaxin-1 binding (GO:0017075),-0.5908842920901156,-1.785489667829915,0.009456264775413711,0.09303530576897655,0.628,9/22,7.01%,LRRK2;SYT1;UNC13C;SNPH;STXBP5;SYNPR;CPLX2;SNAP25;DAPK1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5118826276510363,-1.783266032388687,0.0,0.08778363274320039,0.635,11/42,6.34%,LRRC4C;PDLIM5;CD47;TMOD3;CNTN6;EMB;NPTN;PALLD;S100A11;PDLIM1;STXBP6
prerank,ligand-gated anion channel activity (GO:0099095),-0.6324175673247047,-1.7718488560609118,0.004291845493562232,0.09138931541077178,0.673,11/17,15.51%,GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GLRA2;GABRA5;CFTR
prerank,GTPase activator activity (GO:0005096),0.3913377587940992,1.761033901301957,0.0,0.3654902837856384,0.725,80/313,11.31%,DOCK4;SRGAP2;RAPGEF5;ELMO1;CHN2;DOCK8;TBC1D16;FGD2;HPS4;ARHGAP22;ARHGAP45;OPHN1;SIPA1L2;ARHGAP39;RASGRP3;ASAP1;CYTH4;ARHGEF2;PREB;SMAP2;HERC2;PREX1;DENND4A;VAV2;TBC1D17;DENND6B;ARHGAP27;RAP1GDS1;ASAP3;TBC1D9B;RAB3IL1;RCBTB2;ARFGAP3;RGS10;ARAP3;TBC1D10B;TBC1D7;CDC42EP2;ARHGAP25;RGL2;RANBP2;TBCK;TBC1D8;GARNL3;DENND2C;TBC1D15;FLCN;RP2;EIF2B3;ARHGAP30;ARHGAP28;HACD3;ACAP2;RASA4;CCZ1;ARHGAP17;SIPA1;PSD;SGSM2;RAB3GAP2;RANBP3;RAB3GAP1;LAMTOR2;FRMD7;ARHGAP8;DOCK10;RALGPS1;JUN;AKAP13;CYTH3;EEF1B2;NCKAP1L;EIF2B4;RGS14;LAMTOR5;TBC1D9;RUNDC1;SPATA13;RAPGEF3;FGD3
prerank,GABA receptor activity (GO:0016917),-0.585015440768809,-1.7519985634047734,0.006521739130434782,0.10476360124669225,0.739,11/21,15.74%,GABRB1;GABBR1;GABBR2;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5;GABRQ
prerank,triglyceride lipase activity (GO:0004806),0.6329995588344894,1.7517310240324846,0.012280701754385965,0.3204993569965385,0.758,5/20,8.06%,LIPC;LIPH;DAGLB;PLA2G15;PNPLA1
prerank,BMP binding (GO:0036122),0.7264986655256613,1.745756838117466,0.0055658627087198514,0.2849750677313923,0.778,2/11,12.55%,GREM1;ENG
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5917981472555975,-1.7088284598030707,0.01072961373390558,0.15296655172182003,0.881,5/18,6.34%,PDLIM5;TMOD3;S100A11;PDLIM1;STXBP6
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.6896192445149196,-1.683452907324887,0.015350877192982455,0.18135663388346324,0.941,6/10,17.44%,B3GALT1;B4GALT5;B4GALT6;B3GALT4;B3GALT2;B4GALT7
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6162305065024616,1.6711745601509624,0.011111111111111112,0.506792745207246,0.958,4/18,1.04%,TGFBR1;TGFBR2;SMAD3;SMAD7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5116082742995332,-1.670393751216651,0.008849557522123894,0.19335063854513734,0.955,16/29,22.32%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC26A7;SLC46A1;SLC25A12;SLC26A2;SLC25A18;SLC13A5;SLC1A1;SLC1A4;ABCC2;SLC26A8;SLC26A3;SLC26A4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5346843127699777,1.6556428514754045,0.016423357664233577,0.5106616581864761,0.978,13/29,21.15%,GANAB;GUSB;NEU3;HPSE2;CHIT1;ACER3;HEXD;ACER2;PARG;PGGHG;CTBS;MGAM;GAA
prerank,metalloaminopeptidase activity (GO:0070006),-0.6118122772678424,-1.6526950782178598,0.013729977116704805,0.21315122588378224,0.966,10/16,17.82%,MMP16;NPEPPS;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP;MMP14;LNPEP
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.560834754541704,-1.6458493418258415,0.020642201834862386,0.21379203721255385,0.972,11/21,13.67%,PDE7B;PDE4B;PDE4D;PDE1C;PDE9A;PDE7A;PDE11A;PDE8A;PDE10A;PDE4A;PDE2A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6974439290529703,1.6437648309475144,0.009560229445506692,0.5090079786648233,0.991,6/11,17.88%,PRMT2;PRMT8;PRMT1;PRMT6;FBXO11;CARM1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6560178555940814,1.6322633928418966,0.02952029520295203,0.5062211220283328,0.994,3/12,3.53%,TGFBR1;TGFBR2;LTBP4
prerank,ion channel activity (GO:0005216),-0.40329211777725504,-1.630346800898552,0.0026246719160104987,0.22866982468910316,0.981,20/80,10.96%,GRIK2;GRID2;GRIA4;UNC80;GABRB1;GRIA1;GRIN2A;GRIN2B;NALCN;TRPM3;GRIA2;GRIA3;MCUB;PKD2;GRIK4;GRIN3A;GRIN2D;CHRNA4;CALHM6;GRIK1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.648200315617823,1.6257577300615984,0.01904761904761905,0.48752739638356185,0.998,4/12,12.73%,SLC25A42;ENTPD1;NUDT15;ENTPD7
prerank,MHC class II protein complex binding (GO:0023026),-0.6552949419602405,-1.62457477787137,0.018367346938775512,0.2296726057892849,0.986,6/11,25.47%,CD74;YWHAE;HSPA8;MS4A1;CD4;HSP90AB1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5431895094024655,-1.6242263532660315,0.016548463356973995,0.2201803169882521,0.986,11/23,13.67%,PDE7B;PDE4B;PDE4D;PDE1C;PDE9A;PDE7A;PDE11A;PDE8A;PDE10A;PDE4A;PDE2A
prerank,myosin V binding (GO:0031489),-0.606471518056582,-1.6214667120977289,0.0091324200913242,0.21586426537247286,0.986,6/15,16.22%,RAB3C;RAB6A;RAB3D;RAB8A;RAB3A;RAB27B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.38973959671981145,1.6109943670589648,0.0,0.5078964891502696,1.0,35/147,11.31%,DOCK4;RAPGEF5;ELMO1;DOCK8;FGD2;HPS4;CYTH4;ARHGEF2;PREB;HERC2;PREX1;DENND4A;VAV2;DENND6B;RAB3IL1;RCBTB2;RGL2;DENND2C;EIF2B3;CCZ1;PSD;RAB3GAP2;RAB3GAP1;LAMTOR2;FRMD7;DOCK10;RALGPS1;AKAP13;CYTH3;EEF1B2;EIF2B4;LAMTOR5;SPATA13;RAPGEF3;FGD3
prerank,GTPase regulator activity (GO:0030695),0.36864188429592964,1.6024373639370166,0.0,0.5050875278442591,1.0,46/212,7.34%,SRGAP2;CHN2;TBC1D16;ARHGAP22;ARHGAP45;SIRPA;OPHN1;SIPA1L2;ARHGAP39;RASGRP3;ASAP1;PREB;SMAP2;PREX1;TBC1D17;ARHGAP27;RAP1GDS1;ASAP3;TBC1D9B;ARFGAP3;RGS10;ARAP3;TBC1D10B;TBC1D7;CDC42EP2;GPS2;ARHGAP25;RANBP2;TBCK;TBC1D8;GARNL3;TBC1D15;FLCN;RP2;ARHGAP30;ARHGAP28;RHOH;HACD3;ACAP2;RASA4;ARHGAP17;SIPA1;SGSM2;RAB3GAP2;RANBP3;RAB3GAP1
prerank,water transmembrane transporter activity (GO:0005372),-0.6390262374771982,-1.596583987206593,0.02610441767068273,0.2514326429920614,0.994,5/11,31.60%,AQP4;AQP11;AQP1;SLC5A1;SLC4A11
prerank,voltage-gated ion channel activity (GO:0005244),-0.6075256539222521,-1.5932995733272486,0.028199566160520606,0.24719902728634505,0.995,5/14,8.83%,KCND2;CACNA1E;HCN1;PKD2;ANO6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.5217896837535093,-1.5927818620788758,0.02702702702702703,0.23945747625730418,0.995,5/23,4.87%,HIP1;CLVS2;SESTD1;SNX14;PLEKHA5
prerank,sequence-specific mRNA binding (GO:1990825),0.6818626410425138,1.5882832824795832,0.018518518518518517,0.5263115854628209,1.0,6/10,19.56%,SSB;ETF1;DHX9;RBM24;SHFL;TYMS
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6262811246162736,-1.5854903035926264,0.02826086956521739,0.24505602721033562,0.997,8/12,12.92%,GABRB1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5
prerank,GABA-A receptor activity (GO:0004890),-0.5567569160097396,-1.580988831248973,0.02666666666666667,0.24375736369045506,0.997,9/18,15.74%,GABRB1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5;GABRQ
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5567178184504551,-1.5790215518188582,0.04100227790432802,0.23869316895996198,0.997,10/16,22.32%,SLC12A5;SLC26A7;SLC4A8;SLC26A2;CFTR;SLC1A1;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,muscle alpha-actinin binding (GO:0051371),-0.5918542925160477,-1.5714814315638925,0.030042918454935622,0.244074138883992,0.998,5/15,12.81%,PDLIM5;PALLD;PDLIM1;PKD2;PDLIM4
prerank,lipase activity (GO:0016298),0.47167653092495354,1.5628665891631397,0.018363939899833055,0.603002038295558,1.0,11/43,13.08%,LIPC;LIPH;DAGLB;ABHD12;PLA2G15;PNPLA1;PLB1;SMPD2;ABHD15;ABHD6;PLBD2
prerank,anion channel activity (GO:0005253),-0.4180582357548856,-1.559546748209842,0.009732360097323601,0.25805044549530476,0.999,20/61,15.74%,LRRC8C;GABRB1;GLRA1;CLCN5;GABRA3;GABRG3;GABRG1;ANO3;GABRA2;LRRC8B;GABRG2;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;CLCC1;CFTR;GABRQ
prerank,vinculin binding (GO:0017166),-0.6290790862977601,-1.5466897457306599,0.036637931034482756,0.27477542164267044,0.999,4/11,5.46%,DMD;CTNNA1;UTRN;SYNM
prerank,voltage-gated cation channel activity (GO:0022843),-0.3746500684825761,-1.5457316037321749,0.005089058524173028,0.2680897763933257,0.999,22/97,8.77%,KCND2;KCNB2;CACNA2D3;CACNA1E;HCN1;KCNC2;GRIN2A;GRIN2B;KCNQ5;KCNH1;CACNG2;KCND3;CACNA1C;KCNA6;KCNQ3;KCNH7;PKD2;GRIN3A;OPRM1;KCNH5;CACHD1;GRIN2D
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5979128257559233,-1.5410554137846055,0.041304347826086954,0.2687140677319951,0.999,8/13,12.92%,GLRA1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GLRA2;GABRA5
prerank,calcium channel regulator activity (GO:0005246),-0.4545030342288476,-1.5405263050176359,0.02403846153846154,0.2623102644478353,0.999,7/37,7.94%,NRXN1;PRKG1;ITPR1;YWHAE;CALM1;MCUB;STIM2
prerank,semaphorin receptor activity (GO:0017154),-0.6190561965373602,-1.538446566472163,0.03549060542797495,0.2590691883680248,1.0,5/11,14.19%,PLXNC1;PLXND1;PLXNA2;PLXNB2;PLXNB1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.5105596204216124,-1.5357693020810637,0.04390243902439024,0.2572748872928454,1.0,4/21,9.95%,GRM5;GRIA1;GRM1;CHRNA4
prerank,potassium channel activity (GO:0005267),-0.37273812195429784,-1.5279710828116282,0.009925558312655087,0.2638800340508381,1.0,24/89,13.88%,GRIK2;KCND2;KCNT2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNMB2;KCNH1;KCND3;KCNA6;KCNQ3;KCNH7;PKD2;GRIK4;KCNH5;TMEM38B;TMEM38A;GRIK1;KCNMB4;KCNQ1;HCN2
prerank,calcium channel inhibitor activity (GO:0019855),-0.6141537172107772,-1.525506399085476,0.04042553191489362,0.26171983706063845,1.0,3/11,6.18%,ITPR1;CALM1;MCUB
prerank,3'-5' DNA helicase activity (GO:0043138),0.5677375124217874,1.5236948263122565,0.053475935828877004,0.7539152048715773,1.0,4/16,6.66%,NAV2;FANCM;MCM2;DHX9
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5489802454273186,1.5219194466209889,0.030303030303030304,0.7188099965883888,1.0,3/18,3.53%,TGFBR1;TGFBR2;LTBP4
prerank,cysteine-type endopeptidase activity (GO:0004197),0.40654654339419943,1.5214226516530418,0.008361204013377926,0.6810990869181411,1.0,20/78,14.63%,USP35;CAPN3;CFLAR;UCHL1;USP8;USP12;CAPN9;CASP1;CTSS;LGMN;CAPN5;USP28;USP25;PIGK;USP36;USP5;CTSF;USP9Y;PDIA3;PYCARD
prerank,myosin binding (GO:0017022),-0.4077344187943203,-1.5186547754171555,0.014778325123152709,0.26814603028766376,1.0,12/55,9.04%,DMD;STXBP5L;GSN;RAB3C;SPATA6;RAB6A;STXBP5;GIPC1;RAB3D;SHROOM1;RAB8A;RAB3A
prerank,lysophospholipase activity (GO:0004622),0.5390088915351972,1.5178920942078986,0.04,0.6620482422476416,1.0,6/20,8.13%,ABHD12;PNPLA7;PLA2G4A;PLA2G6;PLA2G4B;PLB1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5515330052948056,-1.5177103566435965,0.035343035343035345,0.2634075913533051,1.0,9/16,18.23%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC25A12;SLC25A18;SLC13A5;SLC1A1;SLC1A4
prerank,O-acyltransferase activity (GO:0008374),0.48002011844724396,1.5082311748629174,0.027777777777777776,0.6700329888732445,1.0,9/30,12.02%,LPCAT2;LPCAT4;MBOAT2;DGAT1;PLA2G4A;PLA2G15;MOGAT1;MOGAT2;MBOAT1
prerank,solute:anion antiporter activity (GO:0140323),-0.5623213764806081,-1.5081862902703358,0.04555808656036447,0.2746787117235458,1.0,7/14,22.32%,SLC26A7;SLC7A11;SLC26A2;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,alpha-actinin binding (GO:0051393),-0.496508580307657,-1.507475235040191,0.04103671706263499,0.26998373600694675,1.0,10/24,15.24%,PDLIM5;PPARG;KCNN2;PALLD;CACNA1C;PDLIM1;PKD2;RARA;PDLIM4;DAG1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5402409357994361,-1.5059960827543308,0.05128205128205128,0.2662999485399614,1.0,7/16,9.90%,CD36;MSR1;STAB1;LDLR;PLTP;SCARF1;CDH13
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.49917649645189416,-1.5032433715426354,0.04377880184331797,0.2544283454439941,1.0,9/22,17.33%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.49917649645189416,-1.5032433715426354,0.04377880184331797,0.2544283454439941,1.0,9/22,17.33%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,serotonin receptor activity (GO:0099589),-0.49917649645189416,-1.5032433715426354,0.04377880184331797,0.2544283454439941,1.0,9/22,17.33%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,ligand-gated calcium channel activity (GO:0099604),-0.509529125173916,-1.5029998500519064,0.04186046511627907,0.2496149642579006,1.0,5/19,2.60%,ITPR1;GRIN2A;GRIN2B;RYR3;RYR2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.45494316984000926,1.4934851954279176,0.02707275803722504,0.7075579592645871,1.0,15/37,21.36%,KARS1;AARS2;CARS2;NARS1;SARS1;SARS2;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2;MARS2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5386999269087567,-1.4863345886336587,0.06711409395973154,0.27147048740648133,1.0,8/15,22.32%,SLC26A7;SLC4A8;SLC26A2;CFTR;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,potassium channel regulator activity (GO:0015459),-0.403033259594698,-1.484404217506675,0.023195876288659795,0.2694655295285416,1.0,9/49,6.40%,KCNIP4;DPP6;DPP10;KCNIP1;KCNMB2;YWHAE;NEDD4L;SGK2;KCNAB2
prerank,sodium channel activity (GO:0005272),-0.4347114972802342,-1.4831779466761736,0.04772727272727273,0.2661487038843912,1.0,14/37,22.79%,GRIK2;HCN1;SCN2A;SCN3A;PKD2;GRIK4;GRIK1;HCN2;GRIK3;ASIC3;SCN9A;CACNA1G;SCN1A;HCN4
prerank,ligand-gated cation channel activity (GO:0099094),-0.3676602803643055,-1.4768785342246051,0.01282051282051282,0.2720097566778796,1.0,14/75,10.96%,GRIK2;GRIA4;KCNN2;GRIA1;GRIN2A;GRIN2B;KCNJ3;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,carboxylic acid binding (GO:0031406),-0.42365607266849786,-1.4703283644727385,0.030232558139534883,0.27763462575954595,1.0,10/38,13.07%,GRM7;EPDR1;GRIN2B;GLRA1;GRIN3A;PADI4;SRR;GLRA2;GNMT;SHMT1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6247578764855902,1.4671972069018622,0.08670520231213873,0.8121168376336549,1.0,4/10,6.31%,SIRPA;DSP;CXADR;DSG2
prerank,hexosaminidase activity (GO:0015929),0.5872582704095664,1.466385907054962,0.07129455909943715,0.7818568490200468,1.0,3/12,9.25%,HEXB;HEXA;HEXD
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5210357623150877,-1.4641790479703147,0.06108597285067873,0.283542721168001,1.0,5/17,17.86%,DPYD;DECR2;LBR;SRD5A3;DHCR7
prerank,amyloid-beta binding (GO:0001540),-0.3662703972536218,-1.4616491108016945,0.015625,0.28251459136962975,1.0,16/79,5.13%,NLGN1;CD74;GRIA4;CD36;MSR1;GRIA1;GRIN2A;GRIN2B;LILRB3;LILRB1;IAPP;LDLR;GRIA2;APOE;APBA2;GRIA3
prerank,phospholipase activity (GO:0004620),0.4010664841417902,1.4487726169402175,0.021922428330522766,0.8383341889769382,1.0,15/67,13.59%,LIPC;LIPH;ABHD12;PLCL1;PNPLA7;PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;PLB1;SMPD2;PLD4;ABHD6;PLBD2;PDIA3
prerank,amino acid binding (GO:0016597),-0.44299861301866317,-1.446433867962477,0.04697986577181208,0.3044758912412074,1.0,12/31,18.54%,GRM7;GRIN2B;GLRA1;GRIN3A;PADI4;SRR;GLRA2;GNMT;SHMT1;DDAH2;GLDC;AARS1
prerank,FMN binding (GO:0010181),0.6007719518662206,1.4453421224034892,0.08646616541353383,0.8226800790919672,1.0,6/11,22.93%,PPCDC;NOS2;HAO1;NOS1;POR;PNPO
prerank,insulin-like growth factor I binding (GO:0031994),0.5715899054637317,1.445000685483952,0.07915057915057915,0.7930654940765091,1.0,4/13,3.71%,ITGA6;IGFBP3;ITGAV;IGF1R
prerank,MAP kinase kinase activity (GO:0004708),-0.5303115156748435,-1.441800336974681,0.08260869565217391,0.3074630358095267,1.0,7/15,19.63%,LRRK2;MAPK10;PAK3;MAPKAPK5;MAP2K6;SBK2;MAP2K5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.512131780622642,-1.4407164416413902,0.08037825059101655,0.2990199439391801,1.0,4/16,1.54%,PTPRG;PTPRD;PTPRN2;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.512131780622642,-1.4407164416413902,0.08037825059101655,0.2990199439391801,1.0,4/16,1.54%,PTPRG;PTPRD;PTPRN2;PTPRT
prerank,cysteine-type peptidase activity (GO:0008234),0.3853290576458336,1.434051656388916,0.020477815699658702,0.81888764072231,1.0,18/73,15.00%,USP35;CAPN3;UCHL1;USP8;USP12;OTULIN;CASP1;CTSS;LGMN;USP28;USP25;OTULINL;USP36;USP5;CTSF;USP9Y;PDIA3;ATG4C
prerank,lipoprotein particle binding (GO:0071813),-0.4828037486533584,-1.430345247858561,0.06511627906976744,0.31335032987551115,1.0,7/20,9.90%,CD36;MSR1;STAB1;LDLR;PLTP;SCARF1;CDH13
prerank,chloride channel activity (GO:0005254),-0.3854111615996745,-1.4293361686048522,0.02977667493796526,0.31009364719933336,1.0,18/59,15.74%,GABRB1;GLRA1;CLCN5;GABRA3;GABRG3;GABRG1;ANO3;GABRA2;GABRG2;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;CLCC1;CFTR;GABRQ
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5933430889661465,-1.428150760583186,0.0944206008583691,0.30713688743695394,1.0,3/10,1.64%,DPP6;DPP10;DPP4
prerank,cell adhesion mediator activity (GO:0098631),-0.46705718114479006,-1.4247381515835758,0.0746606334841629,0.3086254953215431,1.0,9/24,14.57%,LRRC4C;CD47;CNTN6;EMB;NPTN;PALLD;NINJ1;JAM3;NTNG1
prerank,tRNA binding (GO:0000049),0.424048424247226,1.4141379655332285,0.04900181488203267,0.8930915069082026,1.0,15/43,17.90%,KARS1;TRNT1;XPOT;SSB;AARS2;EIF2A;SARS1;SARS2;PSTK;NSUN6;TRMT10B;HSD17B10;DARS2;NEMF;TYW5
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5683581899840131,-1.4136244147155574,0.08438818565400844,0.32432321891072824,1.0,7/11,16.83%,KCND2;KCNT2;KCND3;PKD2;KCNQ1;KCNIP2;KCNT1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3517106263845592,-1.4077426672084103,0.03636363636363636,0.3300869511016922,1.0,15/80,8.15%,KCND2;KCNT2;KCNB2;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;KCNH1;KCND3;KCNA6;KCNQ3;KCNH7;PKD2;KCNH5
prerank,acylglycerol lipase activity (GO:0047372),0.5728522973859741,1.3964934667075481,0.11962616822429907,0.9605961659571164,1.0,4/11,17.23%,ABHD12;ABHD15;ABHD6;LIPE
prerank,glutamate receptor binding (GO:0035254),-0.4963657290028329,-1.395119187291311,0.08177570093457943,0.34973903396365885,1.0,5/17,8.32%,HIP1;SHISA6;SHANK3;HOMER1;SYNDIG1
prerank,sodium:proton antiporter activity (GO:0015385),0.583685191351947,1.394825073639419,0.08481262327416174,0.9378477428799439,1.0,2/11,3.02%,SLC9A9;SLC9A8
prerank,deubiquitinase activity (GO:0101005),0.3626928752807785,1.3902592554826916,0.02926829268292683,0.9347950382399726,1.0,21/88,13.03%,USP35;UCHL5;UCHL1;USP8;USP12;OTULIN;OTUD6B;OTUD5;ZRANB1;JOSD2;MYSM1;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;MINDY2;OTUB2;USP9Y
prerank,poly(A) binding (GO:0008143),-0.4688694471793965,-1.3889120687420933,0.08296943231441048,0.35688654860601204,1.0,6/21,8.21%,RBMS1;KHDRBS2;RBMS3;EIF4A3;PABPC1;ELAVL4
prerank,potassium:proton antiporter activity (GO:0015386),0.5874590252919876,1.3859732501175603,0.09270216962524655,0.9277853740856897,1.0,2/10,3.02%,SLC9A9;SLC9A8
prerank,thiol-dependent deubiquitinase (GO:0004843),0.3661431913851194,1.3835640485037342,0.043478260869565216,0.9132451319578034,1.0,20/83,13.03%,USP35;UCHL5;UCHL1;USP8;USP12;OTULIN;OTUD6B;OTUD5;ZRANB1;JOSD2;MYSM1;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;OTUB2;USP9Y
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5631448919993589,-1.3813240461035678,0.10845986984815618,0.36746067164848684,1.0,4/11,8.56%,ITPR1;TRPC5;TRPC4;TRPC3
prerank,actinin binding (GO:0042805),-0.4631542995058311,-1.378144550131722,0.07838983050847458,0.3679746564378237,1.0,8/21,15.24%,PDLIM5;PPARG;KCNN2;CACNA1C;PKD2;RARA;PDLIM4;DAG1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5130402226357882,-1.376137178548896,0.11403508771929824,0.366831978582256,1.0,3/14,18.69%,RDH10;DHRS9;RDH12
prerank,microtubule motor activity (GO:0003777),-0.37294346132376816,-1.3757756455002492,0.045346062052505964,0.3623963050347935,1.0,19/51,12.85%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;DNAH8;KIF22;DNAH2;KIF14;CENPE;KIF5B;KIF11;DYNLRB1;APPBP2;KIF20A;KIF6;DNAH3;KIF18B;KIF21A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5344310019218119,-1.374707987147138,0.12033195020746888,0.3595662740420319,1.0,7/12,13.67%,PDE7B;PDE4B;PDE4D;PDE7A;PDE8A;PDE4A;PDE2A
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5408676658738866,1.374400367342163,0.10507880910683012,0.9365885863222804,1.0,3/14,6.00%,CAPN3;CAPN9;CAPN5
prerank,insulin-like growth factor binding (GO:0005520),0.5219751608760144,1.369394950138777,0.10810810810810811,0.9367091438650353,1.0,4/15,3.71%,ITGA6;IGFBP3;ITGAV;IGF1R
prerank,tropomyosin binding (GO:0005523),-0.4932013714119171,-1.3672456340110397,0.10062893081761007,0.3691526782585283,1.0,11/16,35.08%,TMOD3;NEBL;SMTNL2;LMOD3;LMOD1;TNNT2;TMOD4;TNNT1;TNNT3;CALD1;TMOD1
prerank,adenylate cyclase binding (GO:0008179),-0.5582520007544106,-1.3665737693868825,0.12527472527472527,0.36544130530740465,1.0,4/10,6.39%,AKAP6;ADCY2;CALM1;ADCY5
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5527399332442409,-1.3650304943892364,0.14285714285714285,0.36370115861150587,1.0,3/11,5.11%,RPS3;NEIL3;APEX2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5569631391311495,-1.3648420320898709,0.12742980561555076,0.3593127717631136,1.0,6/10,12.92%,GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRA5
prerank,transforming growth factor beta binding (GO:0050431),0.4694831900373818,1.3624461169620694,0.09090909090909091,0.9486427459212909,1.0,4/23,3.63%,TGFBR1;TGFBR2;LTBP4;ITGAV
prerank,syntaxin binding (GO:0019905),-0.35027856212203323,-1.3606272942900735,0.04866180048661801,0.3626696918757658,1.0,14/61,8.09%,STXBP5L;LRRK2;NAPB;SYT1;UNC13C;SNPH;STXBP5;SYT10;SYNPR;CPLX2;SNAP25;SCFD1;DAPK1;PTPN2
prerank,SH2 domain binding (GO:0042169),0.42956929692959755,1.3602658239629903,0.08395522388059702,0.9349788250531897,1.0,6/31,6.18%,PAG1;ARHGAP5;BLNK;LAT2;SRC;AFAP1L2
prerank,cGMP binding (GO:0030553),-0.5480717713175263,-1.3596245515411973,0.11777301927194861,0.360168687880198,1.0,4/11,13.67%,PDE11A;RAPGEF2;PDE10A;PDE2A
prerank,GTPase inhibitor activity (GO:0005095),-0.5200612346289346,-1.3589074985217058,0.12008733624454149,0.35726589230138406,1.0,3/13,1.59%,IQGAP2;IQGAP1;SLIT2
prerank,hyaluronic acid binding (GO:0005540),-0.554702311869423,-1.3583991654008176,0.11363636363636363,0.35393797094420665,1.0,2/10,1.37%,LYVE1;CD44
prerank,metalloexopeptidase activity (GO:0008235),-0.37626146940191235,-1.3571949435919692,0.06278026905829596,0.3517985318996952,1.0,22/51,26.07%,AGBL4;CPQ;MMP16;NPEPPS;AGBL1;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP;AEBP1;VASH2;MMP14;LNPEP;AGBL2;ACE;ACE2;CPXM2;XPNPEP1;CPA2;PEPD
prerank,myosin II binding (GO:0045159),-0.5559490187458329,-1.3553958095944343,0.13320079522862824,0.35109054257320477,1.0,4/10,8.73%,STXBP5L;GSN;STXBP5;SHROOM1
prerank,tubulin binding (GO:0015631),-0.27745134196011645,-1.353695329130898,0.0,0.3501168894023156,1.0,70/295,13.15%,DNM3;UNC5C;LRRK2;KIF5C;AGBL4;CCDC88C;TTLL11;HTT;MAP1B;REEP3;TPPP;KIF1B;MTUS2;MACO1;SYBU;GAS2L3;APC2;RPS3;VAPA;SGIP1;SNPH;EML5;KIF23;MAP2;MID2;TTLL7;RACGAP1;KIF26B;DNM1L;STMN4;ARL4C;NCALD;TOGARAM2;CDK5RAP2;EML1;AGBL1;KIF22;RMDN3;DNM1;TPX2;SAXO2;TTLL5;BIRC5;KIF14;CCDC69;CENPE;PRKN;NUSAP1;KIF5B;CCSAP;MTCL1;DLGAP5;CCDC88A;MAP9;PRC1;TBCA;SPAG5;TTLL12;STMN2;KIF20A;KIF6;VASH2;REEP4;NEFH;KIF18B;IFT81;ALMS1;KIF21A;RAD51D;FAM83D
prerank,methyl-CpG binding (GO:0008327),0.46526493987385364,1.3522671119209817,0.1213235294117647,0.9533926157466425,1.0,6/22,12.42%,ZBTB21;TET3;PRMT1;MBD1;CXXC5;ERH
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.39124812078093496,-1.3480707195481914,0.0831353919239905,0.3565466566549586,1.0,9/38,4.64%,MAGI2;SORBS1;LRRK2;STAP1;NCK2;IRS1;DEDD2;GRIP1;SHANK3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5659301859879733,-1.3452464334001935,0.16149068322981366,0.35761982879111254,1.0,2/10,1.56%,ADARB2;GDA
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.40423026646750154,-1.3445110628272692,0.10114942528735632,0.35474268989175306,1.0,6/32,5.44%,KCNB2;KCNC2;KCNQ5;KCNH1;KCNA6;KCNQ3
prerank,aspartic-type peptidase activity (GO:0070001),0.5819213596933681,1.3423312924483353,0.1326923076923077,0.9810469402301988,1.0,2/10,15.07%,CTSD;CTSE
prerank,carboxylic ester hydrolase activity (GO:0052689),0.35828095283648254,1.3418144386520132,0.0688,0.9594729913130995,1.0,16/85,11.37%,LIPC;DAGLB;ABHD12;PNPLA7;AARS2;PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;PNPLA1;PLB1;PTRH1;ABHD15;PAFAH2;PON2;ABHD6
prerank,receptor tyrosine kinase binding (GO:0030971),0.37962673172005806,1.3390846288071894,0.07130730050933787,0.9506151273739462,1.0,14/56,15.59%,DOCK4;BLNK;PIK3R1;GAB2;PCNA;RNF41;FIZ1;TRADD;FRS2;TOB1;PTPN1;LRP4;ACP4;PITPNM1
prerank,pre-mRNA binding (GO:0036002),0.438601961578416,1.3374100809395286,0.0944741532976827,0.936160757400712,1.0,8/28,14.03%,DDX5;SNRPC;U2AF2;CELF2;RBM24;TRA2B;U2AF1L4;SLU7
prerank,omega peptidase activity (GO:0008242),0.34793629754259037,1.3369179251701726,0.05737704918032787,0.9163414610216017,1.0,20/89,13.03%,USP35;UCHL5;UCHL1;USP8;USP12;OTULIN;OTUD6B;OTUD5;ZRANB1;JOSD2;MYSM1;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;OTUB2;USP9Y
prerank,Wnt-activated receptor activity (GO:0042813),0.5034316053826274,1.3334321986773385,0.13805970149253732,0.913725709464096,1.0,10/15,26.43%,LRP5;RYK;FZD2;FZD6;FZD1;TSPAN12;FZD5;FZD9;FZD3;FZD10
prerank,potassium ion antiporter activity (GO:0022821),0.5045557805000278,1.3327720997384305,0.13568773234200743,0.8970208353453665,1.0,3/15,3.14%,SLC9A9;SLC9A8;SLC24A3
prerank,store-operated calcium channel activity (GO:0015279),-0.559483145603234,-1.332495312304761,0.13655462184873948,0.3732121218232049,1.0,4/10,8.56%,TRPC5;TRPC4;STIM2;TRPC3
prerank,phospholipase inhibitor activity (GO:0004859),-0.548268647005975,-1.330928996537528,0.1261061946902655,0.3720793914743234,1.0,6/10,25.19%,ANXA4;ANXA2;SNCA;ANGPTL3;ANXA1;ANXA5
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.4324724345122407,-1.329288902342549,0.11181434599156118,0.37136162963261715,1.0,10/21,30.82%,FGF10;NPTN;FGF7;FGF9;FGF5;FGF22;KL;FGF16;FGF23;KLB
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.4946401066104877,-1.3246948463374673,0.12093023255813953,0.3764310027695052,1.0,4/14,9.29%,CYBB;NCF2;KMO;CYBA
prerank,anion transmembrane transporter activity (GO:0008509),0.5166450855482887,1.3242095954996926,0.13565891472868216,0.9171945468356031,1.0,2/12,8.64%,SLCO2B1;SLC22A6
prerank,galactosyltransferase activity (GO:0008378),-0.5172379884912527,-1.3180638259572854,0.14730290456431536,0.3843398167721277,1.0,4/11,17.44%,B4GALT5;B4GALT6;B4GALT2;B4GALT7
prerank,carboxy-lyase activity (GO:0016831),0.44400720989676684,1.3165290080022733,0.12430426716141002,0.9351600954787951,1.0,7/23,12.51%,PPCDC;CSAD;GAD1;PISD;FAHD1;BCKDHA;UROD
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.5382034165485762,-1.3164369436587064,0.15268817204301074,0.3836465134083167,1.0,7/11,34.04%,KCNJ3;KCND3;KCNQ1;KCNE3;KCNJ8;KCNE2;KCNH2
prerank,leucine zipper domain binding (GO:0043522),0.5579579469870144,1.3134544755278816,0.14922480620155038,0.930438716432932,1.0,2/10,4.28%,DDIT3;AATF
prerank,histone methyltransferase binding (GO:1990226),-0.5276732959247892,-1.310530757732196,0.17547568710359407,0.3910468519313866,1.0,7/11,25.47%,WIZ;LCORL;LCOR;CBX3;CBX1;CTNNB1;HSP90AB1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.47666804728598444,-1.309302547726261,0.1425438596491228,0.38925486799739467,1.0,4/16,4.80%,CD38;MACROD2;RPS3;NEIL3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4937747920277109,1.3065980882440815,0.15613382899628253,0.945090294864572,1.0,7/15,15.54%,PI4KB;PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,hormone activity (GO:0005179),0.37012009666339096,1.3042249889430462,0.08818635607321132,0.9374313409544915,1.0,18/54,26.06%,NPY;HCRT;GNRH1;PPY;EDN3;EDN2;INHA;METRN;NPFF;VIP;NMB;AGT;PENK;PTHLH;CCL25;NPPC;CHGB;AMH
prerank,ribosomal small subunit binding (GO:0043024),0.48051065229290885,1.3016024227124092,0.15947467166979362,0.9316801720815402,1.0,10/17,26.03%,ABCE1;EIF4H;NME1;MTIF2;EIF1B;EIF1;DHX29;DDX3X;LARP1;CPEB2
prerank,snoRNA binding (GO:0030515),0.41540549682762146,1.297694878923997,0.1307300509337861,0.9315178830816777,1.0,10/30,21.28%,UTP6;TBL3;NOP14;IMP4;NHP2;ISG20;WDR3;NOP56;NUDT16;BYSL
prerank,ubiquitin-specific protease binding (GO:1990381),0.456449542619224,1.2974217728526654,0.137546468401487,0.9149364299799488,1.0,3/19,6.37%,BAG6;SUMO1;SART3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5040642674112366,1.2939086176278423,0.14590747330960854,0.914764906977703,1.0,5/13,14.77%,HSD3B2;DDT;ECI1;ECH1;IDI1
prerank,aminopeptidase activity (GO:0004177),-0.41369193738837395,-1.2918426942047396,0.14027149321266968,0.42076549794869383,1.0,8/26,10.09%,MMP16;NPEPPS;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP
prerank,actin binding (GO:0003779),-0.28516878283662994,-1.2913236472490377,0.049723756906077346,0.4175446222935347,1.0,45/170,18.76%,IQGAP2;EPS8;PDLIM5;DMD;MTSS1;SORBS1;LRRK2;UTRN;MAP1B;GSN;ABLIM1;SYNE2;GAS2L3;PHACTR2;SYNE1;FXYD5;NCALD;PDLIM1;MICAL3;GIPC1;PAWR;PRKN;MSRB1;FHL3;SPTBN4;CCDC88A;ADCY8;PHACTR1;ALKBH4;KLHL2;VASH2;PDLIM4;MYO6;DAG1;SNCA;VPS16;TMSB10;ADD2;PARVG;ITGB1;HPCA;PRKCE;MYRIP;EPS8L2;PARVB
prerank,epidermal growth factor receptor binding (GO:0005154),-0.41474129756614697,-1.289849470199937,0.14222222222222222,0.416326763821744,1.0,10/25,26.51%,HIP1;LINGO1;ERBB4;CCDC88A;FER;FAM83B;ATXN2;SNX2;CNOT9;PLSCR1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5242767529623079,1.2865894682555155,0.15547024952015356,0.9319181558023033,1.0,5/12,9.72%,BLNK;PIK3R1;GAB2;TRADD;FRS2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5384296585291424,1.2857899858561248,0.16570327552986513,0.9192850934297463,1.0,7/11,30.00%,MAP4K2;MAP3K11;TCF3;DUSP19;PPEF2;TRAF6;STK38
prerank,SUMO binding (GO:0032183),0.5033025304589784,1.2851397477573825,0.15355805243445692,0.9064446683950756,1.0,5/13,17.68%,HERC2;UBA2;USP25;SIMC1;RNF4
prerank,translation initiation factor activity (GO:0003743),0.4019805426489705,1.2816472012943938,0.13949579831932774,0.9070034881864217,1.0,16/36,24.63%,EIF4A2;EIF4G1;EIF2B3;EIF2S1;EIF2A;EIF3K;EIF2B4;EIF2S2;EIF3D;EIF2D;EIF1B;EIF5;EIF1;EIF4G2;EIF2B2;EIF3G
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5119271554291397,-1.2812955590290165,0.1789709172259508,0.42997496661615725,1.0,3/11,2.60%,ITPR1;RYR3;RYR2
prerank,nuclear receptor coactivator activity (GO:0030374),0.36849489505142424,1.2785562306487177,0.11092436974789915,0.9055087739582004,1.0,17/52,18.23%,BRD8;ETS1;TACC1;ELK1;CALCOCO1;RBM14;PRKCB;CCDC62;MED4;ZMIZ2;NCOA3;ZMIZ1;CCAR1;KDM1A;RNF4;CARM1;PPRC1
prerank,O-methyltransferase activity (GO:0008171),0.5499485279987029,1.2743681755129594,0.18130841121495328,0.9097406129119161,1.0,4/10,16.33%,COMT;ASMT;BCDIN3D;FTSJ3
prerank,kinase binding (GO:0019900),-0.2510715128844095,-1.27414097934854,0.01195219123505976,0.44040953302815816,1.0,106/434,16.93%,DLG2;IQGAP1;UNC5C;FRMD5;ANK2;CNTLN;CADPS;ATF2;UTRN;SYN1;STAP1;POLA1;BICD1;EGFR;HTT;GSN;SHC3;ATG13;AP2A2;PTPN22;RND3;SNAP91;LATS1;NBEA;PRKAG2;ACSL3;RPS3;FAF1;TAX1BP1;RPS7;USF1;JAK2;CD226;DLG3;SP100;TRIP6;RACGAP1;CCND2;EXOC2;CNKSR2;CALM1;GSK3B;CDK5RAP2;CDC42;BARD1;SKAP1;SLC12A4;DNM1;TPX2;KIF14;TRAP1;PDE8A;PRKN;TNS2;AXIN1;PTPN2;IRGM;ACTB;MOB1B;SMCR8;AURKB;DNAJC3;ABI2;BCAR1;KIF11;SIK1;PRC1;CACUL1;EEF1A2;ADRA2A;BECN1;LRBA;KIF20A;SRCIN1;CSPG4;FBXO7;ARHGAP33;CEBPA;MAP3K13;NEFH;RGCC;MAP2K6;FAM83D;WWC1;CDKN2A;CDKN1A;INKA2;THY1;ACVRL1;PKD1;TEX14;ERCC6L2;TRIP4;PER1;FAM83B;CDC25C;LAX1;NR3C1;FAM83H;TIAM1;PPP1R12A;RCC2;CD3E;NPM1;ADD2;VRK1
prerank,fatty acid synthase activity (GO:0004312),-0.5416667946951514,-1.2733716611103887,0.17960088691796008,0.43761208886219644,1.0,4/10,20.48%,ELOVL7;ELOVL5;CBR4;MCAT
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.48284295841569386,1.2730339659943808,0.1675485008818342,0.9001865139179647,1.0,3/15,9.07%,PLA2G4A;PLA2G4B;PLA2G5
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5296849073280365,-1.271018521365798,0.18599562363238512,0.4384201535313084,1.0,3/10,9.29%,CYBB;NCF2;CYBA
prerank,retinoid binding (GO:0005501),-0.4298680541070059,-1.2703777974640764,0.1444954128440367,0.43557613159458775,1.0,10/22,25.22%,RARA;RBP4;ABCA4;CYP26C1;RBP1;CRABP1;UGT1A1;UGT1A8;UGT1A7;UGT1A4
prerank,calcium ion binding (GO:0005509),-0.2606166062545251,-1.2695726534930292,0.0234375,0.43295546443043875,1.0,69/323,15.29%,KCNIP4;NRXN1;IQGAP1;ADGRL3;KCNIP1;ITPR1;AOAH;SPOCK1;PAM;MCTP2;SLIT2;CDH8;GSN;ANXA4;SYT1;RYR3;RYR2;ITSN1;ASTN2;RAPGEF2;SPARCL1;ATP2A2;SYT10;LETM1;PCLO;S100A11;TPT1;CALM1;CDH22;EML1;RCN3;PKD2;CDH4;FBN1;CDH7;CDH20;RET;RASGRP2;EFCAB11;MICU2;STIM2;SLC25A24;CDH10;PADI4;MMP12;CDH11;CDH13;SRR;MICU3;PLSCR4;PLSCR2;DYSF;CDHR3;TESC;MCTP1;CDH5;ENPP2;CLEC6A;CDH1;GJB2;CHP2;HSPA5;MELK;KCNIP2;ANXA2;S100A1;SYT3;SLC25A12;SNCA
prerank,1-phosphatidylinositol binding (GO:0005545),-0.46707830451951904,-1.263930466277885,0.16985138004246284,0.4405161538961374,1.0,6/15,11.89%,SNAP91;SESTD1;EEA1;SNX9;FRMPD2;EPB41
prerank,microtubule binding (GO:0008017),-0.2661969892445824,-1.2638636602412912,0.026058631921824105,0.43649661855673766,1.0,55/222,13.15%,DNM3;LRRK2;KIF5C;CCDC88C;MAP1B;REEP3;TPPP;KIF1B;MTUS2;MACO1;SYBU;GAS2L3;APC2;RPS3;VAPA;SGIP1;SNPH;EML5;KIF23;MAP2;MID2;RACGAP1;KIF26B;DNM1L;TOGARAM2;CDK5RAP2;EML1;KIF22;RMDN3;DNM1;TPX2;SAXO2;BIRC5;KIF14;CCDC69;CENPE;NUSAP1;KIF5B;CCSAP;MTCL1;DLGAP5;CCDC88A;MAP9;PRC1;SPAG5;KIF20A;KIF6;VASH2;REEP4;CLIP4;NEFH;KIF18B;ALMS1;KIF21A;FAM83D
prerank,damaged DNA binding (GO:0003684),0.3788799697487045,1.2636681496917705,0.1353637901861252,0.928797717161445,1.0,16/44,18.87%,PCNA;CRY2;DDB2;NBN;MPG;ERCC2;CUL4B;FANCG;APTX;DCLRE1B;ERCC4;RAD1;DCLRE1C;HMGB2;NTHL1;DCLRE1A
prerank,GTPase activity (GO:0003924),-0.27233103831143884,-1.2632169565778726,0.039886039886039885,0.43381546467727966,1.0,41/192,12.36%,DNM3;RIT2;LRRK2;RAB3C;GFM2;TPPP;SEPTIN9;RND3;GNAO1;RAB22A;RAB6A;GBP3;ATL2;DNM1L;RAB1B;CDC42;RRAGB;RAB5C;DNM1;GPN2;DNAJC27;RAN;GFM1;SAR1B;IRGM;RAB28;AGAP3;RAB8A;RAB3A;GBP4;RASL12;RHOT2;EEF1A2;TBCC;RERG;HBS1L;GNAI1;RHOU;GBP2;TRIM23;IFT22
prerank,phospholipase A2 activity (GO:0004623),0.41840791840561836,1.254823768396911,0.16579406631762653,0.9557725445146468,1.0,6/26,9.07%,PLA2G4A;PLA2G15;PLA2G6;PLA2G4B;PLB1;PLA2G5
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4749959675288692,-1.2543019329143479,0.18143459915611815,0.44826622989118703,1.0,8/14,31.75%,SPOCK1;SPOCK3;TIMP3;BST2;COL4A3;TIMP4;RARRES1;NGF
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3668090072701608,1.253653818527869,0.14329738058551617,0.9460842868252912,1.0,12/46,10.96%,HEXB;LARGE1;MGAT4A;B3GNT2;POMGNT1;HEXA;GCNT2;RFNG;B3GNT4;MGAT2;MGAT5;MGAT1
prerank,monocarboxylic acid binding (GO:0033293),-0.43531439652604353,-1.253142567978099,0.16331096196868009,0.44672849970488304,1.0,9/18,29.87%,NAPEPLD;RARA;CYP26C1;NR1H4;UGT1A1;UGT1A8;UGT1A7;UGT1A4;AKR1C1
prerank,protein serine/threonine kinase activity (GO:0004674),0.277247632500352,1.2520260234797396,0.045584045584045586,0.9389312887556699,1.0,90/334,19.97%,TGFBR1;NUAK1;TGFBR2;BMP2K;ULK2;CSNK1E;CDKL3;PIM2;MAP4K4;IRAK2;RIPK2;CLK1;RPS6KA1;CAMKK1;CHEK2;PRKCA;PRKACA;CDK9;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;MAP4K3;NEK3;CAMK1D;PTK2B;ULK3;NEK8;RPS6KA5;PDPK1;NRBP1;PKN3;CLK4;VRK3;TSSK4;TSSK6;ARAF;MAP3K8;MTOR;WNK1;NUAK2;GRK2;PRKCB;TRIO;TAF1;MAP4K2;PHKG2;PINK1;MAP3K2;PRKD3;UHMK1;CDK11B;TAOK2;MAP3K10;MAP3K11;MARK2;NEK7;PLK3;LATS2;MAST3;MAPK8;DYRK1A;AKT1;DYRK4;MAPK14;STK39;PASK;MAP2K1;AURKA;ACVR2B;STK35;MASTL;ULK1;CDC42BPB;RPS6KA4;MAPK7;EIF2AK2;VRK2;ROCK2;MAP3K14;MAP4K5;CAMK1;CAMK1G;MAP3K15;EIF2AK3;MARK4;CSNK1G2;WNK3
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.46884462220505485,1.2497036471637748,0.20503597122302158,0.9211435970761493,1.0,6/16,16.86%,ATP6V0B;ATP6V1D;TCIRG1;ATP6V0A2;ATP6V0A4;ATP6V0E2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.46884462220505485,1.2497036471637748,0.20503597122302158,0.9211435970761493,1.0,6/16,16.86%,ATP6V0B;ATP6V1D;TCIRG1;ATP6V0A2;ATP6V0A4;ATP6V0E2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.35169291765453403,1.2496770474150543,0.13310580204778158,0.9077695927684609,1.0,21/57,26.39%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;NDUFS4;NDUFS3;NDUFB3;COX5A;CYB561A3;NDUFA13;CYB561D2;NDUFS5;NDUFV3;NDUFV2;COX6B1;NDUFA9;NDUFC2;COX6A2;NDUFV1;NDUFB4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.42817868891794214,1.2460996804036737,0.19600725952813067,0.9103134484411559,1.0,9/24,18.87%,CAMKK1;MKNK1;CAMK1D;PTK2B;EEF2K;PHKG2;PHKA2;CAMK1;CAMK1G
prerank,chemokine receptor binding (GO:0042379),0.3959118286110115,1.2454964160843571,0.17491166077738515,0.8999161299832769,1.0,4/35,8.81%,CX3CR1;ITCH;CCL3;CXCL1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.43707741141682727,1.2426878681286722,0.19250425894378195,0.8990487787014975,1.0,8/21,11.27%,PJA2;AKAP8;PRKACA;AKAP8L;AKAP5;AKAP14;ACBD3;PRRC1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3755352898106795,-1.2419381990345773,0.16666666666666666,0.46669923742863306,1.0,13/31,23.89%,KCNK10;HCN1;SLC12A8;SLC12A4;PKD2;SLC12A5;TMEM38B;TMEM38A;SLC12A1;KCNK5;AQP1;SLC12A3;KCNA1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5121587779023765,-1.2404104453084828,0.21855670103092784,0.46606426144226865,1.0,6/10,33.20%,SLC10A6;SLC6A1;SLC6A12;SLC6A13;SLC10A2;SLC10A1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4192187745628394,-1.2385920350200212,0.19821826280623608,0.4656985780256566,1.0,10/22,25.09%,HCN1;SCN2A;SCN3A;PKD2;HCN2;SCN9A;CACNA1G;SCN1A;HCN4;HCN3
prerank,NAD binding (GO:0051287),0.4162623191670917,1.2376678093139792,0.1741472172351885,0.9085071306457652,1.0,7/26,14.73%,QDPR;SIRT2;HPGD;ALDH1B1;SORD;NNT;CRYL1
prerank,clathrin adaptor activity (GO:0035615),-0.4576612209195466,-1.23740839889716,0.19212962962962962,0.46415232324753725,1.0,7/15,18.67%,DAB2;HIP1;AP2A2;AP1M1;AP2B1;AP1G2;STON2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5252424064368244,1.237367455031926,0.20662768031189083,0.8975056869024001,1.0,5/11,17.80%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.4105170248704862,-1.2371977442451725,0.2,0.4606510251106198,1.0,6/21,30.52%,GRIK2;CHRNA4;P2RX1;CHRNB2;CHRNA9;CHRNB4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4801081803316172,-1.2298923448691568,0.1963470319634703,0.47200594685415564,1.0,6/12,24.73%,TENT5A;PAPOLA;TENT2;TUT1;PAPOLG;PAPOLB
prerank,kinase activity (GO:0016301),0.3067025699153106,1.2291085961756305,0.10967741935483871,0.9198517238551193,1.0,31/109,16.75%,PI4KB;MAP4K4;LYN;CSNK2A1;PIK3CG;DGKK;CCL3;PANK4;PIK3C3;DGKD;PGK1;GK5;PIK3CD;CHKB;CKB;PSTK;PIK3CB;MTOR;CERK;PANK2;TAF1;PINK1;PRKD3;ABL1;PAPSS1;AKT1;NADK2;STK39;FCSK;MASTL;DCAKD
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.41953764969552565,1.2263857983298576,0.18525179856115107,0.9189209741121215,1.0,9/25,16.74%,ADAP2;DAPP1;GAB2;ARAP3;PLEK;PLEKHA4;HIP1R;AKT1;FCHSD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3465898654263665,1.2256337221178188,0.17010309278350516,0.9099760375202619,1.0,15/54,16.98%,TGM2;SIRT2;HDAC10;SUDS3;VNN1;ACER3;ACER2;ASAH1;AMDHD2;NIT2;PM20D2;HDAC5;NTAN1;ASPG;HDAC8
prerank,protein kinase C binding (GO:0005080),0.3726779414095381,1.2211601550513593,0.17540687160940324,0.9173474682972327,1.0,14/43,15.13%,TWF2;PRKCSH;DSP;PLEK;ITGAV;ADCY4;PRKCB;TOP2B;ADCY6;TRPV4;ABL1;DACT3;HDAC5;PICK1
prerank,cytochrome-c oxidase activity (GO:0004129),0.46080459634963555,1.2175830863947588,0.21828358208955223,0.9206761682858727,1.0,8/15,34.78%,COX7A2L;COX8A;COX5A;COX6B1;COX6A2;COX6A1;CYB5A;COX10
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5148002987868884,1.2080963119841106,0.22960151802656548,0.9508763628556007,1.0,2/10,4.84%,CFLAR;CASP1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5037338321538151,1.2065676004098715,0.2215909090909091,0.945395027778766,1.0,8/11,32.54%,CTC1;TERF1;HNRNPA2B1;HNRNPA1;STN1;RPA1;TERF2;RPA2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.40292665965153174,-1.2062059292323821,0.20601851851851852,0.519812311221227,1.0,8/23,16.05%,PLCB1;CCR1;PLCH1;CHRM3;PLCB4;PLCH2;CCL5;PLCD1
prerank,DNA binding (GO:0003677),0.25146650304990764,1.2023042941969195,0.02586206896551724,0.9517000951279898,1.0,195/694,24.46%,IKZF1;ARID3B;ETV5;MLXIPL;SMAD3;DENND4A;DNMT3A;ETS1;QRICH1;NFE2L2;GTF3C2;DDIT3;CEBPZ;LYL1;SOX8;FLI1;COLEC11;POLR2H;SRRT;PCNA;PPARD;FOXE1;KMT2D;CDK9;RAD51AP2;CRY2;DDB2;FAM111A;MAU2;NKX2-8;EGR1;ZCCHC3;NBN;ERF;PAX6;REXO4;MEIS3;CTC1;CUX1;WDR48;ZBTB21;MPG;SLPI;CHD8;CALCOCO1;MYCL;RNF138;MLX;TAF12;JRK;POLR2D;FOXK2;ZBTB18;PCBP2;ILF2;MCM2;DHX9;TAF6L;RAD51B;TAF6;ERCC2;KDM5B;SWSAP1;THAP1;CGAS;EGR2;NLRP3;SLTM;CUL4B;CHTF18;ZMYND11;CNBP;TAL2;ALX4;ZBTB32;TIGD3;POU4F1;KLF12;CHD3;PATZ1;JUN;HMGN1;NR2F1;MBD1;C1D;MEF2A;CXXC5;SMARCA5;E2F2;NUP35;BRCA1;FANCG;APTX;PAX2;IMPDH1;TBX6;NFYA;SMARCA2;DCLRE1B;TAF1;GTF3C6;LIN9;EXO1;ERCC4;RAD1;RLF;SSBP1;CEBPG;ARNT;TARDBP;DCLRE1C;TERF1;ABL1;ZNF3;TAF4;HP1BP3;SAFB;ZNF292;BLM;CSRNP2;PRDM2;PROX1;TCF7L1;TCF3;POU2F2;SPTY2D1;POLG2;DNASE2;RNF11;AIM2;NABP1;IRF3;POU2F1;RNF4;RFC1;GATA3;HMGB2;CUX2;NTHL1;ARID1A;TOP3A;IRF2;FBH1;KHDRBS1;DCLRE1A;E2F3;MCM3;NR1H2;PALB2;REPIN1;XRCC6;TSNAX;PRDM9;SAP30L;TSN;TOPORS;PARP4;GZF1;ZNF513;MCMDC2;PLAGL2;MAPT;KDM5A;TSG101;DNTTIP1;ZC3H12A;HDGF;IRX1;DDX3X;RPA3;ZFPL1;ZBTB6;SAFB2;PARK7;KDM2B;HDGFL2;MBD6;RC3H2;SCRT1;GLYR1;SYCP2;SPRTN;TFAP4;YY1;MTERF2;SMARCA4;TP53;RTF2;RAD51C;HNRNPA1;SOX9;OTP;WDR76;RAD23B;PCID2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.46151451839346647,1.2020710072316374,0.19963031423290203,0.9409628228329272,1.0,4/16,8.74%,SLC7A8;SLC25A42;SLC22A2;SLC29A4
prerank,metal ion binding (GO:0046872),-0.23760381010429027,-1.1963567942908517,0.04090909090909091,0.5379194758694245,1.0,97/477,15.29%,KCNIP4;NRXN1;IQGAP1;ADGRL3;LRRK2;KCNIP1;ITPR1;AOAH;SPOCK1;NLRC4;PAM;MCTP2;SLIT2;CDH8;GSN;ANXA4;TPPP;PAPOLA;ADCY2;SYT1;RYR3;GSS;RYR2;ITSN1;ERN1;ASTN2;RAPGEF2;LATS1;TOP2A;PPA1;SPARCL1;ATP2A2;ACVR1C;APOE;STK26;SYT10;SIK3;LETM1;PCLO;S100A11;TPT1;CALM1;CDH22;EML1;RCN3;PKD2;CDH4;FBN1;CDH7;CDH20;RET;RAN;HMGCLL1;POSTN;RASGRP2;EFCAB11;YDJC;MICU2;STIM2;SLC25A24;CDH10;CDC42BPA;PADI4;NLK;MMP12;CDH11;SIK1;CDH13;NUDT3;SRR;MICU3;GNAI1;PLSCR4;PLSCR2;DYSF;CDHR3;TESC;MCTP1;CDH5;GEN1;ENPP2;CLEC6A;EYA2;CDH1;FIGNL1;PDE2A;GJB2;CHP2;HSPA5;CDC42BPG;MELK;KCNIP2;ANXA2;S100A1;SYT3;SLC25A12;SNCA
prerank,ATPase activator activity (GO:0001671),-0.39995736950387384,-1.1957030947184515,0.23198198198198197,0.5347773956156898,1.0,6/20,13.99%,DNAJA2;DNAJC15;DNAJB4;ATP1B3;TOR1AIP2;MYBPC3
prerank,cation channel activity (GO:0005261),-0.2841561676003139,-1.195278742558486,0.11290322580645161,0.531167880651222,1.0,25/94,18.47%,KCNK10;CACNA1E;UNC80;HCN1;MCU;TRPC5;TMEM63C;RYR2;NALCN;TRPM3;SLC24A2;PKD2;TRPC3;ANO6;TMEM38B;CALHM6;TMEM38A;PANX1;ANO10;PKD1;ANXA2;ASIC3;TRPV6;TRPV3;PIEZO2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.49602773637852143,1.1935142765804545,0.22932330827067668,0.965383025700725,1.0,2/10,8.64%,SLCO2B1;SLC22A6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.27858175924093764,1.1928051831353785,0.11982248520710059,0.9573642594640598,1.0,32/188,12.07%,ETV5;BASP1;SMAD3;ETS1;NFE2L2;DDIT3;MEF2C;FLI1;KMT2D;KLF11;CRY2;EGR1;PAX6;ELK1;ATMIN;TFE3;ZNF568;CALCOCO1;CREB3L2;FOXK2;BCOR;ATF3;DHX9;EGR2;SOX17;CHD3;JUN;BRCA1;PAX2;NFYA;SMARCA2;RUNX1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.49510110730494533,1.1921365892762408,0.23929961089494164,0.9492241649700804,1.0,5/12,17.80%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,ephrin receptor binding (GO:0046875),0.41926119286096547,1.1920469643554614,0.22580645161290322,0.9386632975231807,1.0,9/21,24.34%,LYN;SRC;PIK3CG;PTPN1;ABL1;EFNB1;EFNA1;EFNA3;EFNA2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.26157088846188664,1.1901093841217854,0.07272727272727272,0.9368482436461669,1.0,86/346,20.91%,HERC2;RNF38;TRIM69;RNF216;SEL1L;PJA2;FBXO22;SMURF1;ITCH;TRIM11;TRIM5;DDB2;NEURL1B;NEURL3;UBA7;FBXO24;RNF41;TRAF5;TRIM36;UBE2H;RNF138;RFFL;BCOR;HLTF;RNF141;TRIM44;MAEA;TRIM72;AKTIP;TRIM45;CDC34;CUL4B;ZFP91;DTX4;ASB4;RNF8;RNF103;RNF31;MSL2;BFAR;RNF20;RNF25;MYLIP;DTX1;AREL1;RNF166;BRCA1;MIB2;TAF1;UHRF2;RNFT2;TRIM62;UBE2U;RNF187;ZNRF3;WWP2;FBXO21;UBE3A;RNF7;MKRN3;FBXL22;ANKRD39;RNF144B;DTX3;XIAP;FBXO11;RNF11;ANAPC11;DTX3L;PELI2;UBE2A;RNF4;TNFAIP1;TRIM47;RNF214;STUB1;CUL4A;MGRN1;RNF2;RNF123;TRIM3;UBE2T;TOPORS;RNF121;TRAF7;SYVN1
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.407346427276149,-1.1858551642923143,0.21052631578947367,0.5485729642102527,1.0,6/19,13.89%,NRG3;GRM5;ERCC6;ERBB3;EFNA5;CCL5
prerank,peptide hormone receptor binding (GO:0051428),0.4914616916347899,1.1854130946974284,0.23809523809523808,0.9464419473924743,1.0,3/11,22.72%,GNRH1;VIP;PTHLH
prerank,dynactin binding (GO:0034452),-0.4631262634759463,-1.1845014363765836,0.24786324786324787,0.5471091657168481,1.0,3/12,5.38%,BICD1;HTT;GSK3B
prerank,ribonuclease activity (GO:0004540),0.33263950193642267,1.1844128222320434,0.20627062706270627,0.9398979521494855,1.0,20/56,23.51%,RNASE1;YBEY;INTS11;DIS3L2;PIWIL1;RCL1;KHNYN;RNASE6;ZC3H12C;EXOSC10;EXOSC5;ZC3H12B;ELAC2;EXOSC8;TSNAX;SND1;RNASEH1;ZC3H12A;EXOG;AGO1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4827685493810979,1.1823964345145292,0.2475442043222004,0.9375224288756844,1.0,2/12,3.02%,SLC9A9;SLC9A8
prerank,cadherin binding (GO:0045296),-0.2422036868155375,-1.1819746827738153,0.06563706563706563,0.5488493834621132,1.0,48/315,8.64%,CTNND2;AHNAK;PDLIM5;CTNNA2;ANK3;CTNNA3;IQGAP1;SPTBN1;CTNNA1;PTPRT;EGFR;CDH8;DIAPH3;SEPTIN9;CTTN;SLK;TMOD3;TRPC4;LRRFIP1;YWHAE;PRDX1;VAPA;EHD1;PUF60;FXYD5;RPS2;AFDN;S100A11;CDH22;PDLIM1;RPL7A;CAST;TBC1D2;RTN4;STXBP6;CDH4;BAG3;GIPC1;CDH7;CDH20;CNN2;PKP4;EIF3E;RAN;SPTBN2;SNX9;KIF5B;CDH10
prerank,lipoprotein particle receptor binding (GO:0070325),0.38690494575568374,1.1769427630262381,0.23,0.9496988248087455,1.0,7/27,14.29%,PICALM;AP2A1;CLU;MESD;LRP1;ANKRA2;LDLRAP1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4411846263184206,-1.1763242656649133,0.24503311258278146,0.558320888216041,1.0,6/14,22.32%,SLC25A30;SLC26A7;SLC26A2;SLC26A8;SLC26A3;SLC26A4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.41635482525293205,1.176172345086621,0.24314442413162707,0.9426326875599881,1.0,4/20,9.86%,SENP2;OTUD5;USP25;OTULINL
prerank,motor activity (GO:0003774),-0.31039467070686483,-1.175967493360177,0.17892156862745098,0.5546088037214288,1.0,20/60,13.79%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;DNAH8;KIF22;DNAH2;KIF14;CENPE;KIF5B;KIF11;DYNLRB1;APPBP2;KIF20A;KIF6;DNAH3;KIF18B;KIF21A;MYO6
prerank,P-type ion transporter activity (GO:0015662),-0.4638206676252944,-1.174672318976828,0.26824034334763946,0.5529454516122527,1.0,4/12,10.26%,ATP2B1;ATP2A2;ATP7A;ATP2A3
prerank,single-stranded DNA binding (GO:0003697),0.30199194940214374,1.1713456494328338,0.1702127659574468,0.9538101664889519,1.0,37/93,26.28%,POLR2H;RAD51AP2;CRY2;FAM111A;REXO4;CTC1;WDR48;RNF138;POLR2D;PCBP2;MCM2;DHX9;RAD51B;SWSAP1;POU4F1;NUP35;APTX;ERCC4;SSBP1;BLM;NABP1;HMGB2;TOP3A;FBH1;MCM3;MCMDC2;MAPT;RPA3;PARK7;SPRTN;HNRNPA1;RAD23B;STN1;LONP1;RADX;MCM6;TDP1
prerank,poly-purine tract binding (GO:0070717),-0.3725014195311737,-1.170023929953583,0.24945295404814005,0.5598332579517923,1.0,6/27,8.21%,RBMS1;KHDRBS2;RBMS3;EIF4A3;PABPC1;ELAVL4
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.31955142890215643,-1.1692131162219503,0.21705426356589147,0.5573262612374505,1.0,21/49,28.42%,MCTP2;ANXA4;SYT1;SYT10;PCLO;CPNE8;CPNE4;DYSF;MCTP1;ANXA2;SYT3;CPNE2;CPNE6;DOC2B;ANXA1;SYT5;ANXA8;ANXA5;C2CD5;PLA2G4C;SYT8
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4959235117830566,1.1687408131147776,0.2928709055876686,0.9542947883463612,1.0,6/10,15.54%,PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.48137067112157783,1.1662293883821206,0.28383458646616544,0.9547897537859888,1.0,4/11,21.68%,CFLAR;CASP1;PYCARD;CASP12
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.42344480218028013,1.1613561235816245,0.27140255009107467,0.9653489755150382,1.0,5/18,19.19%,PIK3R1;SOCS6;AGAP2;PIK3R3;WDR81
prerank,UDP-glycosyltransferase activity (GO:0008194),0.31293506834551355,1.159419763153551,0.1910828025477707,0.9639087483737575,1.0,14/70,12.50%,HEXB;LARGE1;MGAT4A;XXYLT1;B3GNT2;POMGNT1;HEXA;GCNT2;RFNG;B3GNT4;CHPF;CHPF2;B4GALNT1;GXYLT2
prerank,small GTPase binding (GO:0031267),0.27568922009047564,1.158511838974852,0.15870570107858242,0.958106174565611,1.0,43/169,17.78%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;KIF3B;PICALM;MLPH;TBC1D7;CDC42EP2;GOLGA5;CYRIB;RANBP2;PIH1D2;RNF41;RHOH;ARFIP2;SGSM2;RAB3GAP2;RAB3GAP1;PPP6R1;GOLGA4;AKAP13;RABGGTA;RAB34;CYFIP1;FGD3;MYO5B;IFT20;GCC1;OPTN;TBC1D30;SOD1;CIB1;PDE6D;RABGEF1;TNPO3;KIF3A;ULK1;SGSM3;GGA3;TNFAIP1;LZTR1
prerank,neuropeptide hormone activity (GO:0005184),0.3964380806200172,1.1564259803499017,0.28426395939086296,0.9573301085350412,1.0,7/22,19.48%,NPY;HCRT;PPY;NPFF;VIP;NMB;PENK
prerank,receptor antagonist activity (GO:0048019),0.4292644623031737,1.155034186492207,0.27071823204419887,0.9538076479289188,1.0,6/17,24.19%,AGTR2;IL18BP;FST;DKK3;PXDN;LRPAP1
prerank,microtubule plus-end binding (GO:0051010),0.4084895312778321,1.1549096665593002,0.27915869980879543,0.9448278218762899,1.0,6/20,21.81%,DST;NUMA1;CLIP3;MAPRE1;CLIP2;TTBK2
prerank,estrogen receptor binding (GO:0030331),0.3723778730290952,1.1548314442610328,0.26071428571428573,0.9359666624906077,1.0,10/32,15.73%,PRMT2;CNOT1;PHB2;TACC1;PADI2;PPID;MMS19;CCDC62;DDX54;NRIP1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.3330676613430036,-1.152472996545826,0.23146067415730337,0.5945107586443902,1.0,7/37,8.54%,CACNA2D3;CACNA1E;CACNG2;CACNA1C;PKD2;OPRM1;CACHD1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3650996358018838,1.1521447593441383,0.23752151462994836,0.9282240787885495,1.0,14/34,26.39%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFC2;NDUFV1;NDUFB4
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3650996358018838,1.1521447593441383,0.23752151462994836,0.9282240787885495,1.0,14/34,26.39%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFC2;NDUFV1;NDUFB4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4289219219892441,1.1521377887081363,0.2761904761904762,0.9194024388384255,1.0,2/16,3.00%,ALOXE3;BCO2
prerank,neurexin family protein binding (GO:0042043),-0.47887253681585973,-1.1515528274861315,0.3070539419087137,0.5923817031815476,1.0,1/10,0.13%,NLGN1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3613592148915074,-1.1509673882230824,0.2290249433106576,0.5892377134920844,1.0,12/27,25.11%,SLC25A30;GET3;SLC26A7;XPR1;SLC26A2;SLC22A8;SLC26A8;SLC26A3;SLC4A1;SLC26A4;SLC5A5;ANO1
prerank,NF-kappaB binding (GO:0051059),-0.3734308880493567,-1.147307205091392,0.26359832635983266,0.5937424971689681,1.0,9/24,18.31%,ANXA4;FAF1;GSK3B;NFKBIA;TAF4B;CDKN2A;NPM1;FOXP3;CDK5RAP3
prerank,nucleotidyltransferase activity (GO:0016779),-0.4049880057752704,-1.146572451723279,0.289044289044289,0.5911126581713808,1.0,7/19,19.57%,CRPPA;PAPSS2;TUT4;TENT2;DNTT;TUT1;TERT
prerank,protease binding (GO:0002020),0.28878056392172896,1.145905723078034,0.1970684039087948,0.9353299352469763,1.0,19/99,15.11%,BIN1;BAG6;CST3;SUMO1;CFLAR;CRADD;RIPK2;ITGAV;UBC;RFFL;SART3;NFRKB;ADAMTS4;BFAR;SERPINE1;PINK1;INSL3;PYCARD;ANXA9
prerank,retinoid X receptor binding (GO:0046965),-0.4616620710522733,-1.144748528008873,0.267223382045929,0.5911911198270333,1.0,4/11,10.13%,PPARG;NR4A2;RARG;NSD1
prerank,RNA polymerase binding (GO:0070063),0.42229560757195145,1.1444860116229085,0.30978260869565216,0.9325080327333917,1.0,5/18,10.88%,BIN1;PHRF1;DHX9;PABPN1;BRCA1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.47449116422316917,1.1436486922394444,0.3041825095057034,0.9273437151424068,1.0,4/11,17.70%,SLC5A11;SLC5A3;SLC23A2;SLC23A1
prerank,peptidase inhibitor activity (GO:0030414),0.3606299414341735,1.141241932958064,0.27378964941569284,0.9289624922186485,1.0,4/33,4.96%,CST3;UCHL5;PROS1;SLPI
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.24542909972274707,1.140743557364213,0.12385919165580182,0.9222030966750968,1.0,99/431,18.84%,TGFBR1;DNM2;TWF2;ABCD2;TUBA4A;MYO1B;RAC1;GUK1;MAP4K4;MYO1F;RND1;TRNT1;TGM2;ABCF3;ARL5C;UBA2;TBCK;PFKL;NEK6;RHOQ;MYH9;RHOB;MKNK1;RHOBTB1;TAP2;AARS2;MAP4K3;EIF4G1;FICD;CHD8;CARS2;TUBB;TUBB1;KSR1;RND2;RPS6KA5;TUBG1;RHOH;ARFIP2;RAB4A;DHX9;ABCB8;HSPA4;PGK1;ABCE1;SARS2;TSSK4;TSSK6;RRAS2;RAB39A;WNK1;NUAK2;PDK2;SMARCA5;TUBA8;GBP6;PEX6;MAP4K2;PINK1;RAB35;RRAD;NMUR2;UHMK1;CDK11B;TUBA1A;AGAP2;MARK2;PRPS1L1;PRPS1;ABL1;PXK;ABCF1;DIRAS2;LATS2;SCG5;BLM;AKT1;NDUFA13;RRAGA;RAB32;NVL;ARL3;HSPA13;DARS2;RAB27A;GBP5;CDC42BPB;MRAS;RPS6KA4;ATP5F1D;TRIB1;RAB13;NME1;ARL11;GNL1;GBP7;MAP4K5;PEX1;P2RX5
prerank,receptor ligand activity (GO:0048018),0.2588964908604218,1.139582365500146,0.16338028169014085,0.9182031731578579,1.0,42/245,15.89%,IL18;GREM1;SLURP1;SEMA3B;OSGIN2;SEMA4C;ARTN;CCL3;NPY;SEMA4G;TNFSF13B;VEGFB;GNRH1;SHH;PDGFB;PPY;WNT2B;EDN3;WNT10B;CNTF;AMBN;LEFTY1;EDN2;GDNF;IL12B;SEMA3G;CTF1;CXCL1;INHA;JAG2;WNT7B;CSPG5;IL33;OSGIN1;METRN;SEMA4D;IL34;CSF1;VIP;NMB;GPNMB;OSM
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.401460984490174,1.137959238519435,0.29038112522686027,0.9163485536234387,1.0,4/20,12.74%,SLC30A5;SLC30A10;SLC30A8;SLC39A2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.39280009047634096,1.1378991129063802,0.28,0.9084638274173221,1.0,6/22,14.29%,PICALM;AP2A1;CLU;MESD;ANKRA2;LDLRAP1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.42769286605933704,1.1353257149398912,0.3025830258302583,0.9103826800255864,1.0,8/15,28.32%,KMT2D;CXXC1;SETD4;PRDM9;SETD3;KMT2B;WDR5;KMT2A
prerank,calcium channel activity (GO:0005262),-0.2763244091506143,-1.1347534274396949,0.19592875318066158,0.6124129147563118,1.0,14/84,8.56%,CACNA2D3;CACNA1E;MCU;TRPC5;RYR2;TRPC4;SLC24A2;CACNG2;CACNA1C;PKD2;OPRM1;STIM2;CACHD1;TRPC3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3926985328243146,1.1340347761312917,0.2978723404255319,0.9072866137928276,1.0,6/22,11.63%,ATP6V0B;ATP2C1;ATP6V1D;TCIRG1;ATP6V0A2;ATP6V0A4
prerank,retinoic acid binding (GO:0001972),-0.4539911916311982,-1.1327465914141353,0.32293986636971045,0.6130126678332934,1.0,6/12,25.22%,RARA;CYP26C1;UGT1A1;UGT1A8;UGT1A7;UGT1A4
prerank,sulfotransferase activity (GO:0008146),0.3600725944580517,1.1322872068725771,0.25426621160409557,0.9060696126397111,1.0,7/33,10.49%,CHST11;GAL3ST4;TPST2;CHST1;SULT2A1;HS3ST3A1;CHST7
prerank,exonuclease activity (GO:0004527),0.3322429730987118,1.131809787572689,0.2600671140939597,0.9003106774807507,1.0,16/46,23.25%,DXO;REXO4;REXO5;REXO2;DCLRE1B;EXO1;RAD1;DCLRE1C;ISG20L2;EXOSC10;EXOSC5;ISG20;EXOSC8;RAD9A;ZC3H12A;EXOG
prerank,snRNA binding (GO:0017069),0.3371028392604472,1.1296075274436104,0.2585034013605442,0.900951621000225,1.0,7/42,6.61%,SNRNP70;SNRPA;CDK9;SNRPC;COIL;SART3;SNRPA1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.39665195146773574,1.1288160044117743,0.3111888111888112,0.896267419046426,1.0,5/20,8.94%,LPCAT2;DGAT1;PLA2G15;MOGAT1;MOGAT2
prerank,translation elongation factor activity (GO:0003746),-0.4208440208880385,-1.1285607527373316,0.2835164835164835,0.6190130421080893,1.0,5/14,13.98%,GFM2;GFM1;EEF1A2;EIF5A;EIF5AL1
prerank,sodium channel regulator activity (GO:0017080),-0.3238922245552273,-1.1276681600997356,0.24597701149425288,0.616919840210619,1.0,7/37,8.47%,FGF14;FGF12;NEDD4L;FXYD5;PTPN3;SGK2;FGF11
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.35927992271287307,1.1266137897616215,0.26595744680851063,0.897061499595899,1.0,13/32,24.83%,PHYHD1;PHYH;EGLN1;TET3;JMJD7;KDM4A;ALKBH5;KDM8;TYW5;KDM7A;KDM2A;KDM2B;PHF8
prerank,kinase activator activity (GO:0019209),0.35678387675277196,1.1260711019020915,0.2893772893772894,0.8917690305856916,1.0,8/30,13.12%,FGF13;STRADA;RPTOR;GPRC5A;NCKAP1L;WNK1;AGAP2;MARK2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.45618522613948637,1.1227050970182793,0.3303249097472924,0.8971866921573743,1.0,4/12,17.33%,YWHAH;PIK3R1;GNAS;ARRB1
prerank,steroid hydroxylase activity (GO:0008395),0.4208252446089021,1.1217642992556043,0.29528985507246375,0.8932725832572634,1.0,5/16,18.45%,CH25H;CYP46A1;CYP7B1;CYP2R1;CYP2A6
prerank,GTPase binding (GO:0051020),0.2619074790584389,1.1203506102568015,0.21013412816691504,0.8914049711718338,1.0,48/194,17.78%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;KIF3B;PICALM;MLPH;TBC1D7;CDC42EP2;GOLGA5;CYRIB;RANBP2;ATG14;PIH1D2;RNF41;RHOH;ARFIP2;SGSM2;RAB3GAP2;RAB3GAP1;PPP6R1;GOLGA4;AKAP13;RABGGTA;RAB34;CYFIP1;RASIP1;FGD3;MYO5B;IFT20;GCC1;OPTN;TBC1D30;SOD1;GNB2;CIB1;PDE6D;RABGEF1;IARS1;TNPO3;KIF3A;ULK1;EPRS1;SGSM3;GGA3;TNFAIP1;LZTR1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.23432089916013615,-1.1191497668468193,0.17275747508305647,0.6340277954349974,1.0,48/248,12.73%,DNM3;RIT2;LRRK2;RAB3C;GFM2;ATP2B1;TPPP;SEPTIN9;RND3;ATAD1;GNAO1;RAB22A;CLPX;RAB6A;VWA8;GBP3;ATL2;DNM1L;RAB1B;CDC42;RRAGB;RAB5C;DNM1;GPN2;TOR1A;DNAJC27;KIF14;RAN;GFM1;SAR1B;IRGM;RAB28;AGAP3;RAB8A;RAB3A;GBP4;RASL12;RHOT2;EEF1A2;TBCC;RERG;HBS1L;GNAI1;RHOU;GBP2;TRIM23;IFT22;KIF18B
prerank,thioesterase binding (GO:0031996),0.46860100051336806,1.118920297102249,0.344,0.8898248895711447,1.0,3/11,7.35%,RAC1;TRAF5;HAUS7
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.44551780921806944,-1.1187501847466048,0.32983193277310924,0.6305427980106789,1.0,6/11,38.88%,PPP1R14C;PABIR1;PPP1R17;PPP1R14A;PPP1R8;PPP1R11
prerank,pentosyltransferase activity (GO:0016763),0.34406623050030916,1.118327300708685,0.2958477508650519,0.8848695827291182,1.0,6/36,8.33%,LARGE1;QTRT1;SIRT2;ART4;PNP;UPP1
prerank,ATP binding (GO:0005524),0.25230711638535624,1.1132944624861834,0.18803418803418803,0.8959916135586617,1.0,59/266,17.17%,TGFBR1;TWF2;ABCD2;MYO1B;GUK1;MAP4K4;MYO1F;TRNT1;ABCF3;UBA2;TBCK;PFKL;NEK6;MYH9;MKNK1;TAP2;AARS2;MAP4K3;EIF4G1;FICD;CHD8;CARS2;KSR1;RPS6KA5;DHX9;ABCB8;HSPA4;PGK1;ABCE1;SARS2;TSSK4;TSSK6;WNK1;NUAK2;PDK2;SMARCA5;PEX6;MAP4K2;PINK1;UHMK1;CDK11B;AGAP2;MARK2;PRPS1L1;PRPS1;ABL1;PXK;ABCF1;LATS2;BLM;AKT1;NDUFA13;NVL;HSPA13;DARS2;CDC42BPB;RPS6KA4;ATP5F1D;TRIB1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.34678993215048715,1.1105473884316737,0.3080895008605852,0.8985223627962773,1.0,11/35,17.81%,CLK1;LYN;SRC;PTK2B;CSK;PKDCC;ABL1;BMX;DYRK1A;TEC;FES
prerank,protein heterodimerization activity (GO:0046982),-0.24222756057055345,-1.109350236532502,0.17559523809523808,0.6509941000740372,1.0,32/178,11.90%,HIP1;KCNB2;TENM3;CYBB;ADRA1A;EXT1;NPAS3;TENM2;GABBR2;YWHAE;TOP2A;VAPA;USF1;TAF7;MIGA1;NR4A2;BARD1;SDCBP;PSMF1;UBA3;RAN;MICU2;TENM4;ERBB3;CYBA;BAK1;ADCY8;ADRA2A;PPP2R1A;ATP1A1;AHR;FBXO7
prerank,protein kinase binding (GO:0019901),-0.21673307896893707,-1.107680689372236,0.08333333333333333,0.6507019616138274,1.0,113/479,18.03%,PDLIM5;NEDD9;IQGAP1;UNC5C;FRMD5;ANK2;CNTLN;BANK1;CADPS;ATF2;GRM5;GRK5;UTRN;SYN1;STAP1;POLA1;BICD1;SHC3;IRS1;ATG13;AP2A2;RYR2;RND3;SNAP91;PKIA;LATS1;NBEA;PRKAG2;TOP2A;ACSL3;RPS3;FAF1;RPS7;USF1;JAK2;CD226;RACGAP1;CCND2;EXOC2;CNKSR2;CALM1;GSK3B;CDK5RAP2;CDC42;SKAP1;SLC12A4;DNM1;HINT1;TPX2;KIF14;MAPKAPK5;TRAP1;PRKN;SIRT1;AXIN1;PTPN2;IRGM;DUSP10;ACTB;SMCR8;DNAJC3;BCAR1;KIF11;CCDC88A;SIK1;PRC1;CACUL1;RARA;EEF1A2;ADRA2A;BECN1;LRBA;KIF20A;SRCIN1;CSPG4;FBXO7;ARHGAP33;MAP3K13;CDH5;DUSP16;NEFH;RGCC;MAP2K6;FAM83D;KCNQ1;CDKN2A;CDKN1A;INKA2;THY1;DACT2;ACVRL1;PKD1;TEX14;ERCC6L2;TRIP4;FAM83B;CDC25C;LAX1;NR3C1;FAM83H;PPP1R12A;RCC2;CD3E;NPM1;ADD2;VRK1;ITGB1;CCNB1;TFRC;MSN;SPDYA;GSTP1;DUSP2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4468751017842377,1.1060273363148947,0.34296724470134876,0.9082388726829503,1.0,6/12,15.54%,PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,PDZ domain binding (GO:0030165),-0.29084980867373594,-1.1016976072222138,0.28640776699029125,0.6617711674471196,1.0,10/61,7.58%,NLGN1;GRID2;CCDC88C;GRIA1;ATP2B1;PLEKHA1;RAPGEF2;KIDINS220;KIF14;PRKN
prerank,metal ion:proton antiporter activity (GO:0051139),0.4384337275424152,1.1009627756173022,0.3416506717850288,0.919975491969006,1.0,2/13,3.02%,SLC9A9;SLC9A8
prerank,adrenergic receptor binding (GO:0031690),-0.3929098909147903,-1.1007463873705976,0.31956521739130433,0.6597626193605141,1.0,5/16,10.54%,MAGI2;PDE4D;RAPGEF2;ARRDC3;ADRA2A
prerank,exopeptidase activity (GO:0008238),-0.3016258659434071,-1.0994667597416434,0.30935251798561153,0.6584913404854571,1.0,9/50,10.09%,DPP6;DPP10;DPP4;NPEPPS;MME;XPNPEP3;TRHDE;ENPEP;ANPEP
prerank,ubiquitin binding (GO:0043130),0.29177546465024834,1.0966492244480905,0.2620232172470978,0.9294320434216593,1.0,17/73,17.31%,MVB12B;SMAD3;NBR1;UCHL1;SIRT2;WDR48;USP25;CKS1B;OTULINL;RNF31;USP5;AUP1;OTUB2;VPS36;UBXN2A;GGA3;NUP62
prerank,alanine transmembrane transporter activity (GO:0022858),0.4520527159372508,1.0935036763747952,0.34709193245778613,0.9348045782400974,1.0,2/12,2.37%,SLC7A8;SLC36A1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3477507193631358,-1.0925608550647248,0.31353919239904987,0.672707703298122,1.0,12/27,28.71%,DCUN1D2;ZMYM2;RNF19A;PRKN;DCUN1D3;RNF19B;RNF217;SIAH2;ANKIB1;PPARA;UBE3D;RNF14
prerank,GABA receptor binding (GO:0050811),0.4634158117933265,1.0922158012145367,0.35647279549718575,0.9328538060190658,1.0,4/11,14.09%,TRAK1;AKAP5;PLCL2;GABARAPL1
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.29238703874448485,-1.0918622762743153,0.3055555555555556,0.670071872066929,1.0,16/55,17.85%,ITPR1;MCU;TRPC5;ATP2B1;RYR2;ATP2A2;SLC24A2;PKD2;TMEM165;TRPC3;ATP2A3;PANX1;PKD1;ANXA2;TRPV6;TRPV3
prerank,AMP binding (GO:0016208),-0.4382838829898683,-1.0909249584478087,0.3248407643312102,0.6679000705527326,1.0,4/11,12.90%,MPPED2;PRKAG2;APRT;PFKP
prerank,hydro-lyase activity (GO:0016836),0.3291653959792845,1.0872873609928553,0.3055555555555556,0.9440563849284025,1.0,9/41,15.66%,TBXAS1;ECHS1;HACD3;ACO2;FAHD2A;ECI1;ECHDC2;NAXD;HADHB
prerank,ubiquitin protein ligase binding (GO:0031625),0.24505882740134774,1.082199818278394,0.24854651162790697,0.9569798209304545,1.0,46/254,14.80%,BAG6;SMAD3;HERC2;SUMO1;SMAD7;FHIT;UCHL1;ARRB2;SKI;SNCAIP;CHEK2;PRKACA;NEK6;TRAF5;CLU;TUBB;RPS27A;UBC;RFFL;HLTF;PCBP2;ARRDC1;USP25;MID1;EGR2;CUL4B;ASB4;PATZ1;JUN;RNF8;CKB;RNF31;RNF20;DTX1;LAPTM4B;BRCA1;AUP1;ANKRA2;PINK1;FZD6;KDM4A;GABARAPL1;TMBIM6;LRPPRC;BAG4;RRAGA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24674086356169256,1.0821506991761125,0.2621776504297994,0.9501441338380086,1.0,45/232,16.64%,HERC2;RNF38;TRIM69;RNF216;SMURF1;ITCH;TRIM11;TRIM5;NEURL1B;NEURL3;RNF41;RNF138;RFFL;HLTF;TRIM44;TRIM72;EGR2;DTX4;RNF8;MSL2;BFAR;RNF25;MYLIP;DTX1;AREL1;RNF166;UHRF2;RNFT2;TRIM62;RNF187;ZNRF3;WWP2;PIAS3;UBE3A;PIAS2;RNF7;MKRN3;FBXL22;RNF144B;DTX3;XIAP;RNF11;ANAPC11;DTX3L;PELI2
prerank,iron ion binding (GO:0005506),0.31978480299346185,1.0815022115761268,0.32014388489208634,0.9455453370960628,1.0,16/48,18.91%,AGMO;FECH;PHYH;EGLN1;ISCU;ACO2;JMJD6;ABCE1;KDM3A;FDX1;CYP2R1;SCD5;TYW5;SCD;DNAJC24;KDM7A
prerank,double-stranded RNA binding (GO:0003725),-0.27334066209463204,-1.0798715502496588,0.2896039603960396,0.6936514773056143,1.0,24/70,25.47%,ADARB2;OAS2;STAU2;LRRFIP1;DDX60;VIM;AGO4;DHX15;ZFR;STRBP;OAS3;DROSHA;TLR8;DUS2;EIF4B;TFRC;MSN;SIDT1;IFIH1;DHX33;RFTN1;ADAR;OASL;HSP90AB1
prerank,LRR domain binding (GO:0030275),0.42028285275307986,1.0791664277166322,0.34593572778827975,0.9474416771881732,1.0,3/14,4.28%,DDIT3;POLR2J;AATF
prerank,histone methyltransferase activity (GO:0042054),0.34005283112692913,1.0771604350244797,0.3267504488330341,0.9480328796794925,1.0,15/32,23.64%,PRMT2;PRMT8;PRMT1;EHMT2;PRMT6;SETD2;EZH2;EED;CARM1;PRDM9;SETD7;FBL;SMYD1;KMT5A;SETDB1
prerank,DNA polymerase activity (GO:0034061),-0.36296112009638504,-1.076777230003887,0.3614457831325301,0.6971467430962602,1.0,10/22,25.92%,POLA1;POLL;POLE2;POLG;POLD1;POLD3;TERT;POLH;POLQ;POLM
prerank,rRNA binding (GO:0019843),-0.29786750281470203,-1.0754999804186407,0.32116788321167883,0.6959040871519445,1.0,14/42,20.21%,RPS3;MRPL18;TST;MRPL16;PPAN;RPS14;ERI1;MRPS7;RPS9;RPLP0;MDM2;CAVIN1;RRS1;RPS5
prerank,phospholipase binding (GO:0043274),0.42820104181660623,1.0754976403119436,0.37476099426386233,0.9476675784656652,1.0,4/13,7.80%,BLNK;SRC;PDPK1;SELE
prerank,active ion transmembrane transporter activity (GO:0022853),0.3275661848048122,1.0746623309674403,0.37037037037037035,0.9439920246157147,1.0,6/37,12.94%,SLCO2B1;COX7A2L;COX8A;SLC22A6;COX5A;SLC16A7
prerank,endoribonuclease activity (GO:0004521),0.3382540720585053,1.0735369682644196,0.3540587219343696,0.9415366204127521,1.0,13/32,23.51%,YBEY;INTS11;PIWIL1;RCL1;KHNYN;ZC3H12C;ZC3H12B;RIDA;TSNAX;SND1;ZC3H12A;EXOG;AGO1
prerank,phospholipid transfer activity (GO:0120014),0.3643796959259482,1.0728776908212645,0.3745704467353952,0.9374434890438815,1.0,8/21,24.85%,PITPNC1;CPTP;C2CD2L;PITPNM1;MTTP;PITPNM2;PRELID2;PITPNB
prerank,GTP binding (GO:0005525),0.25351897049069044,1.0724019601607375,0.2815829528158295,0.9328040203389026,1.0,63/172,28.63%,DNM2;TUBA4A;RAC1;RND1;TGM2;ARL5C;RHOQ;RHOB;RHOBTB1;TUBB;TUBB1;RND2;TUBG1;RHOH;ARFIP2;RAB4A;RRAS2;RAB39A;TUBA8;GBP6;RAB35;RRAD;NMUR2;TUBA1A;AGAP2;DIRAS2;SCG5;RRAGA;RAB32;ARL3;RAB27A;GBP5;MRAS;RAB13;NME1;ARL11;GNL1;GBP7;NUDT16;TUBD1;RAC3;ARHGEF5;ARF1;ARF4;RAB9A;RALB;TUBB3;NRAS;EIF2B2;RHOC;SEPHS1;RAP2B;ARL8B;ANXA6;RAP1B;MMAA;RANBP17;RRAS;ARL6;NOA1;RAB2A;RAB26;PIP4K2B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.26118291118806625,-1.0688853665518128,0.32,0.7096972878651923,1.0,13/91,6.34%,HIP1;PLCB1;CLVS2;GSN;FRMPD4;SNAP91;SESTD1;KCNH1;SNX14;PLEKHA5;MYO1G;SDCBP;STXBP6
prerank,single-stranded DNA helicase activity (GO:0017116),0.3860964620340813,1.0688241023618756,0.38738738738738737,0.9389840983499955,1.0,4/19,7.36%,RFC2;MCM2;DHX9;CHTF18
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4158083984039748,1.0681121596594536,0.3927272727272727,0.9350861389287156,1.0,9/14,34.69%,NME4;CMPK1;NME6;NME1;AK8;DTYMK;AK1;AK7;CMPK2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.33496105827295714,1.0676372496782844,0.3607705779334501,0.9305109162246936,1.0,5/34,2.56%,ADAP2;MYO1B;DAPP1;GAB2;ARAP3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.40505395761795776,1.065829745288833,0.38661710037174724,0.9306991874430992,1.0,6/14,20.57%,QDPR;CRYM;ALDH4A1;MTHFD1;PYCR1;PYCR2
prerank,androgen receptor binding (GO:0050681),0.36065236151983115,1.065098221834037,0.3489208633093525,0.9269549636943636,1.0,5/25,11.15%,PRMT2;DDX5;TGFB1I1;KDM3A;PRKCB
prerank,ion channel inhibitor activity (GO:0008200),-0.31342992383342344,-1.0645262702037166,0.3333333333333333,0.7167651206956268,1.0,5/35,6.18%,ITPR1;KCNMB2;NEDD4L;CALM1;MCUB
prerank,C2H2 zinc finger domain binding (GO:0070742),0.4368893283135852,1.0643610313139016,0.3890977443609023,0.923488382731926,1.0,3/11,10.54%,GATA2;EHMT2;SRRM2
prerank,DNA-binding transcription factor binding (GO:0140297),0.24966259728947615,1.062902349679786,0.3222543352601156,0.9226659199884416,1.0,38/189,15.68%,SMAD3;NFE2L2;DDIT3;MEF2C;SKI;PPARD;MTA1;NEK6;NBN;MEF2D;ELK1;RBL2;NFATC1;FIZ1;DHX9;SIN3A;EGR2;NLRP3;MTDH;TLE6;ANKRD2;JUN;MEF2A;CXXC5;CRTC1;TBX6;BBS2;TAF1;MAP3K10;DDX20;WWP2;RERE;PIAS3;HDAC5;GTF2I;PIAS2;TAL1;TCF3
prerank,cytokine receptor activity (GO:0004896),0.27941757797140304,1.0613162740535884,0.3441226575809199,0.9221303679820393,1.0,20/83,17.92%,CX3CR1;CSF3R;IL1RL2;EBI3;IL6ST;IL12B;IL6R;IL12RB2;IL10RB;GFRA4;IL10RA;CCR5;IFNGR2;GHR;IL4R;IL1RL1;IL1R2;CSF2RA;IL7R;IL20RA
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3998444450864412,1.0586141553290158,0.3713733075435203,0.925607644002028,1.0,1/15,0.04%,CX3CR1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3120330056739509,-1.0582854931408763,0.375886524822695,0.7286636017343611,1.0,10/35,17.05%,MPPED2;PDE11A;APEX2;NAPEPLD;PLCB4;GDPD1;ENPP2;FAM83B;PLCXD2;GPCPD1
prerank,endopeptidase regulator activity (GO:0061135),0.32436424498821675,1.057332998721356,0.3716216216216216,0.9242234233872647,1.0,5/40,4.96%,CST3;UCHL5;VSIR;PROS1;SLPI
prerank,mitogen-activated protein kinase binding (GO:0051019),0.34035187849708437,1.0565264891484019,0.3736654804270463,0.9213207420635435,1.0,10/29,20.11%,NBR1;NFATC1;PRMT1;DUSP5;ABL1;MAPK14;DUSP6;MAPK7;PTPRJ;TNIP1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4316183631364697,1.0542666693426346,0.4123134328358209,0.9232474001272322,1.0,4/12,14.63%,CASP1;APAF1;RPS27L;PYCARD
prerank,pyrophosphatase activity (GO:0016462),0.30464797180776576,1.0540360706013927,0.36427320490367776,0.9180754892312419,1.0,16/50,22.30%,ENTPD1;TRPM2;DXO;DHX9;NUDT15;PLPP1;NUDT14;DCPS;BNIP2;ENTPD7;NUDT6;ATCAY;NUDT16;DHX29;DDX3X;ENTPD6
prerank,histone acetyltransferase binding (GO:0035035),0.37203018652620634,1.053442566579246,0.3951048951048951,0.9143897206436765,1.0,5/21,10.31%,SIRT2;PCNA;EGR1;PAX6;MEF2A
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4110658001449972,-1.0532593491918931,0.3585746102449889,0.7381027238707369,1.0,7/12,35.25%,SLC2A8;SLC2A2;SLC2A4;SLC2A3;SLC5A1;MFSD4A;SLC2A6
prerank,nuclease activity (GO:0004518),0.3021087970678369,1.0519240377317045,0.3741935483870968,0.9138500039657235,1.0,15/52,23.25%,RNASE1;REXO4;REXO5;DIS3L2;EXO1;RNASE6;ISG20L2;DIS3;ISG20;NME1;NTHL1;SND1;RNASEH1;ZC3H12A;EXOG
prerank,histone demethylase activity (GO:0032452),0.3462571059567527,1.050783575363886,0.3732394366197183,0.9120971062302714,1.0,13/27,24.83%,KDM5B;JMJD6;UTY;KDM3A;KDM4A;HR;KDM1A;KDM8;KDM7A;KDM2A;KDM5A;KDM2B;PHF8
prerank,death receptor activity (GO:0005035),0.4379079757547314,1.0504137069824324,0.4011090573012939,0.9076139483809645,1.0,4/11,20.83%,TNFRSF25;EDA2R;TNFRSF19;TNFRSF14
prerank,growth factor activity (GO:0008083),0.2827582710502541,1.050317322547701,0.3646496815286624,0.902318634148068,1.0,16/74,16.93%,OSGIN2;ARTN;VEGFB;PDGFB;CNTF;AMBN;GDNF;IL12B;CXCL1;INHA;JAG2;CSPG5;OSGIN1;CSF1;OSM;AGT
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.31302106573515454,-1.0492494045372498,0.36343115124153497,0.7446840773090285,1.0,10/33,20.33%,SCAF8;GTF2B;WAC;CDC73;CCAR2;SMYD2;ESRRB;SUPT4H1;ZNF326;DRAP1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3461131289068475,1.0480136797852966,0.37985865724381623,0.9047581195890079,1.0,9/27,22.88%,POLR2J;PRIMPOL;POLR2D;POLR3H;POLR2E;POLR1C;POLR1D;POLR2I;MED20
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3293325872038985,1.0472042789059666,0.38974358974358975,0.9019072897239828,1.0,9/34,16.62%,CNOT1;DIS3L2;REXO2;EXOSC10;EXOSC5;PAN3;DIS3;ERI3;ISG20
prerank,growth factor receptor binding (GO:0070851),-0.25238275754451606,-1.0470498395723418,0.36883116883116884,0.7459889091753013,1.0,27/95,23.50%,HIP1;FGF10;LINGO1;ERN1;PDGFD;JAK2;TRIP6;CD300LF;SDCBP;ERBB4;VEGFD;CCDC88A;FGF7;FGF9;IL1RAP;FER;FAM83B;ATXN2;FGF5;TSLP;FYN;SNX2;FGF22;KL;NCSTN;IL2;CNOT9
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4315513932244635,1.0468260676360437,0.39097744360902253,0.8976064005530338,1.0,4/12,17.81%,CBR1;DHRS4;CRYZL1;NQO1
prerank,transition metal ion binding (GO:0046914),0.2271624269004579,1.045919637134741,0.3190921228304406,0.8952974550119576,1.0,92/397,20.37%,LARGE1;ARHGEF2;SLC30A5;SMAD3;XXYLT1;AGMO;SKI;SIRT2;PRIMPOL;HPF1;HDAC10;EGR1;POMGNT1;PLA2G15;PLSCR3;LOXL3;MT1X;MT1B;MT1H;MT1A;MT1G;MT1M;MT1F;MT1E;SNRPC;ATAD3A;PITRM1;MDM4;ISCU;TET3;ACO2;KDM5B;SHH;JMJD6;THAP1;ZMYND11;GALNT1;ABCE1;SLC30A8;ZBTB32;PAPPA2;TAB2;MGAT2;MT2A;ACER3;CHD3;TIMM8B;RNF8;LIMS1;DPEP1;MBD1;MGAT5;CXXC5;KDM3A;MGAT1;PTPN1;RNPEP;SORD;KDM4A;BAZ1B;GALNT3;ABL1;ZNF3;SLU7;SOD1;IMPA1;BLM;PRDM2;RNF7;FDX1;RBSN;UBA5;ZEB1;RNF11;CCS;CYP2R1;SCD5;EPRS1;TYW5;CHMP1A;SCD;DNAJC24;CZIB;KDM7A;RNF2;NUDT16;KDM2A;SAP30L;PCK2;DUSP12;NOS1;GALNT2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.23526968207254412,1.045424663816374,0.3457142857142857,0.8915843902969376,1.0,47/269,14.80%,BAG6;SMAD3;HERC2;SUMO1;SMAD7;FHIT;UCHL1;ARRB2;SKI;SNCAIP;ITCH;CHEK2;PRKACA;NEK6;TRAF5;CLU;TUBB;RPS27A;UBC;RFFL;HLTF;PCBP2;ARRDC1;USP25;MID1;EGR2;CUL4B;ASB4;PATZ1;JUN;RNF8;CKB;RNF31;RNF20;DTX1;LAPTM4B;BRCA1;AUP1;ANKRA2;PINK1;FZD6;KDM4A;GABARAPL1;TMBIM6;LRPPRC;BAG4;RRAGA
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.433642238342323,-1.0445157679137442,0.38626609442060084,0.7485389562500998,1.0,4/11,22.79%,HCN1;HCN2;AQP1;HCN4
prerank,RNA binding (GO:0003723),0.21123432754886018,1.044304863226432,0.28444444444444444,0.8899835963317942,1.0,340/1321,22.68%,SRRM1;SNRNP70;TLR7;UTP6;SON;FBRSL1;CCDC59;TWF2;PRPF38B;SUMO1;FAM98B;ADAT1;UCHL5;UBFD1;CSNK1E;GDI2;CEBPZ;SECISBP2;NCBP1;RBM18;WDR46;KARS1;EIF4A2;SNRPA;DSP;DDX5;QKI;POP1;TRNT1;AKAP8;SRRT;XPOT;CNOT1;FUS;AKAP8L;SRP72;EMG1;SSB;HNRNPDL;PNISR;MYH9;TRMT6;ZCCHC3;CSTF2;ETF1;STXBP1;AARS2;RBM19;HNRNPA3;DXO;AATF;BUD23;SF3B1;SF3B2;ATXN2L;MRPS24;REXO4;EIF4G1;TBL3;PRKRIP1;FSCN1;GANAB;ZRANB2;THUMPD1;MRPL37;MRPL2;SLPI;CCDC124;RPS27A;UBC;MAGOHB;MAGOH;EIF2S1;EIF2A;NSUN5;HNRNPC;SNRPC;U2AF2;RRBP1;POLR2D;RBM14;MOV10;HLTF;EWSR1;ZCCHC9;SART3;PES1;CELF2;NUP42;PCBP2;SNRPF;ILF2;MRPL43;SNRPA1;DHX9;NTPCR;HNRNPH1;JMJD6;RBM39;MACF1;TIAL1;RNMT;SLTM;MTDH;C1QBP;SARS1;SARS2;ZFP36L1;CNBP;ZFP36L2;NANOS2;PKP3;PIWIL1;PTRH1;RPUSD2;DHX38;CHD3;JUN;KRR1;DUT;MRPL9;PRMT1;TNPO1;HNRNPR;DDX17;SRP9;PSTK;EIF4H;MAP4;BOP1;USP36;C1D;LRP1;RPL15;PABPN1;SRSF5;ANP32A;NIP7;MRPS5;ESRP1;G3BP1;SRRM2;NSUN6;TOP3B;BRCA1;RPL10;APTX;RBM8A;TRMT10B;TRA2B;PEBP1;ZYX;PTPN1;SNUPN;KHNYN;CSDC2;RPP21;NOP14;ERH;RPS8;DDX54;RPS27L;SSBP1;CDK11B;HDLBP;IMP4;GNL3L;MARK2;ZC3H12C;DCP1B;TARDBP;CHCHD1;PRPF31;KCTD12;GSPT2;LUC7L3;PDIA3;DDX20;MRPS21;GCN1;ISG20L2;ABCF1;EXOSC10;LSM5;CCT3;SF3A1;RPS24;NSRP1;SAFB;MRPL13;PSMC1;IGF2BP2;LRPPRC;FIP1L1;EIF2S2;BAG4;BUD13;MYEF2;CFAP20;NOM1;ALYREF;SHFL;FARSA;MKRN3;NELFE;SLC4A1AP;MRPS11;ZC3H12B;R3HDM2;SLC25A11;TRA2A;HADHB;NVL;SREK1;HSD17B10;ALKBH5;RSRC2;MAPRE1;DARS2;ANXA7;NHP2;NEMF;FTSJ3;ERI3;DUSP11;BRIX1;METTL14;RIDA;HNRNPUL2;CCAR1;TRMT2A;EPRS1;LUC7L;EIF3D;IBA57;EIF2AK2;DQX1;MRPS35;MRPS28;ELAC2;KDM1A;PCF11;NME1;NQO1;MTO1;TYW5;HMGB2;ROCK2;DUS3L;FASTKD3;PRPF3;PDIA4;WDR3;API5;PPRC1;FXR2;MTIF2;ZCCHC8;SRP14;EIF1B;RPL9;KHDRBS1;ZCCHC7;METAP2;PCDH20;DDX43;SBDS;REPIN1;EIF5;NDUFV3;RPL39;NOP56;SNRNP40;TDRD7;RBMX;EIF1AX;EIF1;XRCC6;PDCD11;NUDT16;CRKL;CAPRIN1;PSMD4;UBTF;TSNAX;MEX3A;SND1;TSN;MRPL11;NANOS1;MRPL41;MRPL27;FAM133B;WDR6;RTCB;MRPL54;DHX29;MYO18A;TNRC6B;RNASEH1;PRRC2B;TFB1M;LSM7;WBP4;SRSF9;HNRNPH3;FASTKD2;FBL;DDX19B;RBM38;MAPT;SNIP1;HNRNPA2B1;BYSL;ZNFX1;DDX39B;ZC3H12A;RPL28;HDGF;DDX3X;ACAA2;ARF1;LARP1;HNRNPUL1;TASOR;DEK;RBPMS;TUFM;DAZAP1;ELAVL1;CLK3;DAP3;DDX47;RBM25;SAFB2;MPHOSPH10;RBM34;RPL34;EIF4G2;PARK7
prerank,transcription coactivator binding (GO:0001223),0.3627258123274527,1.0432679553786666,0.4068441064638783,0.8882747009681249,1.0,3/20,3.18%,SMAD3;PPARD;CDK9
prerank,acyl-CoA hydrolase activity (GO:0047617),0.384317964562342,1.0429866465904707,0.40298507462686567,0.8840943877055226,1.0,8/17,23.96%,PLA2G6;THEM4;PPT1;ACAA2;ACOT1;ACOT8;ABCD1;ACOT4
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.354112212404893,-1.0417813094891153,0.3854625550660793,0.7514420221988458,1.0,4/20,7.13%,DLG2;CASK;AK6;AK3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.21689990272461368,1.0412818432776363,0.3078817733990148,0.8845002412656355,1.0,144/732,19.85%,ZFHX3;SALL1;IKZF1;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;DDIT3;MEF2C;LYL1;SOX8;FOXJ2;SKI;UBP1;PPARD;MLXIP;FOXE1;MTA1;KLF11;ZNF83;NKX2-8;EGR1;MEF2D;KLF3;PAX6;ELK1;SKIL;TFE3;MEIS3;ZNF568;HBP1;ZIM3;CALCOCO1;MYCL;NFATC1;ELK3;MLX;GTF2IRD1;FOXK2;ATF3;EGR3;ZBTB18;ZBTB24;DHX9;THAP1;EGR2;SARS1;FOXN3;ZNF319;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;PKNOX1;KLF12;ZNF569;PATZ1;JUN;RXRB;NR2F1;IRF8;MEF2A;PRDM1;E2F2;ZSCAN21;NFE2L1;NRF1;PAX2;MYNN;TBX6;NFYA;ZNF367;RUNX1;TEF;SMAD9;CEBPG;ARNT;E4F1;MXI1;RELB;SP9;ZIC1;ZBTB48;SAFB;OLIG2;HDAC5;TAL1;PROX1;MXD1;TCF7L1;TCF3;ZBTB39;POU2F2;NRIP1;ZEB1;MYPOP;STAT6;CCAR1;ZBTB2;IRF3;ZFP62;POU2F1;MAFG;HES6;TGIF1;IRF9;GATA3;MITF;HMGB2;PROX2;ZNF740;IRF2;ZNF260;ZKSCAN1;ZSCAN22;E2F3;ZBTB11;NR1H2;DMTF1;RBMX;ZFP82;ZNF585B;ZNF585A;MGA
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.30349666396622765,1.0396696350684786,0.3822525597269625,0.8848276125392,1.0,8/48,6.35%,CALHM2;SLC12A6;TRPV2;TRPM4;TRPM2;MCOLN1;TRPM6;ABCC9
prerank,chloride channel regulator activity (GO:0017081),0.40571849708468577,1.0385756911002886,0.39920948616600793,0.883080848198678,1.0,5/14,22.53%,STX1A;WNK1;WNK3;WNK2;STX8
prerank,ubiquitin protein ligase activity (GO:0061630),0.2376529230103954,1.0370806817106448,0.3569364161849711,0.8831882595297635,1.0,58/228,23.70%,HERC2;RNF38;TRIM69;RNF216;SMURF1;ITCH;TRIM11;TRIM5;NEURL1B;NEURL3;RNF41;RNF138;RFFL;HLTF;TRIM44;TRIM72;DTX4;RNF8;MSL2;BFAR;RNF25;MYLIP;DTX1;AREL1;RNF166;UHRF2;RNFT2;TRIM62;RNF187;ZNRF3;WWP2;UBE3A;RNF7;MKRN3;FBXL22;RNF144B;DTX3;XIAP;RNF11;ANAPC11;DTX3L;PELI2;UBE4A;STUB1;MGRN1;RNF2;TRIM3;TOPORS;RNF121;SYVN1;RNF34;RFWD3;GID4;LTN1;RC3H2;RING1;RNF180;ZNRF1
prerank,GDP binding (GO:0019003),-0.2721140509019289,-1.0353215574591703,0.3723150357995227,0.7650679994164189,1.0,15/63,19.88%,RIT2;RAB22A;RAB5C;RAN;RAB28;RAB8A;RASL12;RERG;GNAI1;TRIM23;RAB27B;NME2;RHEBL1;RAB9B;RAB5A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4003895036940754,1.0348537892446779,0.396709323583181,0.885369017181372,1.0,3/15,15.54%,PIK3R1;SOCS6;PIK3R3
prerank,protein tyrosine kinase binding (GO:1990782),0.27887307983141013,1.0335662658468752,0.4003322259136213,0.8843088209539186,1.0,14/71,15.59%,DOCK4;BLNK;SIRPA;PCNA;RNF41;FIZ1;CEACAM1;TOB1;PTPN1;PTPN11;LRP4;TJP2;ACP4;PITPNM1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2445793178603612,1.0322366346687477,0.3962536023054755,0.8835638631623847,1.0,52/173,23.70%,ZFHX3;HEYL;HOXD9;SKI;PPARD;ZFP90;DEAF1;ERF;SKIL;ZBTB21;ELK3;MLX;GTF2IRD1;FOXK2;ATF3;ZBTB18;THAP1;OVOL2;BCL6B;ZBTB32;KLF12;PATZ1;JUN;NR2F1;IRF8;PRDM1;E4F1;MXI1;ZNF3;PRDM2;PROX1;MXD1;TCF3;ZBTB39;ZEB1;MYPOP;ZBTB2;TGIF1;GATA3;MITF;KCNIP3;ZNF692;GZF1;IRX1;ZBTB45;ZBTB6;FOXP4;ZBTB1;MNT;SCRT1;BATF3;YY1
prerank,channel activity (GO:0015267),-0.2923565171368021,-1.0318515641491925,0.3726851851851852,0.7703271726928687,1.0,10/41,18.86%,AQP4;MCUB;SLC14A1;PANX2;AQP11;PANX1;BCL2;TRPV6;TRPV3;TMEM266
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.21503548687171622,1.0318368173998795,0.33705080545229243,0.8799433122071509,1.0,143/731,19.85%,ZFHX3;SALL1;IKZF1;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;DDIT3;MEF2C;LYL1;SOX8;FOXJ2;SKI;UBP1;PPARD;MLXIP;FOXE1;MTA1;KLF11;ZNF83;NKX2-8;EGR1;MEF2D;KLF3;PAX6;ELK1;SKIL;TFE3;MEIS3;ZNF568;HBP1;ZIM3;CALCOCO1;CREB3L2;MYCL;NFATC1;ELK3;MLX;GTF2IRD1;FOXK2;ATF3;EGR3;ZBTB18;ZBTB24;DHX9;THAP1;EGR2;SARS1;ZNF319;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;PKNOX1;KLF12;ZNF569;PATZ1;JUN;RXRB;NR2F1;IRF8;MEF2A;PRDM1;E2F2;ZSCAN21;NFE2L1;NRF1;PAX2;MYNN;TBX6;NFYA;ZNF367;RUNX1;TEF;SMAD9;CEBPG;ARNT;E4F1;MXI1;RELB;SP9;ZIC1;ZBTB48;SAFB;OLIG2;HDAC5;TAL1;PROX1;MXD1;TCF7L1;TCF3;ZBTB39;POU2F2;NRIP1;ZEB1;MYPOP;STAT6;CCAR1;ZBTB2;IRF3;ZFP62;POU2F1;MAFG;HES6;TGIF1;IRF9;GATA3;MITF;PROX2;ZNF740;IRF2;ZNF260;ZKSCAN1;ZSCAN22;E2F3;ZBTB11;NR1H2;DMTF1;RBMX;ZFP82;ZNF585B;ZNF585A;MGA
prerank,leak channel activity (GO:0022840),-0.36354066873371904,-1.030679234676262,0.4048140043763676,0.7689071455145979,1.0,8/18,28.48%,KCNK10;NALCN;PANX1;KCNK12;KCNK5;KCNK2;RHAG;KCNK7
prerank,neuropeptide receptor activity (GO:0008188),-0.31789247393012426,-1.0285791737635195,0.397196261682243,0.7697529868357403,1.0,12/29,37.52%,SORCS1;OPRM1;HCRTR2;GALR1;NTSR1;GAL;NMUR1;GPR143;NPY2R;SORCS3;NPSR1;GPR37
prerank,calcium-release channel activity (GO:0015278),-0.35920317174919736,-1.028390881181341,0.40093240093240096,0.7655433182230326,1.0,4/17,6.54%,ITPR1;RYR3;RYR2;PKD2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.27351625744736574,1.0278933374664205,0.39932885906040266,0.8877255783275675,1.0,20/74,17.87%,HK2;PI4KB;PIK3CG;DGKK;PANK4;PIK3C3;DGKD;GK5;PIK3CD;CHKB;PIK3CB;PANK2;XYLB;PAPSS1;FAM20B;NADK2;FCSK;DCAKD;KHK;GNE
prerank,protein kinase C activity (GO:0004697),0.4014423422155097,1.0263517031742835,0.43169398907103823,0.8877439643238976,1.0,5/14,12.54%,PRKCA;PRKCD;CCL3;PRKCB;PRKD3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3357639482784433,1.026282622765287,0.426497277676951,0.8830927229442107,1.0,6/30,12.74%,SLC30A5;SLC30A10;SLC40A1;SLC25A37;SLC30A8;SLC39A2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.42856763741186044,-1.026056249515136,0.4282608695652174,0.7670851349310847,1.0,2/10,8.83%,CLCN5;ANO6
prerank,manganese ion binding (GO:0030145),0.2978631155042748,1.0259607780991735,0.3952702702702703,0.8792325940948694,1.0,11/48,14.38%,LARGE1;XXYLT1;PRIMPOL;POMGNT1;GALNT1;MGAT2;MGAT5;MGAT1;GALNT3;ABL1;IMPA1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.42276580006250597,1.0252545862467395,0.4413919413919414,0.8765132538375011,1.0,6/12,30.18%,CNOT1;PAN3;CNOT2;PNLDC1;PARN;CNOT8
prerank,mRNA binding (GO:0003729),0.2315560293889357,1.0248390607612843,0.38248175182481753,0.8729058739730896,1.0,102/249,29.14%,SNRNP70;SECISBP2;NCBP1;DDX5;QKI;SSB;CSTF2;ETF1;DXO;SF3B1;EIF4G1;SLPI;EIF2A;HNRNPC;RBM14;CELF2;PCBP2;DHX9;C1QBP;ZFP36L1;CNBP;NANOS2;PIWIL1;RBM24;HNRNPR;RNF20;SRSF5;ESRP1;G3BP1;SRRM2;RBM8A;TRA2B;KHNYN;CSDC2;HDLBP;ZC3H12C;DCP1B;TARDBP;LUC7L3;NSRP1;MRPL13;IGF2BP2;EIF2S2;MYEF2;SHFL;SLC4A1AP;MRPS11;ZC3H12B;METTL14;RIDA;LUC7L;EIF3D;PCF11;FXR2;KHDRBS1;TDRD7;RBMX;TYMS;NUDT16;NANOS1;BOLL;SNIP1;HNRNPA2B1;ZC3H12A;DDX3X;CPEB1;LARP1;RBPMS;DAZAP1;ELAVL1;RBM25;EIF4G2;PARK7;RC3H2;NOVA2;TP53;LSM14B;XPO5;HNRNPLL;PCBP4;PTBP3;SAMD4B;YTHDF3;PARN;CCT5;CPEB2;RBM4;ZC3H11A;RPL7;IREB2;LARP4B;THOC5;PUM1;RPS26;UNK;CALR;LUC7L2;RPS13;CARHSP1;HNRNPK;HNRNPL;DCP1A
prerank,ribosome binding (GO:0043022),0.30197550493103115,1.0247745663344678,0.39416058394160586,0.8683721015215986,1.0,14/46,21.78%,BAG6;SRP72;GTPBP6;ETF1;EIF2S1;EIF2A;C1QBP;SHFL;SEC61A1;SBDS;MAIP1;EFL1;ZC3H12A;CPEB1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3531785296164287,1.0245732326051076,0.4025735294117647,0.8644642493190787,1.0,5/23,6.87%,SSB;HNRNPC;U2AF2;DIS3L2;HNRNPH1
prerank,sialyltransferase activity (GO:0008373),-0.3443805627061943,-1.0220582439768793,0.4144144144144144,0.7739361796390573,1.0,5/20,8.39%,ST3GAL1;ST3GAL4;ST8SIA4;ST8SIA1;ST8SIA2
prerank,tau protein binding (GO:0048156),0.3072713819863398,1.021085206725223,0.3989547038327526,0.8703732692788029,1.0,12/40,21.81%,BIN1;PICALM;CLU;LGMN;TAOK2;MARK2;PIN1;DYRK1A;ROCK2;STUB1;MARK4;TTBK2
prerank,ankyrin binding (GO:0030506),-0.3397695285370782,-1.0177465169196152,0.4111111111111111,0.7814319246373868,1.0,4/19,13.46%,SPTBN1;NRCAM;SPTBN4;CDH1
prerank,hexosyltransferase activity (GO:0016758),0.2576375995690128,1.016917513337119,0.43140243902439024,0.8787319588888753,1.0,19/101,11.65%,HEXB;LARGE1;MGAT4A;B3GNT2;DPY19L4;ALG12;POMGNT1;PIGV;HEXA;ALG6;GCNT2;RFNG;B3GNT4;FUT7;CHPF;POMT1;CHPF2;POFUT1;B4GALNT1
prerank,solute:proton symporter activity (GO:0015295),0.3782191414404947,1.0154081420556014,0.41509433962264153,0.878874510364906,1.0,5/16,21.92%,SLC36A1;SLC15A4;SLC15A2;SLC25A3;CTNS
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.38608430501194285,-1.0149886789451334,0.4406779661016949,0.7848712826620449,1.0,3/13,6.96%,ERN1;PDGFD;VEGFD
prerank,chloride channel inhibitor activity (GO:0019869),0.42691141531717686,1.0141429870115928,0.4367816091954023,0.8784402691652351,1.0,5/10,22.53%,STX1A;WNK1;WNK3;WNK2;STX8
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.34524275646558206,-1.012526191048635,0.4444444444444444,0.7875756776256383,1.0,9/21,25.92%,POLA1;POLL;POLE2;POLG;POLD1;POLD3;POLH;POLQ;POLM
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.28453430816776365,1.0115706912972964,0.4353518821603928,0.8817661633676153,1.0,8/53,13.04%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC15A4;SLC22A2;SLC17A8;SLC6A9
prerank,histone deacetylase activity (GO:0004407),0.3651890828115982,1.0103310259103746,0.45955882352941174,0.880965572628893,1.0,6/19,19.04%,SIRT2;HDAC10;SUDS3;HDAC5;HDAC8;MIER3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3856810476480189,-1.0100780789558084,0.43555555555555553,0.7898451106358567,1.0,7/13,23.15%,AGPAT4;GPAT3;AGPAT1;ABHD5;AGPAT3;PNPLA3;GPAT2
prerank,MHC class I protein binding (GO:0042288),0.39238099856536135,1.0099532403675742,0.4616822429906542,0.8776499876782581,1.0,3/13,5.19%,PILRA;TAP2;TUBB
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.27578077284128377,1.006293141161887,0.42033898305084744,0.8838764726969689,1.0,11/60,12.66%,MERTK;TGFBR2;CSF1R;IGF1R;RYK;MET;EPHA8;AXL;PDGFRB;DDR2;MUSK
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.4189601393891694,-1.0060003568445584,0.45770065075921906,0.7968706097454409,1.0,6/10,21.99%,SUV39H1;SETD5;PRDM16;SETDB2;SUV39H2;EHMT1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.33464121472297387,1.0050973809452304,0.4446397188049209,0.8830623621472131,1.0,8/25,24.19%,CH25H;CYP46A1;NOS2;AKR1D1;FMO5;NOS1;POR;MICAL1
prerank,5'-3' exonuclease activity (GO:0008409),0.3892138563727475,1.004138124443479,0.4542190305206463,0.8815494988182989,1.0,6/14,23.25%,DXO;DCLRE1B;EXO1;DCLRE1C;DCLRE1A;EXOG
prerank,diacylglycerol kinase activity (GO:0004143),-0.4077013758568167,-1.0028404909972348,0.43548387096774194,0.8013279292234408,1.0,3/11,12.01%,DGKB;DGKI;DGKH
prerank,NAD+ binding (GO:0070403),0.3980444512229345,1.0022003074534753,0.4493006993006993,0.883098717035155,1.0,3/12,14.73%,SIRT2;HPGD;CRYL1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3175365265840944,-1.0014697106361399,0.45433255269320844,0.8007243182369933,1.0,4/26,3.83%,B3GALT1;CHSY3;EXTL2;B3GALNT2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.30196170079944323,0.9991395888233506,0.4363957597173145,0.8877129116234909,1.0,20/40,30.39%,DNMT3A;COMT;PRMT8;ASMT;ARMT1;CARNMT1;GAMT;FBL;SETD3;THUMPD3;HNMT;METTL8;RRP8;ICMT;METTL4;LCMT1;METTL2B;METTL2A;LRTOMT;PEMT
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2062524115788872,0.9985256872979985,0.4727932285368803,0.8850420871161581,1.0,159/831,19.85%,ZFHX3;SALL1;IKZF1;ETV5;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;DDIT3;MEF2C;LYL1;SOX8;FOXJ2;SKI;UBP1;PPARD;MLXIP;FOXE1;MTA1;KLF11;ZFP90;ZNF83;DEAF1;NKX2-8;EGR1;MEF2D;KLF3;PAX6;ELK1;SKIL;TFE3;MEIS3;HOXB8;ZNF568;HBP1;CUX1;ZIM3;RBL2;CALCOCO1;MYCL;NFATC1;ELK3;MLX;GTF2IRD1;FOXK2;ATF3;EGR3;ZBTB18;ZBTB24;DHX9;THAP1;EGR2;SARS1;ZNF319;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;TWIST2;POU4F1;HMX2;PKNOX1;KLF12;ZNF569;PATZ1;JUN;NPAS1;RXRB;NR2F1;IRF8;MEF2A;PRDM1;E2F2;ZSCAN21;NFE2L1;NRF1;PAX2;MYNN;TBX6;NFYA;ZNF367;TAF1;RUNX1;TEF;SMAD9;CEBPG;ARNT;E4F1;MXI1;RELB;SP9;ZNF3;ZIC1;ZBTB48;SAFB;OLIG2;PRDM2;ZBTB8B;HDAC5;TAL1;PROX1;MXD1;TCF7L1;TCF3;ZBTB39;POU2F2;NRIP1;ZEB1;MYPOP;STAT6;CCAR1;ZBTB2;IRF3;ZFP62;POU2F1;MAFG;HES6;TGIF1;IRF9;GATA3;MITF;CUX2;PROX2;ZNF740;IRF2;ZNF260;ZKSCAN1;ZSCAN22;E2F3;ZBTB11;NR1H2;DMTF1;RBMX;ZFP82;ZNF585B;ZNF585A;BHLHA9;MGA
prerank,ion gated channel activity (GO:0022839),-0.3201826443803768,-0.9984629094701148,0.4637002341920375,0.8046008711842559,1.0,7/24,16.83%,KCNT2;TMEM63C;ANO3;ANO6;ANO5;ANO10;KCNT1
prerank,single-stranded RNA binding (GO:0003727),0.2961806396050832,0.9975502430448473,0.4606164383561644,0.8836471766302552,1.0,8/43,9.98%,TLR7;SNRPC;U2AF2;POLR2D;DHX9;JMJD6;CNBP;EIF4H
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.41327243149146753,0.9967919980112884,0.47714808043875684,0.8772559159816192,1.0,5/11,26.32%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.41327243149146753,0.9967919980112884,0.47714808043875684,0.8772559159816192,1.0,5/11,26.32%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4182595697049546,-0.9964860158817745,0.4612159329140461,0.8057050796628747,1.0,4/10,25.41%,USP15;DNAJC2;DNAJB2;ANKRD13A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.42274544464154296,0.9955960163718164,0.4756335282651072,0.8764968869938724,1.0,6/10,31.24%,OTUD5;STAMBPL1;OTUD4;STAMBP;TNFAIP3;CYLD
prerank,endodeoxyribonuclease activity (GO:0004520),-0.33427121228119744,-0.9952812926507292,0.45265588914549654,0.8045030916034566,1.0,8/20,27.53%,RPS3;ZRANB3;RBBP8;MRE11;SETMAR;FEN1;ENDOV;ERCC1
prerank,adenylyltransferase activity (GO:0070566),-0.3316044293869638,-0.9950365370976649,0.4420131291028446,0.8007528131238782,1.0,10/21,25.31%,GPHN;OAS2;PAPOLA;OAS3;TENT2;TUT1;COASY;PAPOLG;PAPOLB;OASL
prerank,deoxyribonuclease activity (GO:0004536),-0.372358019526233,-0.9943581021488358,0.4703196347031963,0.7980475782115429,1.0,2/14,5.24%,RPS3;ZRANB3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3098553984009693,-0.9923698887856194,0.48306997742663654,0.7993145037979985,1.0,12/28,23.66%,LRRK2;MAPK10;PAK3;MAPKAPK5;AURKB;TTK;MAP2K6;RPS6KA2;SBK2;MAP2K5;RPS6KB1;PRKCG
prerank,phospholipase C activity (GO:0004629),-0.322172090680469,-0.9919583115643045,0.45734597156398105,0.7960595686862584,1.0,8/25,16.05%,PLCB1;CCR1;PLCH1;CHRM3;PLCB4;PLCH2;CCL5;PLCD1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.38361220237923654,-0.9913076260497538,0.4700665188470067,0.7935573376114624,1.0,4/12,16.62%,TRIM37;TRAP1;BABAM2;TRAF1
prerank,G protein-coupled receptor activity (GO:0004930),-0.2110219910512915,-0.9886828872737177,0.4694533762057878,0.7964641545028681,1.0,86/239,31.63%,ADGRB3;ADGRL3;GRM8;ADGRE5;GRM5;ADRA1A;GRM1;GPR141;GPR176;HRH1;ADGRG6;RORB;GABBR1;GABBR2;GPR35;GPR45;OPRM1;HCRTR2;GPR173;OPRD1;LGR5;GALR1;GPR161;ADRA2A;P2RY1;PTAFR;XPR1;FFAR1;LGR4;GPR171;ADGRG5;CNR2;GPR174;TSHR;LPAR4;LPAR2;FFAR4;APLNR;RXFP2;ADCYAP1R1;FPR3;ADGRL4;NTSR1;S1PR2;RRH;AVPR2;ADRA1B;MC4R;P2RY10;PAX8;FPR2;GPR83;NPR3;S1PR5;GPR15;PTH1R;TM2D1;GPR65;CXCR6;GPR156;TPRA1;GPR37L1;S1PR4;LANCL1;OXTR;ADGRG4;NMUR1;OPN1MW3;OPN1MW;OPN5;GPR151;CRHR2;OPN4;AVPR1A;BDKRB1;ADGRD1;GPR143;CYSLTR2;DRD1;LGR6;GPR12;GPR3;FPR1;TAS1R3;AGTR1;ADRA2C
prerank,purinergic nucleotide receptor activity (GO:0001614),0.37924405538594336,0.9870594741334661,0.49056603773584906,0.8977805392259022,1.0,2/15,4.41%,P2RY12;GPR34
prerank,Tat protein binding (GO:0030957),-0.40632259359909795,-0.9864307078527119,0.48868778280542985,0.7984262690598772,1.0,3/10,16.75%,MDFIC;ACTB;NPM1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.23695586348116962,-0.9849006164090229,0.49869451697127937,0.7981849050561737,1.0,16/100,9.43%,IQGAP2;HIP1;IQGAP1;CLVS2;SESTD1;KCNH1;DENND1B;RACGAP1;PLEKHA5;MYO1G;GOLPH3;DENND1A;PLEKHA3;BTK;PLEKHB2;RUBCN
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4091666499235795,-0.9847668742006342,0.48299319727891155,0.7943123818366684,1.0,3/10,4.94%,SLC8A3;SLC24A2;SLC8B1
prerank,symporter activity (GO:0015293),-0.4115516781418147,-0.9844551128290723,0.481981981981982,0.7908219437651368,1.0,4/10,23.12%,SLC28A2;MFSD2A;SLC5A6;SLC5A5
prerank,endopeptidase activator activity (GO:0061133),-0.4064065455756424,-0.9821085548050428,0.4720357941834452,0.7929719028767724,1.0,3/10,8.10%,NLRC4;PSMD14;PSME2
prerank,histone deacetylase binding (GO:0042826),0.2529096962728691,0.982038097357041,0.4835680751173709,0.9084687145001403,1.0,17/88,15.25%,MEF2C;AKAP8;SIRT2;MTA1;AKAP8L;HDAC10;MEF2D;SUDS3;BCOR;MEF2A;PRDM1;TOP2B;ANKRA2;BRMS1L;MAPK8;HDAC5;TAL1
prerank,magnesium ion binding (GO:0000287),-0.22480615144041724,-0.9806964954061662,0.5378378378378378,0.7925607135933667,1.0,33/135,19.14%,LRRK2;NLRC4;TPPP;PAPOLA;ADCY2;GSS;ERN1;LATS1;TOP2A;PPA1;STK26;SIK3;RAN;YDJC;CDC42BPA;NLK;SIK1;NUDT3;SRR;GNAI1;TESC;GEN1;EYA2;FIGNL1;PDE2A;CDC42BPG;SNCA;IDH2;SRPK2;MSH6;PIF1;IRAK3;NIM1K
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2943011179671183,-0.980621032497708,0.48868778280542985,0.7884986396691441,1.0,9/33,19.22%,SCAF8;GTF2B;WAC;CDC73;CCAR2;SMYD2;ESRRB;SUPT4H1;ZNF326
prerank,adenyl ribonucleotide binding (GO:0032559),0.22039678880830377,0.9799749352972619,0.5345557122708039,0.9104165080275621,1.0,66/291,18.84%,TGFBR1;TWF2;ABCD2;MYO1B;GUK1;MAP4K4;MYO1F;TRNT1;ABCF3;UBA2;TBCK;PFKL;NEK6;MYH9;MKNK1;TAP2;AARS2;MAP4K3;EIF4G1;FICD;CHD8;CARS2;KSR1;RPS6KA5;DHX9;ABCB8;HSPA4;PGK1;ABCE1;SARS2;TSSK4;TSSK6;WNK1;NUAK2;PDK2;SMARCA5;PEX6;MAP4K2;PINK1;UHMK1;CDK11B;AGAP2;MARK2;PRPS1L1;PRPS1;GCLC;ABL1;PXK;ABCF1;LATS2;BLM;AKT1;NDUFA13;NVL;HSPA13;DARS2;CDC42BPB;RPS6KA4;ATP5F1D;TRIB1;NME1;SLC19A1;ACSS2;MAP4K5;PEX1;P2RX5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.26683083705853056,0.9799084810154199,0.48135593220338985,0.9062305219529124,1.0,31/69,31.82%,LPCAT4;DGAT1;CERS3;PLA2G4A;PLA2G15;PORCN;PNPLA1;MOGAT1;MOGAT2;ZDHHC5;ZDHHC13;ZDHHC7;CERS2;ASPG;ZDHHC12;DBT;KAT6B;ELP3;SCP2;HHAT;CERS4;ZDHHC2;NMT1;AWAT2;PLA2G4E;ZDHHC6;ZDHHC8;KAT2B;NAA10;EP300;LPCAT3
prerank,four-way junction DNA binding (GO:0000400),0.3638246787723321,0.9798949278982861,0.47833935018050544,0.9019111806747843,1.0,7/17,23.99%,FANCM;RAD51B;ABL1;BLM;HMGB2;YY1;RAD51C
prerank,lysine-acetylated histone binding (GO:0070577),0.349115464997877,0.9792728004470179,0.47309833024118736,0.895213018950267,1.0,10/20,31.36%,DPF2;TAF1;BRD9;PSME4;CARM1;BRD3;SMARCA4;KMT2A;ATAD2B;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),0.349115464997877,0.9792728004470179,0.47309833024118736,0.895213018950267,1.0,10/20,31.36%,DPF2;TAF1;BRD9;PSME4;CARM1;BRD3;SMARCA4;KMT2A;ATAD2B;BRD7
prerank,protein tyrosine kinase activity (GO:0004713),0.24347715374693873,0.976973367429382,0.4897959183673469,0.8978851530268259,1.0,21/108,14.68%,MERTK;CSF1R;CLK1;LYN;IGF1R;SRC;RYK;PTK2B;CSK;CAMKK2;MET;EPHA8;AXL;PDGFRB;PKDCC;DDR2;BAZ1B;MUSK;ABL1;BMX;DYRK1A
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.38732191707740804,-0.9745702958002467,0.4989733059548255,0.8005682192632254,1.0,2/11,2.52%,SGMS1;SGMS2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4038280355398729,0.9726581859838668,0.49142857142857144,0.9062588323663265,1.0,6/11,24.07%,NAA11;NAA25;NAA50;NAA20;NAA40;NAA60
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.3895303885562459,-0.9724221788025381,0.4827586206896552,0.8018341822411803,1.0,4/11,30.52%,CHRNA4;CHRNB2;CHRNA9;CHRNB4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.2643376075176064,0.9674222264659428,0.5042158516020236,0.9175275305209183,1.0,11/60,12.66%,MERTK;CSF1R;EFEMP1;IGF1R;RYK;MET;EPHA8;AXL;PDGFRB;DDR2;MUSK
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.35313544652183404,0.9643815586610068,0.49814126394052044,0.9226756449784805,1.0,4/18,16.16%,RPS6KA1;CD27;DPEP1;XIAP
prerank,mechanosensitive ion channel activity (GO:0008381),0.3854256588627125,0.9633534066359648,0.5,0.9215026055263899,1.0,5/12,26.09%,TMEM63A;PIEZO1;TMEM63B;TMC6;TMC4
prerank,zinc ion binding (GO:0008270),0.21470986429939531,0.9631289859539148,0.5601092896174863,0.9178824995185241,1.0,54/293,16.24%,ARHGEF2;SLC30A5;SMAD3;SKI;SIRT2;PRIMPOL;HPF1;HDAC10;EGR1;PLA2G15;MT1X;MT1B;MT1H;MT1A;MT1G;MT1M;MT1F;MT1E;SNRPC;ATAD3A;PITRM1;MDM4;TET3;KDM5B;SHH;THAP1;ZMYND11;SLC30A8;ZBTB32;PAPPA2;TAB2;MT2A;ACER3;CHD3;TIMM8B;RNF8;LIMS1;DPEP1;MBD1;CXXC5;PTPN1;RNPEP;SORD;KDM4A;BAZ1B;ZNF3;SLU7;SOD1;BLM;PRDM2;RBSN;UBA5;ZEB1;RNF11
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2028641639782153,0.9623597406478851,0.6176836861768369,0.9159103354212724,1.0,99/597,17.98%,ETV5;BASP1;SMAD3;BACH2;ETS1;NFE2L2;HOXD9;DDIT3;MEF2C;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KMT2D;KLF11;CRY2;NKX2-8;EGR1;MEF2D;KLF3;PAX6;ELK1;ATMIN;TFE3;MEIS3;HOXB8;ZNF568;CUX1;CALCOCO1;CREB3L2;NFATC1;ELK3;MLX;FOXK2;BCOR;ATF3;EGR3;ZBTB18;MCM2;DHX9;KDM5B;EGR2;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;SOX17;POU4F1;HMX2;PKNOX1;KLF12;CHD3;JUN;RXRB;NR2F1;IRF8;PRDM1;LBX1;E2F2;BRCA1;PAX2;TBX6;NFYA;SMARCA2;RUNX1;DPF1;ETV3;TEF;CEBPG;ARNT;ABL1;SP9;ZIC1;ZBTB48;OLIG2;TSPYL2;HDAC5;TAL1;PROX1;TCF7L1;POU2F2;ZBTB2;IRF3;MAFG;HES6;TGIF1;ORC3;IRF9;GATA3;CARM1;HMGB2;CUX2
prerank,actin monomer binding (GO:0003785),0.33426320134511156,0.9599509818641588,0.5298651252408478,0.9188717890223032,1.0,5/22,14.18%,TWF2;ABITRAM;MYL3;ABL1;PFN4
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4011668080953631,-0.9590988638029924,0.5370786516853933,0.8339332911647177,1.0,2/10,4.64%,SHISA6;SHANK3
prerank,double-stranded DNA binding (GO:0003690),0.20350588294940172,0.9572953725684654,0.6099110546378653,0.9225236707368285,1.0,93/531,18.69%,ETV5;BACH2;HOXD9;MEF2C;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KLF11;RAD51AP2;MAU2;NKX2-8;EGR1;ZCCHC3;MEF2D;KLF3;PAX6;ELK1;REXO4;TFE3;MEIS3;HOXB8;CUX1;WDR48;NFATC1;ELK3;MLX;ATF3;EGR3;ZBTB18;DHX9;RAD51B;KDM5B;CGAS;EGR2;ZMYND11;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;PKNOX1;KLF12;JUN;RXRB;NR2F1;IRF8;MBD1;PRDM1;LBX1;E2F2;APTX;PAX2;TBX6;DPF1;ETV3;TEF;CEBPG;ARNT;TARDBP;TERF1;ABL1;SP9;ZIC1;ZBTB48;SAFB;OLIG2;PROX1;TCF7L1;POU2F2;POLG2;AIM2;ZBTB2;IRF3;MAFG;HES6;TGIF1;IRF9;GATA3;HMGB2;CUX2;NTHL1;ZNF740;IRF2;FBH1
prerank,sterol binding (GO:0032934),0.2695226766357697,0.9557717955697054,0.5356521739130434,0.9230104668856682,1.0,20/56,32.34%,GRAMD1A;OSBPL11;OSBPL3;NPC1;NPC2;OSBPL5;TSPO;VDAC1;OSBP;SCAP;VDAC2;PTCH1;SCP2;ABCA1;ANXA6;ERLIN2;INSIG2;STARD5;NR1H3;ABCG1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4022616605661735,0.9553405266851192,0.5073529411764706,0.9201940853157596,1.0,4/11,32.23%,SLC25A45;SLC25A20;SLC25A29;SLC25A47
prerank,chemorepellent activity (GO:0045499),-0.3093097974881325,-0.9545201796108779,0.518348623853211,0.8418480640027695,1.0,4/25,4.79%,NRG3;DPP4;SEMA5A;SEMA4A
prerank,DNA polymerase binding (GO:0070182),0.34448943695856354,0.9538284382683284,0.5436363636363636,0.920467182782097,1.0,8/18,27.61%,PCNA;CDK2AP1;FANCI;POLG2;ACD;SMARCA4;LONP1;RTEL1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.290577321844107,-0.9510068858119773,0.5239179954441914,0.8472108782551817,1.0,7/31,11.45%,UBE2J2;UBE2E2;UBE2W;UBE2N;UBE2Q2;UBE2K;UBE2C
prerank,organic anion transmembrane transporter activity (GO:0008514),0.22944278657529385,0.9508846682726745,0.5865237366003063,0.9250748647315332,1.0,25/134,17.80%,SLCO2B1;SLC7A8;SLC1A3;SLC25A42;SLC7A5;SLC36A1;SLC25A25;SLC15A4;SLC52A3;SLC22A6;SLC17A8;MPC1;SLC52A2;SLC35A1;SLC52A1;SLC16A7;SLC6A9;GJA1;LRRC8A;SLC38A1;SLC17A9;SLC35B4;SLC23A2;SLC23A1;SLC19A1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.21565197238462208,0.9505706759796904,0.5923295454545454,0.9218469412132906,1.0,35/254,12.97%,ETV5;RREB1;SMAD3;ETS1;DDIT3;MEF2C;FOXJ2;UBP1;MLXIP;NKX2-8;EGR1;ELK1;ATMIN;MEIS3;NFATC1;ELK3;FOXK2;ATF3;MDM4;EGR2;ZNF319;ALX4;SOX17;POU4F1;JUN;RXRB;MEF2A;E2F2;ZSCAN21;SMARCD3;NRF1;RUNX1;RLF;CEBPG;E4F1
prerank,phosphate ion binding (GO:0042301),-0.40566447772779596,-0.9474471433781809,0.5244897959183673,0.8528375237580057,1.0,6/10,29.28%,PDE2A;ADSS2;MTHFD2;RELA;CHST14;G6PC1
prerank,C-C chemokine receptor activity (GO:0016493),0.3324378908938304,0.9467220540913521,0.511070110701107,0.9285676187184322,1.0,3/21,13.93%,CX3CR1;CCR7;CCR5
prerank,SH3 domain binding (GO:0017124),0.2612143618153361,0.9453334320974136,0.5466666666666666,0.9282460856497974,1.0,6/62,6.18%,ELMO1;DNM2;ABI3;ARHGAP27;AKAP5;AFAP1L2
prerank,cytokine activity (GO:0005125),0.23237315208132267,0.9449913300851723,0.57984496124031,0.9252446197624987,1.0,25/131,24.53%,IL18;SLURP1;CCL3;WNT2B;WNT10B;CNTF;LEFTY1;IL12B;CTF1;CXCL1;INHA;WNT7B;IL33;IL34;CSF1;OSM;CCL24;IL1A;CXCL10;BMP2;IL36G;TGFB1;CCL25;CKLF;AIMP1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.30075647315706533,-0.9441482473901428,0.5345622119815668,0.8573746452247734,1.0,12/24,35.75%,RPS7;RPL41;RPL26;RPS14;SHMT1;SYNCRIP;UTP23;MYH10;GNL3;RPL5;DHX36;FMR1
prerank,nuclear import signal receptor activity (GO:0061608),0.35486777177193324,0.9439418989975477,0.5358490566037736,0.9240587095467623,1.0,9/15,33.95%,TNPO1;IPO4;TNPO3;KPNA3;IPO5;IPO9;HIKESHI;KPNA1;KPNA7
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4045221614899269,0.9430847392063161,0.5510204081632653,0.9224697663405973,1.0,6/10,24.83%,KDM4A;KDM8;KDM7A;KDM2A;KDM2B;PHF8
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.40790217485602676,0.9424986445341057,0.519774011299435,0.9202496696582148,1.0,4/10,18.87%,DCLRE1B;EXO1;DCLRE1C;DCLRE1A
prerank,ferrous iron binding (GO:0008198),0.32835491840256714,0.9414452092485901,0.5416666666666666,0.9193500506091683,1.0,4/21,6.59%,FECH;PHYH;EGLN1;ISCU
prerank,sulfuric ester hydrolase activity (GO:0008484),0.37987439951532026,0.9399890144154698,0.5471698113207547,0.9196108080670162,1.0,6/12,25.37%,ARSB;ARSK;ARSA;GNS;ARSI;SULF1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2720671490434341,-0.9397136956971043,0.5506912442396313,0.8651925459933716,1.0,15/35,28.53%,TBPL1;FOXP1;GTF2B;MMP12;H3-3A;NR3C1;NPM1;KLF10;PIH1D1;DRAP1;HDAC1;FOS;RELA;AGO2;RRN3
prerank,protein homodimerization activity (GO:0042803),-0.18230585016173415,-0.9377649022963522,0.805,0.8660069186649966,1.0,106/589,15.75%,HIP1;DPYD;ZBTB16;LRRK2;TENM3;XDH;NLRC4;KCNN2;PTPRT;MKLN1;SLIT2;DPP4;LILRB1;CPQ;ABCB7;TPPP;GSS;MME;EXT1;ERN1;MTUS2;SLK;B2M;LRRFIP1;CENPF;CRPPA;TENM2;TOP2A;NTRK2;PEX11A;SYNE1;EEA1;LRP6;CACYBP;USF1;MID2;APOE;GBP3;STK26;SLC8B1;DNM1L;S100A11;CEBPB;MIGA1;BARD1;IKZF3;JAML;XPNPEP3;XPA;PKD2;ERBB4;TRIM37;PSMF1;TPD52L1;TAP1;GGCT;ZBTB7B;AXIN1;NECTIN1;SNX9;SYNDIG1;TENM4;GBP4;ATG7;MTCL1;MFF;CCDC88A;BAK1;MTMR1;ADCY8;ADRA2A;SRR;AHR;CR2;TESC;GBP2;CEBPA;KIT;MAP3K13;PDLIM4;GEN1;GYG1;SHMT1;JCHAIN;ALDH3A2;GLA;ACHE;HMOX1;PDE2A;PECAM1;CCL5;INPP5F;HMGCS1;RBPMS2;BANF1;TIMM10;NAGA;S100A1;BCL2;DROSHA;MVD;FOXP2;SLC39A13;NACC2;EXT2;SRF
prerank,Hsp90 protein binding (GO:0051879),0.2969299571966915,0.9371786715237905,0.5579710144927537,0.9235804200673801,1.0,13/33,27.78%,CSNK2A1;USP19;PPID;HDAC8;STUB1;NOD2;MAPT;TELO2;HIF1A;HDAC6;CHORDC1;PPP5C;PPEF2
prerank,mannosyltransferase activity (GO:0000030),0.3275178092343893,0.9362073402460278,0.5532286212914486,0.9222985676148084,1.0,6/21,15.15%,DPY19L4;ALG12;PIGV;POMT1;ALG2;ALG8
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.36630802829456427,0.9358651992170699,0.56353591160221,0.919250164198134,1.0,4/14,14.63%,CASP1;APAF1;RPS27L;PYCARD
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.2604795738527615,-0.9345129752929375,0.5714285714285714,0.8702368146297244,1.0,7/42,9.01%,STAP1;NCK2;SHC3;IRS1;YWHAE;PTPN3;SHF
prerank,transcription cis-regulatory region binding (GO:0000976),0.20334837221544386,0.9339088946630816,0.6724832214765101,0.9205903863336413,1.0,64/406,15.69%,ETV5;BASP1;RREB1;SMAD3;ETS1;NFE2L2;HOXD9;DDIT3;MEF2C;FLI1;MLXIP;KMT2D;KLF11;ZFP90;CRY2;DEAF1;EGR1;MEF2D;PAX6;ELK1;ATMIN;TFE3;HOXB8;ZNF568;CUX1;RBL2;CALCOCO1;CREB3L2;ELK3;MLX;FOXK2;BCOR;ATF3;EGR2;FOXN3;BARHL1;ALX4;SOX17;TWIST2;HMX2;CHD3;JUN;NPAS1;RXRB;MEF2A;E2F2;BRCA1;PAX2;NFYA;SMARCA2;RUNX1;ARNT;E4F1;MXI1;ZNF3;TAF4;ZBTB48;PRDM2;ZBTB8B;HDAC5;TAL1;PROX1;TCF3;POU2F2
prerank,guanyl ribonucleotide binding (GO:0032561),0.21594132283371723,0.930697922386789,0.6511278195488722,0.9251765565190939,1.0,66/196,28.63%,DNM2;TUBA4A;RAC1;RND1;TGM2;ARL5C;RHOQ;RHOB;RHOBTB1;CNGB3;TUBB;TUBB1;RND2;TUBG1;RHOH;ARFIP2;RAB4A;RRAS2;RAB39A;TUBA8;GBP6;RAB35;RRAD;NMUR2;TUBA1A;AGAP2;DIRAS2;SCG5;RRAGA;RAB32;ARL3;RAB27A;GBP5;MRAS;RAB13;NME1;SLC19A1;ARL11;GNL1;GBP7;NUDT16;TUBD1;RAC3;RAB8B;ARHGEF5;ARF1;ARF4;RAB9A;RALB;TUBB3;NRAS;EIF2B2;RHOC;SEPHS1;RAP2B;ARL8B;ANXA6;RAP1B;MMAA;RANBP17;RRAS;ARL6;NOA1;RAB2A;RAB26;PIP4K2B
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3488466330603228,0.9304105815616847,0.5477477477477477,0.9221175805949855,1.0,8/17,25.91%,PCTP;PITPNC1;PITPNM1;ABCB4;MTTP;PITPNM2;PITPNB;ABCA1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.37092224383941724,-0.9295736733615428,0.5581395348837209,0.8790906984052125,1.0,6/11,19.12%,ATP11A;ATP11C;ABCA4;ATP10B;ATP8B2;ATP10A
prerank,SUMO transferase activity (GO:0019789),0.3396062712794264,0.9295521530184964,0.5483271375464684,0.9206971613524496,1.0,5/16,20.54%,RANBP2;EGR2;PIAS3;PIAS2;TOPORS
prerank,RNA polymerase II complex binding (GO:0000993),-0.2805877306529505,-0.9283819856490338,0.5807962529274004,0.8778732346555351,1.0,9/32,19.22%,SCAF8;GTF2B;WAC;CDC73;CCAR2;SMYD2;ESRRB;SUPT4H1;ZNF326
prerank,CXCR chemokine receptor binding (GO:0045236),0.38073012478165214,0.9282064998852957,0.5758157389635317,0.9203661815760447,1.0,2/11,8.81%,ITCH;CXCL1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.34881994245001424,-0.9277108509309808,0.5576519916142557,0.8753075320594658,1.0,6/13,17.94%,PLPP5;PLPPR4;PLPP4;PLPPR1;PLPP3;PLPPR3
prerank,gated channel activity (GO:0022836),0.35833252563533285,0.927695585244591,0.56,0.9179929248000528,1.0,6/14,26.09%,TMEM63A;PACC1;PIEZO1;TMEM63B;TMC6;TMC4
prerank,metalloendopeptidase activity (GO:0004222),-0.23416084290592135,-0.9274602621123804,0.628498727735369,0.8715668537956259,1.0,19/76,19.08%,MMP16;MME;ADAMTS17;TRABD2B;THSD4;ADAMTS19;ADAM33;MMP12;MMP15;ADAMTSL1;ADAMTSL5;MMP19;MMP8;PHEX;MMP14;SPG7;ADAMTS10;ADAMTSL4;ADAMTS12
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.21997427137968528,0.9256422318804984,0.6373134328358209,0.9198293798621977,1.0,43/181,17.61%,SMAD3;NFE2L2;PPARD;MTA1;TACC1;ELK1;RBL2;NFATC1;FIZ1;DHX9;TAF6;SIN3A;EGR2;MTDH;ANKRD2;JUN;MEF2A;RNF25;SMARCD3;COMMD6;DLL1;TBX6;BBS2;TAF1;ARNT;WWP2;RERE;TAF4;GABARAPL1;PIAS3;HDAC5;GTF2I;PIAS2;TAL1;PROX1;MAPK14;NCOA3;TCF3;NRIP1;COMMD7;DTX3L;HES6;KDM1A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2791751889918638,-0.9249830799505736,0.5579710144927537,0.8740539186133003,1.0,13/33,28.71%,DCUN1D2;RPS3;ZMYM2;RNF19A;PRKN;DCUN1D3;RNF19B;RNF217;SIAH2;ANKIB1;PPARA;UBE3D;RNF14
prerank,RNA cap binding (GO:0000339),0.3413668061210915,0.9248793832423188,0.5571955719557196,0.9180883309101081,1.0,6/16,21.91%,NCBP1;CYFIP1;SNUPN;DCPS;EIF3D;LARP1
prerank,alkali metal ion binding (GO:0031420),0.3648365772120904,0.9247124789648743,0.5666666666666667,0.9147936460108663,1.0,3/13,16.32%,CAPN3;IMPA1;ADPRH
prerank,regulatory RNA binding (GO:0061980),0.2828177350550779,0.923359113343743,0.5595238095238095,0.9147086224912517,1.0,11/38,27.57%,TLR7;DHX9;PIWIL1;HNRNPA2B1;ZC3H12A;ELAVL1;AGO1;HNRNPA1;RBM4;TLR9;PUM1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.339121076206347,-0.9219856773442253,0.5504587155963303,0.8776141682011759,1.0,7/15,23.15%,AGPAT4;GPAT3;AGPAT1;ABHD5;AGPAT3;PNPLA3;GPAT2
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.24946469213544237,-0.9216004993260539,0.5979899497487438,0.8743246723842342,1.0,7/53,8.25%,DPYD;CYBB;XDH;MICAL3;SDHA;KDM1B;KMO
prerank,C-C chemokine binding (GO:0019957),0.32442804368068817,0.920329781469063,0.5595463137996219,0.9191310793519457,1.0,1/22,0.04%,CX3CR1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.35374458554231636,-0.9198120875012671,0.5670995670995671,0.874693491829701,1.0,7/13,24.58%,RYR2;PKIA;GSK3B;KCNQ1;EZR;PRKAR1A;PRKAR2B
prerank,peptidase activator activity (GO:0016504),-0.3030706404644665,-0.9195438589913971,0.5707762557077626,0.8712156113267159,1.0,5/22,12.82%,NLRC4;PSMD14;CLPX;PSME2;MAL
prerank,transcription corepressor binding (GO:0001222),-0.28923830472667245,-0.918735218193473,0.5591647331786543,0.8690559798983544,1.0,6/27,14.90%,ZBTB16;MTF2;PER2;WIZ;LCOR;PER1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3688021690352989,0.9184746752242139,0.5531135531135531,0.920400244059588,1.0,2/12,15.07%,SPPL2B;CTSE
prerank,phosphotyrosine residue binding (GO:0001784),0.28256968201871085,0.917373612379401,0.5583756345177665,0.9196049730410776,1.0,11/37,19.83%,VAV2;PIK3R1;PLCG2;SHB;PTPN11;ABL1;LDLRAP1;PIK3R3;PTPN5;SHE;CRKL
prerank,sequence-specific DNA binding (GO:0043565),0.19370672981611328,0.9146665514342206,0.77125,0.9227982467093956,1.0,96/590,17.98%,ETV5;SMAD3;BACH2;NFE2L2;HOXD9;MEF2C;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KLF11;NKX2-8;EGR1;ERF;MEF2D;KLF3;PAX6;ELK1;TFE3;MEIS3;HOXB8;CTC1;CUX1;ZBTB21;CALCOCO1;NFATC1;ELK3;MLX;FOXK2;ATF3;EGR3;ZBTB18;TET3;KDM5B;THAP1;CXXC1;EGR2;NLRP3;SLTM;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;PKNOX1;KLF12;JUN;PRMT1;RXRB;NR2F1;IRF8;MBD1;MEF2A;CXXC5;PRDM1;LBX1;E2F2;PAX2;TBX6;TAF1;DPF1;ETV3;ERH;TEF;CEBPG;ARNT;TERF1;ABL1;SP9;ZIC1;SAFB;OLIG2;CSRNP2;PRDM2;PROX1;TCF7L1;POU2F2;TEN1;ZBTB2;IRF3;POU2F1;MAFG;HES6;TGIF1;KDM1A;IRF9;GATA3;CUX2
prerank,MHC protein binding (GO:0042287),-0.3130192207025362,-0.9119695741533091,0.6083150984682714,0.8820535905622688,1.0,3/20,7.09%,CD74;LILRB1;TAP1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2481336593592401,0.9113498218516359,0.6243567753001715,0.9277109585072154,1.0,18/72,20.74%,ADAP2;TWF2;MYO1B;FLII;PICALM;SNX18;CGAS;AVIL;PLEKHA4;RAB35;HIP1R;LDLRAP1;ANXA9;KCNJ2;GRAMD2A;KRIT1;EXOC1;SDCBP2
prerank,cation transmembrane transporter activity (GO:0008324),0.2649244075563634,0.9112250539899823,0.5982905982905983,0.9243803911394624,1.0,6/48,8.74%,SLC7A8;SLC7A5;SLC36A1;SLC15A4;SLC22A2;SLC29A4
prerank,nuclear receptor binding (GO:0016922),0.23071818605384387,0.9102437995235315,0.6613162118780096,0.9233960555192885,1.0,23/111,16.25%,BRD8;SMAD3;PRMT2;YWHAH;DDX5;TGFB1I1;CNOT1;PHB2;TACC1;PADI2;PPID;MMS19;KDM3A;SMARCD3;PRKCB;TAF1;CCDC62;DDX54;MED4;PROX1;NCOA3;NRIP1;MED25
prerank,calcium activated cation channel activity (GO:0005227),-0.3231649393159678,-0.9097707131816978,0.5763888888888888,0.8835332304559351,1.0,6/17,13.84%,KCNN2;TMEM63C;KCNMB2;ANO6;KCNMB4;ANO10
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.28796849821185844,0.9079266484086034,0.591726618705036,0.9256790703814799,1.0,3/32,2.37%,SLC7A8;SLC7A5;SLC36A1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.33115725135877233,-0.9075613433822673,0.5813449023861171,0.885081977329159,1.0,6/15,18.23%,SLC1A6;SLC1A5;SLC25A12;SLC25A18;SLC1A1;SLC1A4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.35059239630760686,-0.9056791889360863,0.5970772442588727,0.8854966916100662,1.0,6/12,26.65%,TBPL1;GTF2B;H3-3A;HDAC1;FOS;RELA
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.366416688017435,-0.904727319280477,0.5911949685534591,0.8836210489030472,1.0,2/11,12.33%,EGFR;MAP3K13
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.36565219362162593,-0.9042351441363701,0.5894039735099338,0.8807214775862575,1.0,1/10,1.62%,DPYSL5
prerank,neuropeptide receptor binding (GO:0071855),0.3466322909306555,0.9027640961738213,0.5845323741007195,0.9351753011425893,1.0,2/14,7.16%,NPY;PPY
prerank,acetylcholine receptor activity (GO:0015464),0.3162405531276034,0.8973029371943677,0.6237113402061856,0.9457681820777698,1.0,4/22,15.11%,CHRM1;CHRNB3;CHRNA3;ANXA9
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.32942143672181845,0.8971541740325518,0.5857142857142857,0.9424397533713206,1.0,10/17,34.69%,NME4;CMPK1;NME6;NME1;AK8;DTYMK;AK1;CLP1;AK7;CMPK2
prerank,cation:chloride symporter activity (GO:0015377),-0.37278806582173507,-0.8956449848429517,0.5947712418300654,0.8976117327845745,1.0,6/10,23.14%,SLC12A8;SLC12A4;SLC12A5;SLC12A1;SLC6A1;SLC12A3
prerank,5'-nucleotidase activity (GO:0008253),-0.3433506099005985,-0.8944554457785433,0.6017505470459519,0.8962936137519547,1.0,1/13,3.53%,NT5C3B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.34005478450579474,0.8943693727586205,0.6158088235294118,0.9459878081219364,1.0,3/14,6.75%,CIAO3;ISCU;ACO2
prerank,Hsp70 protein binding (GO:0030544),-0.2760168245636866,-0.8938202137708813,0.6152073732718893,0.893608720208532,1.0,11/31,23.11%,ERN1;RPS3;PRKN;SPN;METTL21A;MVD;SNCA;DNAJC2;TSC1;DNAJB2;SACS
prerank,heme binding (GO:0020037),-0.2305331482081752,-0.8937512660247653,0.655940594059406,0.8896705228908232,1.0,19/65,23.23%,CYBB;SDHC;GUCY1B1;JAK2;CYP2U1;FLVCR1;THAP4;PGRMC2;SDHD;FLVCR2;HMOX1;STEAP4;CYCS;CYB5B;CAT;NOX4;CYP51A1;BACH1;CYP2S1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2920007470263191,0.8921078319853515,0.6320582877959927,0.948025531948093,1.0,5/29,9.59%,PKIG;INCA1;SPRY2;RPTOR;INKA1
prerank,kinesin binding (GO:0019894),-0.27846971937915127,-0.8919871232267911,0.6236323851203501,0.8895186315838873,1.0,8/27,15.29%,KIF1B;TOR1A;ACTB;PRC1;NEFH;KIF18B;FAM83D;SNCA
prerank,E-box binding (GO:0070888),-0.2609525649943733,-0.8913507546890357,0.6556603773584906,0.8869714966112353,1.0,14/34,34.17%,PPARG;CLOCK;AHR;SCX;PER1;SNAI2;BHLHE40;SCRT2;NEUROD2;NEUROG2;TCF15;SNAI1;NEUROD1;HES1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.26815495401715717,-0.8913424058499235,0.6543778801843319,0.8829767263071376,1.0,7/34,11.45%,UBE2J2;UBE2E2;UBE2W;UBE2N;UBE2Q2;UBE2K;UBE2C
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2393481568142339,0.8894771409645895,0.6323529411764706,0.9511478102919295,1.0,21/75,24.47%,HSD3B2;HPGD;CBR1;DHRS4;IMPDH1;SORD;KCNAB3;CRYL1;HADHB;HSD17B10;PTGR1;MDH1;LDHAL6B;KCNAB1;AKR1B10;RDH11;NSDHL;LDHA;GLYR1;ME2;SPR
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.345198958665202,-0.8891552924756025,0.6150537634408603,0.8841351888499441,1.0,4/13,10.43%,PIK3C2A;PIK3C2B;PIP5K1B;PIK3C2G
prerank,phosphatidic acid binding (GO:0070300),-0.30296378042928085,-0.8882362742697536,0.6215538847117794,0.882372895937039,1.0,3/19,4.05%,RAPGEF2;SESTD1;PLTP
prerank,kinase inhibitor activity (GO:0019210),-0.2627105118922472,-0.8878008452710975,0.639269406392694,0.879401057646233,1.0,12/33,23.43%,SH3BP5;LRP6;SMCR8;DNAJC3;SPRY4;CDKN1A;SNCA;NPM1;DUS2;CDKN1C;GMFG;SH3BP5L
prerank,phosphatidylinositol binding (GO:0035091),0.23018632267374417,0.887141876655136,0.6897106109324759,0.9532213319966264,1.0,29/91,22.92%,PITPNC1;ITPR2;PICALM;MYO1E;SNX22;NUMA1;C2CD2L;PIGK;APPL1;DPEP1;SNX31;PARD3B;HIP1R;DENND1C;SNX5;PASK;SNX13;PITPNM1;SCARB1;ZFYVE16;FES;PIGU;GRAMD2A;GAP43;MAPT;RNF34;ANKFY1;PITPNM2;EXOC8
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3347938756312546,-0.886498029888065,0.5935483870967742,0.8786201539618628,1.0,5/14,17.16%,KCNJ3;KCND3;KCNQ1;KCNIP2;KCNE3
prerank,phosphatase activity (GO:0016791),-0.22420458123515535,-0.8848768602841095,0.7202970297029703,0.8783072817259941,1.0,27/73,26.26%,PLPP5;PLPPR4;PTPN22;PLPP4;HDDC2;PLPPR1;DUSP10;DUSP26;ACP5;PXYLP1;DUSP16;OCRL;ENOPH1;MDP1;PLPP3;DUSP28;PLPPR3;SACM1L;ALPL;PRUNE1;NOCT;HDHD2;LPIN3;BPNT2;EPHX2;LHPP;DUSP4
prerank,carbohydrate kinase activity (GO:0019200),0.3614085451638544,0.8846112581383709,0.6151142355008787,0.956052987621767,1.0,5/11,22.85%,HK2;XYLB;KHK;GNE;HK3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3446290720414422,0.8820552190132084,0.6340579710144928,0.9584830806646417,1.0,3/14,12.19%,MTMR10;MTMR14;MTMR4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.28707362860262303,-0.8816245884048678,0.6385809312638581,0.8821835161977121,1.0,7/24,17.45%,SESTD1;PLEKHA5;GOLPH3;PLEKHA3;OSBPL8;PLEKHF1;CERT1
prerank,neuropeptide binding (GO:0042923),-0.3041554624758048,-0.8806835097957729,0.625,0.880509159560594,1.0,6/18,37.52%,OPRM1;OPRD1;MC4R;NMUR1;SORL1;GPR37
prerank,CARD domain binding (GO:0050700),0.3470981101099886,0.8790071326191038,0.6175942549371634,0.9621415247729455,1.0,4/14,20.07%,RIPK2;CASP1;MAVS;NOD2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2357237635338919,0.878888193440869,0.6840390879478827,0.9588038795543383,1.0,8/73,9.80%,CX3CR1;HCRTR1;MC2R;RXFP3;CALCR;FSHR;LHCGR;INPP5K
prerank,protein phosphatase 1 binding (GO:0008157),0.31000729918904757,0.878533436006762,0.6182432432432432,0.9560696237185368,1.0,2/21,2.55%,PPP1R3E;PPP1R9B
prerank,endopeptidase inhibitor activity (GO:0004866),0.23228653160493817,0.8775944833472068,0.7027463651050081,0.9545886950555366,1.0,13/82,16.94%,BIN1;CST3;UCHL5;PROS1;SLPI;LXN;GAPDH;SERPINE1;SERPINE2;SERPINF1;SPINT2;AGT;SPINK5
prerank,endonuclease activity (GO:0004519),0.25448842711721653,0.8745594823163203,0.6771523178807947,0.9582069167262971,1.0,16/49,23.51%,YBEY;INTS11;REXO4;PIWIL1;RCL1;KHNYN;ERCC4;ZC3H12C;ZC3H12B;DIS3;NTHL1;TSNAX;SND1;ZC3H12A;EXOG;AGO1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2978221583796852,0.8740961192332947,0.6247689463955638,0.9557749722310965,1.0,9/22,22.16%,ZFP36L1;ZFP36L2;RBM24;CPSF1;ELAVL3;EXOSC8;ZC3H12A;CPEB1;ELAVL1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3691890659293078,0.8733036623249899,0.630188679245283,0.9542064417803859,1.0,5/10,24.07%,NAA11;NAA25;NAA50;NAA20;NAA60
prerank,solute:sodium symporter activity (GO:0015370),-0.2725430723988404,-0.871561697826666,0.6481481481481481,0.8979717939394868,1.0,6/27,19.07%,SLC5A7;SLC4A10;SLC28A2;SLC4A8;SLC13A5;SLC5A6
prerank,NADPH binding (GO:0070402),-0.33287969649560184,-0.8708529144331257,0.6320346320346321,0.8955973464194519,1.0,8/13,28.87%,LBR;HMGCR;DUS2;GRHPR;CBR4;DHFR;CRYZ;DECR1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2511802728677567,0.8703865988005723,0.7096774193548387,0.9575183963375065,1.0,4/51,3.30%,SLCO2B1;SLC7A8;SLC7A5;SLC20A2
prerank,poly(U) RNA binding (GO:0008266),0.3046580606175927,0.8702172910647363,0.6357142857142857,0.9544028645188528,1.0,4/20,6.87%,SSB;HNRNPC;DIS3L2;HNRNPH1
prerank,mRNA 3'-UTR binding (GO:0003730),0.22685492453985417,0.8697628983166233,0.7244732576985413,0.9518663844487946,1.0,33/79,29.47%,SECISBP2;DDX5;HNRNPC;CELF2;ZFP36L1;ZFP36L2;RBM24;RNF20;CPSF1;CSDC2;TARDBP;IGF2BP2;ELAVL3;FXR2;EXOSC8;BOLL;HNRNPA2B1;ZC3H12A;CPEB1;LARP1;DAZAP1;ELAVL1;TP53;PCBP4;PARN;CCT5;CPEB2;RBM4;LARP4B;PUM1;CARHSP1;ILF3;LARP4
prerank,mRNA methyltransferase activity (GO:0008174),0.34779887469334797,0.8673422284511388,0.626641651031895,0.9541316749766781,1.0,5/12,24.28%,RNMT;METTL14;TRMT61A;PCIF1;METTL8
prerank,chemokine receptor activity (GO:0004950),0.29275061360606786,0.8667438069670447,0.6445672191528545,0.9521276029340741,1.0,1/24,0.04%,CX3CR1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.218019233895949,-0.8661792993594001,0.7445054945054945,0.9019312486008729,1.0,9/71,8.09%,PTPRG;PTPRD;PTPRN2;PTPRT;PTPN22;PTPN12;PTPN3;TNS2;PTPN2
prerank,RNA stem-loop binding (GO:0035613),0.34978523743402007,0.8634937724969194,0.6254901960784314,0.9561428109994949,1.0,5/12,23.08%,DHX9;EPRS1;ZC3H12A;DDX3X;RC3H2
prerank,Toll-like receptor binding (GO:0035325),0.36555589945713574,0.8591165455896457,0.6483126110124334,0.9624662337544663,1.0,1/11,0.52%,UNC93B1
prerank,cholesterol binding (GO:0015485),0.2504342703217301,0.8559516104495275,0.723292469352014,0.965971197269124,1.0,16/47,32.34%,GRAMD1A;OSBPL3;NPC1;NPC2;OSBPL5;TSPO;VDAC1;VDAC2;PTCH1;SCP2;ABCA1;ANXA6;ERLIN2;STARD5;NR1H3;ABCG1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.34879682221624553,-0.854758597755894,0.6247288503253796,0.9224958468959675,1.0,5/10,18.66%,NSD3;NSD1;SETD5;SMYD2;SETMAR
prerank,chemokine binding (GO:0019956),0.2728675413624034,0.8540000866789866,0.6724137931034483,0.9667653493923968,1.0,3/30,8.05%,CX3CR1;ITGAV;CCR7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.24482498333316444,0.852157908561026,0.7280701754385965,0.9673614186663886,1.0,13/55,21.99%,SLC7A8;SLC16A6;SLC7A5;SLC36A1;SLC16A7;SLC38A10;SLC38A1;SLC23A2;SLC23A1;SLC19A1;SLC25A10;SLC16A4;SLC38A7
prerank,enoyl-CoA hydratase activity (GO:0004300),0.35795457812273,0.8511555682908666,0.6292134831460674,0.9660152883059056,1.0,4/10,15.66%,ECHS1;ECI1;ECHDC2;HADHB
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.34054597635615536,0.8504476538933409,0.6754716981132075,0.9640570534629797,1.0,3/12,12.33%,NCBP1;CYFIP1;DCPS
prerank,nuclear export signal receptor activity (GO:0005049),0.35195037463999257,0.8488663655254174,0.6299065420560748,0.9640022966649583,1.0,7/11,31.60%,NUP42;CSE1L;XPO5;XPO1;RANBP17;XPO6;NUP214
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.24769302576602903,-0.8475503211952671,0.723404255319149,0.9339695761246142,1.0,15/34,27.56%,SUV39H1;KMT2E;NSD3;EEF1AKMT1;TTLL12;EEF1AKMT2;SMYD2;METTL21A;CAMKMT;EHMT1;EEF1AKMT4;METTL21C;EEF1AKMT3;KMT5B;ETFBKMT
prerank,anion:anion antiporter activity (GO:0015301),-0.3006320121731618,-0.8466366804743636,0.6931818181818182,0.9319625124793609,1.0,6/17,22.32%,SLC26A7;SLC26A2;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,protein phosphatase binding (GO:0019903),0.21107687499987648,0.8453250803045184,0.8125984251968504,0.9685724435868392,1.0,21/117,16.67%,SIRPA;CTTNBP2NL;PPP1R3E;PPP6R3;PIK3R1;PPP1R9B;AKAP5;MET;PPP6R1;VRK3;FBXL2;CEACAM1;DLG4;MTMR4;CD33;SOD1;MAPK14;KIF3A;SNX3;MASTL;STAT6
prerank,amino acid:sodium symporter activity (GO:0005283),0.35048135709330774,0.8416205490404312,0.6672661870503597,0.9731138427910052,1.0,1/11,0.82%,SLC1A3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2712517609194858,0.8398497861680937,0.7078260869565217,0.9734182609772744,1.0,4/30,10.02%,CST3;RPS6KA1;CD27;DPEP1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3291120376636429,0.8397565881098272,0.6859083191850595,0.9701853198572101,1.0,4/14,17.55%,POP1;TSEN2;RPP21;ELAC2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.27424481157724684,-0.8397157851830547,0.6950959488272921,0.942406996861721,1.0,9/26,26.07%,AGBL4;AGBL1;AEBP1;VASH2;AGBL2;ACE2;CPXM2;CPA2;PEPD
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.22996574606578263,0.8395008593961582,0.7764900662251656,0.9674169722699034,1.0,10/60,14.26%,LRRC39;PPM1H;PPM1L;RPAP2;PP2D1;ILKAP;LRRK1;CDC14B;TIMM50;PPP1CB
prerank,MAP-kinase scaffold activity (GO:0005078),-0.337238929242774,-0.8394139256416043,0.6728395061728395,0.9390914218833615,1.0,2/11,4.30%,IQGAP1;SH3RF1
prerank,methyltransferase activity (GO:0008168),0.24844950031221688,0.839122187459109,0.7538200339558574,0.9648576158211043,1.0,19/46,29.78%,BUD23;COMT;MGMT;PRMT8;PRMT1;ASMT;ARMT1;BCDIN3D;CARNMT1;FTSJ3;GAMT;NSUN3;NSUN4;FTSJ1;RRP8;NDUFAF7;METTL4;LCMT1;LRTOMT
prerank,serine-type peptidase activity (GO:0008236),0.21783435025897277,0.8386047561304851,0.7775947281713345,0.9625388506724473,1.0,10/96,8.65%,KLK2;PRSS36;ST14;NAALAD2;F12;MMP2;KLK8;MBTPS1;PRSS38;KLK11
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.34181638873928455,0.8365625884532617,0.6815742397137746,0.9636013942930177,1.0,2/12,4.67%,GREM1;VEGFB
prerank,vitamin D receptor binding (GO:0042809),-0.2996606485620336,-0.8347071989390465,0.7023255813953488,0.9454036228430611,1.0,5/14,28.41%,TAF7;SNW1;MED14;MED16;MED1
prerank,glutathione transferase activity (GO:0004364),-0.2685991538664851,-0.8329469328064852,0.7300469483568075,0.94489528857178,1.0,11/23,32.06%,MGST1;ALOX5AP;GSTT1;PTGES;GSTP1;MGST3;GSTZ1;GSTK1;LANCL1;MGST2;GSTA2
prerank,beta-tubulin binding (GO:0048487),0.2651097386564641,0.8316376524345338,0.6992337164750958,0.9706531448950566,1.0,8/31,18.82%,FGF13;APPL1;TRPV4;GABARAPL1;VAPB;LRPPRC;UXT;EML4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.34559094736301743,-0.8300430164556212,0.6856540084388185,0.9466232093077059,1.0,2/10,3.44%,PKIA;PRKAG2
prerank,mannose binding (GO:0005537),0.3437486233009326,0.8287233449424577,0.7176684881602914,0.9731211392897502,1.0,2/12,8.34%,COLEC11;LMAN1L
prerank,retinoic acid receptor binding (GO:0042974),0.30679979236824767,0.8260367144287575,0.7109090909090909,0.9753024876372611,1.0,3/17,4.27%,PRMT2;CNOT1;TACC1
prerank,3'-5' exonuclease activity (GO:0008408),0.24273009817407062,0.8250510762941882,0.7546218487394958,0.9741029927954774,1.0,9/45,16.62%,REXO4;DIS3L2;REXO2;RAD1;EXOSC10;EXOSC5;DIS3;ERI3;ISG20
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2610799748690829,-0.8249778767006912,0.7312072892938497,0.9528466214505457,1.0,10/27,23.89%,ITPR1;ATP2B1;TMEM165;ATP2A3;SLC4A8;MMGT1;MAGT1;AQP1;SLC12A3;KCNA1
prerank,CCR chemokine receptor binding (GO:0048020),-0.2572715938567704,-0.8248433924126368,0.7579908675799086,0.949136940226811,1.0,11/28,34.98%,CCR2;CX3CL1;CCL5;CCL14;CCL7;NES;CCL19;CCL8;MSMP;CCL4;DEFB130A
prerank,metallopeptidase activity (GO:0008237),-0.1941325925210123,-0.8239147408067863,0.8839779005524862,0.9470141671981707,1.0,29/113,21.55%,MMP16;MME;PSMD14;ADAMTS17;TRABD2B;THSD4;ADAMTS19;ADAM33;MPND;MMP12;MMP15;ADAM12;ANPEP;ADAMTSL1;ADAMTSL5;MMP19;MMP8;PHEX;MMP14;ADAM21;SPG7;LNPEP;ADAMTS10;ADAMTSL4;ADAMTS12;ACE;ADAMTS14;ACE2;ADAM2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3134144609107,-0.8230370367346669,0.7136363636363636,0.9448069579128363,1.0,1/12,0.24%,B3GALT1
prerank,inward rectifier potassium channel activity (GO:0005242),0.27876879856585063,0.8215621379995648,0.71160409556314,0.9776689338996578,1.0,3/24,6.35%,KCNK6;KCNN1;ABCC9
prerank,protein phosphatase 2A binding (GO:0051721),-0.2691145619538112,-0.8175902900602929,0.753880266075388,0.9512952342572888,1.0,5/23,10.29%,SMG7;STRN3;GRIN3A;SMG5;ADCY8
prerank,cytokine receptor binding (GO:0005126),0.21559065141017836,0.8161979762621326,0.8028846153846154,0.9844946937961327,1.0,21/83,24.23%,IL18;SMAD3;VEGFB;IL6ST;CNTF;IL12B;DDT;IL6R;IL34;TIMM50;PYCARD;CSF1;OSM;TYK2;CCRL2;ADAM17;SPRED2;ERAP1;PXDN;CCL25;FADD
prerank,phosphatase binding (GO:0019902),0.20810384232741913,0.8159782251184312,0.8662207357859532,0.9816005048528316,1.0,21/105,16.67%,SIRPA;SMAD3;PPP6R3;PIK3R1;CRY2;MET;PPP6R1;VRK3;WNK1;FBXL2;CEACAM1;SH2D4A;DLG4;MTMR4;CD33;CSRNP2;SFI1;MAPK14;KIF3A;SNX3;STAT6
prerank,endopeptidase activity (GO:0004175),0.18617949719116783,0.8143441314154799,0.9280469897209985,0.9814767174820833,1.0,53/257,22.11%,USP35;KLK2;UCHL1;USP8;USP12;PRSS36;ADAMTS1;CASP1;F12;CTSS;MMP2;LGMN;PITRM1;USP28;KLK8;MBTPS1;USP25;ADAM28;PRSS38;RCE1;MBTPS2;ADAMTS4;USP36;PSEN2;PSMB3;USP5;JMJD7;CTSF;USP9Y;PSMA7;PDIA3;MIPEP;NRDC;HPN;CTSE;KLK9;RHBDD3;PLG;PSMB9;ADAM10;MMP28;KDM8;HTRA2;AFG3L2;PIDD1;PSMB5;ADAMTS20;ADAM17;ADAMTS18;PSMB7;FURIN;MMP24;MMP25
prerank,telomeric DNA binding (GO:0042162),0.25952714336644833,0.812260118375172,0.7535460992907801,0.9821403869669241,1.0,14/32,27.47%,CTC1;TERF1;ZBTB48;BLM;TEN1;KDM1A;ACD;XRCC6;HNRNPA2B1;TELO2;STN1;UPF3A;HMBOX1;RPA1
prerank,ATP hydrolysis activity (GO:0140603),0.24530153631078738,0.8121544117298706,0.7811965811965812,0.9790780397798031,1.0,6/41,9.24%,ABCD2;MYO1E;CLU;DHX9;SWSAP1;CHD3
prerank,lipase activator activity (GO:0060229),0.3452997737358436,0.8103635548938857,0.7258382642998028,0.9793529463250638,1.0,4/10,11.48%,SRC;CCL3;PDPK1;APOH
prerank,protein phosphatase activator activity (GO:0072542),0.3211479986066529,0.809980016932454,0.704331450094162,0.9768856388308313,1.0,4/13,22.83%,IGFBP3;PPP2R5B;PPP2R5A;CALM2
prerank,carboxypeptidase activity (GO:0004180),0.25002749293902965,0.8096790515344252,0.7814207650273224,0.9741898264587684,1.0,9/35,21.47%,NAALAD2;CPE;CPA4;CPB1;MINDY2;CTSA;AGBL3;CPA6;AGTPBP1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.28628605300853,-0.8081880803045313,0.7333333333333333,0.9649111341485513,1.0,8/17,35.25%,SLC2A8;SLC2A2;SLC2A4;SLC2A3;SLC5A1;SLC5A10;MFSD4A;SLC2A6
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.23639153826827322,-0.8070287611321485,0.8177458033573142,0.9630062228045702,1.0,14/38,32.55%,SPOCK1;APP;SERPING1;SERPINI1;SERPINH1;ANXA2;TFPI2;SERPINB2;SERPINE3;SERPINB5;HRG;SERPINA10;WFDC3;SERPINA2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.33532669187739983,-0.8062831437807675,0.7117516629711752,0.960402402485271,1.0,1/10,1.05%,ATF2
prerank,death receptor binding (GO:0005123),-0.2945194249991768,-0.8040032372896265,0.7582938388625592,0.9605655395956916,1.0,6/15,31.92%,BDNF;EDA;CASP8AP2;BID;NGF;NTF4
prerank,wide pore channel activity (GO:0022829),-0.2580850524969698,-0.8030036919289938,0.7573221757322176,0.9584358257540976,1.0,8/23,34.40%,PANX2;PANX1;GJB2;GJD2;GJA5;PANX3;GJC1;GJD3
prerank,nucleotide diphosphatase activity (GO:0004551),0.3053719673358586,0.8027177164469035,0.7345454545454545,0.9837110248541505,1.0,3/14,19.26%,FHIT;NUDT13;NUDT6
prerank,death domain binding (GO:0070513),0.33483893307613966,0.8018408080601941,0.7325174825174825,0.9820152519271146,1.0,2/11,5.53%,CRADD;TRADD
prerank,fibroblast growth factor binding (GO:0017134),0.28440962608810466,0.7994685906442262,0.7523629489603024,0.9829936722240146,1.0,9/21,27.15%,ITGAV;CEP57;API5;THBS1;FGFR4;FGFR2;ITGB3;FIBP;FGFRL1
prerank,ATPase regulator activity (GO:0060590),-0.22950970982538688,-0.7989783193353804,0.8352941176470589,0.9618041501139366,1.0,7/38,13.99%,DNAJA2;DNAJC15;BAG3;DNAJB4;ATP1B3;TOR1AIP2;MYBPC3
prerank,bHLH transcription factor binding (GO:0043425),0.29354895478443827,0.7989270924784369,0.7712765957446809,0.9808058280215793,1.0,6/19,23.12%,SMAD3;MAP3K10;TCF3;KDM1A;TWIST1;LMO2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3084296690198184,-0.7982251810271597,0.7861915367483296,0.9593534952930619,1.0,3/14,12.28%,USP15;USP13;MINDY3
prerank,gap junction channel activity (GO:0005243),-0.261083506026786,-0.7968268786560536,0.7796976241900648,0.9578517423805694,1.0,8/22,34.40%,PANX2;PANX1;GJB2;GJD2;GJA5;PANX3;GJC1;GJD3
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.23481504714495227,-0.7961555796358797,0.7857142857142857,0.9551424434809336,1.0,4/38,6.12%,HIP1;SESTD1;PLEKHA5;DENND1A
prerank,TBP-class protein binding (GO:0017025),0.2795538699850006,0.7949941845891475,0.7732142857142857,0.9845924078920067,1.0,5/21,14.52%,TAF12;BRF2;TAF1;PSMC1;PSMC2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.24901096208348864,-0.7931110388485062,0.7843137254901961,0.9566670445762329,1.0,7/28,18.55%,TRIM37;EDA;TRAP1;BABAM2;TNFSF9;TRAF1;CASP8AP2
prerank,sterol transfer activity (GO:0120015),0.29333182474865493,0.7921503978160923,0.769090909090909,0.9865099803345908,1.0,7/17,32.34%,GRAMD1A;NPC2;OSBP;MTTP;ABCA1;STARD5;ABCG1
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2619167152512823,0.7919716221198628,0.7764084507042254,0.9836519546796929,1.0,3/27,5.45%,SLC9A9;SLC9A8;SLC8A1
prerank,ATPase binding (GO:0051117),-0.20500163690561485,-0.7915827087143605,0.865979381443299,0.9557073787052447,1.0,17/71,22.94%,ANK2;PDE4D;EGFR;SNU13;PTPN3;PKD2;ATP1B3;TMTC4;TOR1AIP2;METTL21A;S100A1;PIH1D1;PEX19;EZR;NCSTN;LCK;PGR
prerank,phosphatidylglycerol binding (GO:1901611),0.31763276685043623,0.7905351823264535,0.7421602787456446,0.9830340672767469,1.0,2/13,6.05%,PITPNC1;NME4
prerank,N-methyltransferase activity (GO:0008170),0.2706935339703782,0.7887876087048543,0.7756653992395437,0.9829831841593977,1.0,7/20,23.91%,METTL5;RNMT;PRMT1;TFB1M;SETD3;HNMT;TRMT1L
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2586858318224924,-0.7865354913538319,0.785234899328859,0.9604301919066393,1.0,6/24,17.76%,ZDHHC21;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2592109382372477,0.7861446638936058,0.7747747747747747,0.9842609050793596,1.0,8/27,22.88%,POLR2J;POLR2D;POLR3H;POLR2E;POLR1C;POLR1D;POLR2I;MED20
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3285797655224446,0.7852180158650497,0.7584269662921348,0.9826399587581617,1.0,2/11,8.47%,PADI2;AGMAT
prerank,thyroid hormone receptor binding (GO:0046966),0.2563059837596999,0.782989969674372,0.799645390070922,0.9831949659594234,1.0,3/28,4.27%,BRD8;PRMT2;TACC1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.31533127463428556,-0.7817150436497277,0.7611650485436893,0.9648352126333193,1.0,2/11,9.07%,UBR5;UBE2K
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2285493731454441,0.7813599261387111,0.8469565217391304,0.9827118383863704,1.0,17/44,24.66%,KMT2D;ASH1L;CXXC1;EHMT2;KMT5C;SETD2;EZH2;EED;SETD4;PRDM9;SETD7;SETD3;KMT2B;SMYD1;KMT5A;SETDB1;WDR5
prerank,ADP binding (GO:0043531),-0.24731975469037928,-0.7743957760211715,0.8377192982456141,0.9728894249751041,1.0,7/25,19.55%,ERN1;PRKAG2;TAP1;MYO6;ME1;MSH6;ACTA1
prerank,G protein-coupled receptor binding (GO:0001664),0.1891504448622596,0.7743762777724168,0.934984520123839,0.9908212801218311,1.0,24/132,20.28%,GNA15;GNA12;ARRB2;NPY;RYK;PPY;WNT2B;C1QBP;WNT10B;GRK2;WNT7B;INSL3;ZNRF3;PICK1;NPFF;USP4;GNAS;FZD1;ARRB1;STUB1;ITGB4;PENK;RSPO1;CCRL2
prerank,protein kinase activator activity (GO:0030295),0.21328198167007395,0.7737031862880013,0.8796610169491526,0.9888287439474763,1.0,11/60,13.12%,FGF13;STRADA;SPRY2;AFAP1L2;RPTOR;GPRC5A;NCKAP1L;WNK1;MLST8;AGAP2;MARK2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.24470304981343266,0.7730563681939285,0.8351254480286738,0.9866957311954094,1.0,7/33,16.62%,DIS3L2;REXO2;EXOSC10;EXOSC5;DIS3;ERI3;ISG20
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.309959359261759,0.7728836967251967,0.7659963436928702,0.9838776412701478,1.0,3/13,23.06%,SRC;PYCARD;BMP2
prerank,nucleotidase activity (GO:0008252),-0.2847257278269368,-0.77251330670423,0.7700892857142857,0.9719934930767978,1.0,3/15,24.11%,NT5C3B;BPNT1;BPNT2
prerank,antiporter activity (GO:0015297),-0.26544362874266686,-0.7720340852576014,0.8130630630630631,0.9690130436288857,1.0,4/20,17.01%,SLC25A30;SLC25A16;SLC35C2;SLC35E1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.31772757065785706,0.7682336974694154,0.7703703703703704,0.9880029534787197,1.0,5/12,18.91%,KDM3A;KDM4A;HR;KDM1A;KDM7A
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.28409522511636465,0.7628701783006558,0.8024691358024691,0.9927360956756569,1.0,3/16,12.19%,MTMR10;MTMR14;MTMR4
prerank,Notch binding (GO:0005112),0.2646650395312302,0.7612949541692776,0.8178571428571428,0.9919831153974475,1.0,5/22,11.32%,JAG2;NOTCH4;DTX1;GALNT11;DLL1
prerank,lipid phosphatase activity (GO:0042577),0.29489983043751095,0.7612869878198226,0.7869481765834933,0.9889304756154751,1.0,4/14,13.84%,INPP5K;PLPP1;PLPP2;PLPPR2
prerank,semaphorin receptor binding (GO:0030215),0.2641891797015924,0.761244675887526,0.8017857142857143,0.985959682177602,1.0,5/23,13.33%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,calcium-activated potassium channel activity (GO:0015269),0.31447928542612447,0.7587810048251721,0.7678571428571429,0.98643488625969,1.0,3/11,10.00%,KCNMA1;KCNN1;KCNU1
prerank,frizzled binding (GO:0005109),-0.2280026921699675,-0.7585067673080536,0.8557692307692307,0.9850866845778814,1.0,9/34,21.81%,CCDC88C;LRP6;SDCBP;WNT4;WNT9A;SFRP1;WNT7A;WNT6;WNT8B
prerank,protein kinase inhibitor activity (GO:0004860),0.22468701718353026,0.7571801651691064,0.8498168498168498,0.9856327886670972,1.0,15/42,24.48%,PRKRIP1;SPRY2;RPTOR;ITPRIP;INKA1;MAPK8IP1;CIB1;QARS1;TRIB1;MBIP;CEP43;IBTK;SPRED2;CDKN1B;DUSP19
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.27703902983874423,-0.7566196710289811,0.8095238095238095,0.9840993218710729,1.0,4/15,17.80%,SESTD1;PLEKHA5;PLEKHF1;VEPH1
prerank,NADP binding (GO:0050661),0.23819254022590422,0.7556023844793762,0.8348134991119005,0.984787974986031,1.0,7/32,13.19%,QDPR;HSD17B1;DUOX1;NOS2;CRYM;CRYZL1;NNT
prerank,phospholipase activator activity (GO:0016004),0.3244840298983477,0.7555510081065387,0.777992277992278,0.9818688581937313,1.0,4/10,13.15%,SRC;CCL3;PDPK1;STX4
prerank,FAD binding (GO:0071949),-0.2432539285499009,-0.7529365195200287,0.8261904761904761,0.985520496861898,1.0,13/24,35.87%,MICAL3;KDM1B;KMO;DAO;STEAP4;CYB5R2;CRY1;AGPS;NQO2;CYB5R3;QSOX1;MICAL2;MTRR
prerank,amino acid transmembrane transporter activity (GO:0015171),0.21963438659497708,0.7506960221878627,0.8856152512998267,0.9856038387052503,1.0,3/47,2.37%,SLC7A8;SLC7A5;SLC36A1
prerank,nucleosomal DNA binding (GO:0031492),-0.2488060959936234,-0.7490459639461496,0.8358862144420132,0.9873960037365731,1.0,4/21,12.29%,SMARCE1;MTA2;ACTB;H3-3A
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.21657382624065297,0.7473866347757556,0.8761061946902655,0.9872759133742739,1.0,17/49,25.85%,BAG6;ZRANB1;TAB2;UFD1;MINDY2;ABRAXAS1;OPTN;TNIP2;UBQLN4;WDR81;PSMD4;TNIP1;ZBTB1;SPRTN;RAD23B;HDAC6;UBXN1
prerank,BMP receptor binding (GO:0070700),0.30997383813826435,0.7467661244911293,0.799625468164794,0.9850811806032259,1.0,3/12,23.06%,SRC;PYCARD;BMP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.2891090499463561,0.746216320010627,0.7953321364452424,0.9828556680584556,1.0,2/14,10.22%,SLC1A3;SLC17A8
prerank,DNA secondary structure binding (GO:0000217),0.23816263776090704,0.7460791243789598,0.8652849740932642,0.9801029152523842,1.0,10/31,23.99%,MEF2C;FANCM;RAD51B;ABL1;BLM;HMGB2;MAPT;LIN54;YY1;RAD51C
prerank,phosphatase activator activity (GO:0019211),0.2905505477906648,0.746049978113343,0.8106060606060606,0.9772151072849624,1.0,5/14,23.06%,FRS2;PPP2R5B;PPP2R5A;CALM2;BMP2
prerank,chemokine activity (GO:0008009),-0.22988955302956773,-0.744529382783012,0.8827586206896552,0.9897245927562297,1.0,11/31,34.19%,PF4;CX3CL1;CCL5;CCL14;CCL7;CCL19;CCL8;CXCL9;CCL4;CXCL16;CXCL12
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.2666566558253373,-0.7435829847999367,0.8369565217391305,0.9874623288140292,1.0,7/18,28.30%,FAR2;ALDH3A2;ALDH9A1;ALDH6A1;ALDH2;FAR1;ALDH18A1
prerank,ephrin receptor activity (GO:0005003),-0.26743199053657235,-0.7406528831594714,0.8374164810690423,0.9837238092142285,1.0,8/17,29.26%,EPHA5;EPHB2;EPHA4;EPHA7;EPHA3;EPHB4;EPHA6;EFNA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.26743199053657235,-0.7406528831594714,0.8374164810690423,0.9837238092142285,1.0,8/17,29.26%,EPHA5;EPHB2;EPHA4;EPHA7;EPHA3;EPHB4;EPHA6;EFNA4
prerank,palmitoyltransferase activity (GO:0016409),-0.23026035416117543,-0.733753485403371,0.8451025056947609,0.9886895935144508,1.0,7/28,17.76%,ZDHHC21;ZDHHC16;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3103734412283965,0.7326134295522416,0.8111753371868978,0.9915628941618481,1.0,3/10,20.25%,CACNB2;CACNA1A;CACNA1D
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.31255146533017986,0.7320450756414686,0.7900763358778626,0.9893011240693886,1.0,1/10,2.33%,INCA1
prerank,protein kinase regulator activity (GO:0019887),-0.17467202088803943,-0.7317666859593713,0.9673366834170855,0.9874200620458191,1.0,27/95,23.69%,SH3BP5;PRKAG2;FAF1;CCND2;CCNF;CCNYL1;KIDINS220;TPX2;SMCR8;CCNJ;DNAJC3;SPRY4;RGCC;CDKN1A;SNCA;RPLP1;NPM1;DUS2;CCNB1;SPDYA;CDKN1C;GMFG;GPRC5C;PRKAR1A;SH3BP5L;CCNH;CAB39
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3080154636114279,-0.7314690351786522,0.8125,0.9805124100498253,1.0,6/10,33.12%,DUSP10;DUSP16;DUSP2;DUSP4;DUSP9;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3080154636114279,-0.7314690351786522,0.8125,0.9805124100498253,1.0,6/10,33.12%,DUSP10;DUSP16;DUSP2;DUSP4;DUSP9;DUSP8
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.20033537646971383,-0.7295673841717731,0.9236276849642004,0.9792792234462766,1.0,15/49,26.26%,MPPED2;PTPN22;DUSP10;GDPD1;PXYLP1;DUSP16;SAMHD1;PLCXD2;DUSP28;SACM1L;PRUNE1;HDHD2;EPHX2;LHPP;DUSP4
prerank,cardiolipin binding (GO:1901612),-0.29811749469675225,-0.7286759522357997,0.8021276595744681,0.9768161072335769,1.0,1/10,2.55%,MME
prerank,copper ion binding (GO:0005507),-0.20379628806424666,-0.7272698332741657,0.9136690647482014,0.9750800428003034,1.0,9/42,22.00%,PAM;ATP7A;SNCA;MOXD1;GPC1;CUTC;DCT;ACR;AOC2
prerank,transferrin receptor binding (GO:1990459),-0.30427568274581596,-0.7246499716225846,0.8053830227743272,0.9746837117044131,1.0,6/10,43.38%,SNX2;RGMA;HFE;CHUK;IKBKG;CD81
prerank,serine-type endopeptidase activity (GO:0004252),-0.18070238486191478,-0.7241493943418273,0.9617346938775511,0.9717647170451096,1.0,26/80,30.51%,DPP4;PCSK2;PCSK5;CD5L;PARL;F7;MMP8;PLAT;PRSS12;HPR;HP;RHBDL3;MASP2;ACR;F11;RHBDD1;PRSS53;RHBDL2;GZMM;MMP9;PLAU;GZMB;GZMA;PRSS56;RHBDL1;TMPRSS3
prerank,telomerase RNA binding (GO:0070034),-0.24074567966754784,-0.7238811055236585,0.8540305010893247,0.9686032012882102,1.0,4/22,11.95%,SMG7;SMG6;SMG5;WRAP53
prerank,tau-protein kinase activity (GO:0050321),-0.2447265476075926,-0.7230613016340742,0.87527352297593,0.9660042948496619,1.0,3/20,5.38%,MARK3;SIK3;GSK3B
prerank,disordered domain specific binding (GO:0097718),-0.23601300911054351,-0.7229797787473909,0.8826185101580135,0.9626648311021359,1.0,8/23,26.53%,FN1;CALM1;HSPA2;MDM2;FYN;KCNA1;HSP90AB1;CALM3
prerank,lysine N-methyltransferase activity (GO:0016278),0.25657254577766514,0.7226057937725892,0.8685612788632326,0.9977650001532429,1.0,8/20,23.39%,EEF2KMT;EHMT2;ANTKMT;SETD2;SETD4;SETD7;SETD3;KMT5A
prerank,chemoattractant activity (GO:0042056),0.24598755236929393,0.7196142079627916,0.8660714285714286,0.9983138280628222,1.0,4/26,8.18%,CCL3;VEGFB;PDGFB;GDNF
prerank,alpha-tubulin binding (GO:0043014),0.22872088968217313,0.7193285487808614,0.8882882882882883,0.9956847456137178,1.0,11/31,26.84%,DIP2B;TRIM36;TRPV4;SETD2;OFD1;EML4;EFHC2;TRAPPC14;HDAC6;TBCEL;ARL8B
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.26391362659910594,0.7188675743204681,0.8479087452471483,0.9932714230056476,1.0,2/18,5.44%,HSD3B2;HSD17B1
prerank,RNA methyltransferase activity (GO:0008173),0.2591560034522773,0.716710535483429,0.8694885361552028,0.9928098292627616,1.0,9/19,28.43%,TGS1;BCDIN3D;FTSJ3;FBL;TRDMT1;METTL8;FTSJ1;METTL4;TRMT9B
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.20791319228995092,-0.7149119321168435,0.9152542372881356,0.9682646036062938,1.0,8/34,20.76%,IQGAP1;CALM1;IRGM;DBF4;CCNB1;CKS2;LTF;ETAA1
prerank,intracellular chloride channel activity (GO:0061778),-0.26097192076684705,-0.7147584655932911,0.851258581235698,0.9615639377829457,1.0,4/16,13.84%,ANO3;ANO6;ANO5;ANO10
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.26097192076684705,-0.7147584655932911,0.851258581235698,0.9615639377829457,1.0,4/16,13.84%,ANO3;ANO6;ANO5;ANO10
prerank,MAP kinase activity (GO:0004707),-0.2737061487156655,-0.7138090232640945,0.8553719008264463,0.959133667952447,1.0,5/14,29.17%,MAPK10;NLK;MAPK1;MAPK15;MAPK13
prerank,histone acetyltransferase activity (GO:0004402),0.23141291591400834,0.7124181578881731,0.8971119133574007,0.9946670109889357,1.0,11/30,24.07%,SRCAP;TAF1;NAA50;NCOA3;ARRB1;KAT5;NAA40;EPC1;TAF10;KAT6B;NAA60
prerank,potassium ion leak channel activity (GO:0022841),-0.26237433317102227,-0.7092543910028988,0.8425531914893617,0.9606992755302387,1.0,4/15,21.78%,KCNK10;KCNK12;KCNK5;KCNK2
prerank,titin binding (GO:0031432),0.2821602538906713,0.7091288145378877,0.838475499092559,0.9954239715047628,1.0,5/13,27.50%,CAPN3;MYBPC1;ANKRD23;CALM2;CAMK2D
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.2793076762510341,0.7080507164131913,0.8367729831144465,0.9936249505233201,1.0,5/13,27.90%,SLC15A4;SLC38A7;SLC7A7;SLC25A29;SLC66A1
prerank,pseudouridine synthase activity (GO:0009982),-0.2722075216807227,-0.7061795709152261,0.8419811320754716,0.9604717091508517,1.0,5/13,25.25%,PUS1;TRUB2;RPUSD1;RPUSD3;RPUSD4
prerank,U6 snRNA binding (GO:0017070),0.26541192807934577,0.704739044702998,0.8703007518796992,0.994301569313934,1.0,5/14,23.55%,SART3;PRPF4;LSM7;DDX39B;LSM8
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.2778143405036291,-0.7043063555078046,0.8655804480651731,0.9591060585375316,1.0,2/12,8.00%,XDH;ISCA2
prerank,DNA replication origin binding (GO:0003688),-0.23120445386890687,-0.7010161033836728,0.9198113207547169,0.959283283124319,1.0,2/23,4.05%,POLA1;MCM9
prerank,methylated histone binding (GO:0035064),0.19671808784805542,0.7010008924232907,0.9494949494949495,0.9953680401051463,1.0,20/62,25.61%,CHD8;CXXC1;ZMYND11;DPF2;TAF1;JMJD7;KDM4A;MORC3;KDM8;KDM7A;KDM5A;CBX8;TDRD3;ZCWPW2;GLYR1;WDR5;RRP8;PHF8;SPIN1;ZCWPW1
prerank,exoribonuclease activity (GO:0004532),0.28198904991748963,0.7008127267650661,0.8451492537313433,0.9927012928602515,1.0,4/12,21.59%,EXOSC10;EXOSC5;EXOSC8;ZC3H12A
prerank,gamma-tubulin binding (GO:0043015),-0.24040131342311152,-0.6963839845958595,0.908675799086758,0.9606196266645156,1.0,4/21,14.84%,RACGAP1;CDK5RAP2;RAD51D;PAK1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.25393706015635154,-0.6912437861918214,0.8675496688741722,0.9622918783202523,1.0,3/15,15.24%,ALDH1L1;ALDH3A2;ALDH9A1
prerank,glucuronosyltransferase activity (GO:0015020),0.24640050732841134,0.6900160826109342,0.8919925512104283,1.0,1.0,4/19,16.28%,LARGE1;CHPF;UGT1A6;CHSY1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.26663017844985215,-0.6894335770198255,0.8782051282051282,0.9607366365961192,1.0,3/13,15.24%,ALDH1L1;ALDH3A2;ALDH9A1
prerank,cholesterol transfer activity (GO:0120020),0.2579406018656031,0.6892780485841286,0.8870967741935484,0.9983607950151437,1.0,6/16,32.34%,GRAMD1A;NPC2;MTTP;ABCA1;STARD5;ABCG1
prerank,miRNA binding (GO:0035198),-0.2123554550025138,-0.6877724956199945,0.920863309352518,0.9589764968497672,1.0,30/30,78.81%,AGO4;TUT4;MATR3;AGO2;ZC3H7B;PNPT1;ZC3H10;FMR1;PUM2;ZC3H7A;AGO3;POU5F1;DND1;LIN28A;SOX2;RBM10;RC3H1;TRIM71;DDX21;TUT7;SPOUT1;ZNF346;YBX1;PUM1;RBM4;HNRNPA1;AGO1;ELAVL1;ZC3H12A;HNRNPA2B1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.21714929818686374,0.684672915513355,0.9324324324324325,0.999837299553158,1.0,13/35,28.43%,QTRT1;AARS2;PTRH1;BCDIN3D;ELAC2;DUS3L;QTRT2;DUS1L;TRDMT1;FTSJ1;ELAC1;GATC;TRMT9B
prerank,WW domain binding (GO:0050699),0.22945101062035497,0.6813573742353273,0.9089347079037801,0.9999052707800097,1.0,3/26,11.87%,PMEPA1;NDFIP2;TCEAL1
prerank,pyridoxal phosphate binding (GO:0030170),-0.2322263112019168,-0.6810510840635329,0.9287356321839081,0.961672570830291,1.0,5/20,17.08%,PSAT1;SRR;SHMT1;PYGM;GLDC
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.22916427002304782,0.6773484065521859,0.9194991055456172,1.0,1.0,11/24,34.69%,NME4;CMPK1;NME6;NME1;IP6K1;AK8;DTYMK;PPIP5K1;AK1;AK7;CMPK2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.22811316765840928,0.6772744581081214,0.9120689655172414,0.9978097304210034,1.0,2/25,3.26%,SIRT2;ART4
prerank,methylation-dependent protein binding (GO:0140034),0.1923274511609692,0.6747776050246813,0.9802955665024631,0.9971185798898243,1.0,18/57,25.61%,CHD8;CXXC1;ZMYND11;JMJD7;KDM4A;MORC3;KDM8;KDM7A;KDM5A;CBX8;TDRD3;ZCWPW2;GLYR1;WDR5;RRP8;PHF8;SPIN1;ZCWPW1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.2350409630095591,0.6741052504336656,0.8923611111111112,0.9921092986711034,1.0,2/21,3.18%,CDKL3;CDK9
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.2350409630095591,0.6741052504336656,0.8923611111111112,0.9921092986711034,1.0,2/21,3.18%,CDKL3;CDK9
prerank,cAMP response element binding (GO:0035497),0.29375987090301053,0.6738767910690442,0.861328125,0.9894988832523404,1.0,3/10,12.97%,CREB3L2;JUN;E4F1
prerank,transcription coregulator binding (GO:0001221),-0.1838337366510641,-0.6719035347290795,0.9647887323943662,0.9659085551715829,1.0,9/50,14.90%,ZBTB16;THRB;MTF2;PER2;CTCF;AHR;WIZ;LCOR;PER1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.2739806611620874,-0.6711969194702635,0.8720682302771855,0.9632184010190888,1.0,2/10,8.53%,DSE;RENBP
prerank,transaminase activity (GO:0008483),-0.27661540527641804,-0.6698180879696682,0.8969298245614035,0.9611181047852991,1.0,2/11,12.58%,PSAT1;BCAT1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.2628426119980678,-0.6643070705283363,0.8962655601659751,0.9623254215872203,1.0,5/12,30.39%,RRH;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,signal sequence binding (GO:0005048),0.20428450353649533,0.6632204822309877,0.9597197898423818,0.9955532820828795,1.0,16/35,33.95%,TOMM20L;TNPO1;IPO4;TOMM20;SEC61A1;KPNA3;KDELR2;NUP153;IPO5;TOMM70;SEC61A2;NUP214;CEMIP;KPNA1;KDELR1;KPNA7
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.22763860046921566,0.6606744399437255,0.9330783938814532,0.9947234746246605,1.0,7/22,23.44%,ZRANB1;TAB2;MINDY2;OPTN;WDR81;ZBTB1;SPRTN
prerank,general transcription initiation factor binding (GO:0140296),0.21816016804111243,0.650485802157418,0.9406474820143885,0.999361917644952,1.0,5/25,14.52%,TAF12;BRF2;TAF1;PSMC1;PSMC2
prerank,ribonuclease P RNA binding (GO:0033204),0.2702495512855291,0.6352465657918397,0.8927335640138409,1.0,1.0,2/10,12.29%,POP1;RPP21
prerank,CoA-ligase activity (GO:0016405),-0.23744034924156715,-0.6293478954285321,0.9432314410480349,0.9820419034621185,1.0,8/14,38.95%,ACSL1;ACSM3;AACS;ACSBG1;SLC27A5;ACSBG2;ACSF3;ACSS3
prerank,ribonuclease P activity (GO:0004526),0.25938430741046986,0.6254928835518836,0.9202772963604853,1.0,1.0,2/11,12.29%,POP1;RPP21
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.24521224710543676,0.6182272791116002,0.9341864716636198,1.0,1.0,2/13,10.84%,GDI2;RGS14
prerank,platelet-derived growth factor binding (GO:0048407),-0.24637668550268174,-0.6143708207662996,0.9094650205761317,0.9866358546404174,1.0,3/11,15.47%,COL4A1;COL1A1;COL5A1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.18729844504127818,0.6134129289526213,0.9845890410958904,1.0,1.0,6/42,14.11%,INCA1;CCNG2;CCNL1;CKS1B;CCND3;CCNE1
prerank,voltage-gated anion channel activity (GO:0008308),-0.22591824644499386,-0.6112463889401825,0.945031712473573,0.9847916092502593,1.0,2/15,8.83%,CLCN5;ANO6
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.23949598947374906,0.6008417465557991,0.9274047186932849,1.0,1.0,2/13,12.56%,SLX4;EXO1
prerank,CoA hydrolase activity (GO:0016289),-0.21744317468290847,-0.5954396066665465,0.9623893805309734,0.9886568813811211,1.0,16/16,78.28%,ACOT13;ACOT11;HIBCH;ACOT12;BAAT;ACSBG2;ACOT9;NUDT7;ACOT6;ACOT2;ACOT7;ACOT4;ABCD1;ACOT8;ACOT1;ACAA2
prerank,acid-thiol ligase activity (GO:0016878),0.2356444055957285,0.5900687221037786,0.9528301886792453,1.0,1.0,3/13,25.40%,ACSS1;ACSS2;AASDH
prerank,protein phosphatase regulator activity (GO:0019888),0.16857960746345924,0.5887623038331887,0.9917491749174917,1.0,1.0,8/53,17.42%,PPP6R3;PPP1R9B;PPP6R1;MGAT5;PPP2R5B;PPP4R2;PPP2R5A;EIF2AK2
prerank,phosphatase inhibitor activity (GO:0019212),0.20359376419424946,0.5847911020197788,0.9596491228070175,1.0,1.0,2/20,10.10%,PPP1R9B;MGAT5
prerank,proton transmembrane transporter activity (GO:0015078),0.1775450488513286,0.5823322962658614,0.9892086330935251,1.0,1.0,4/39,13.19%,COX7A2L;COX8A;COX5A;NNT
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2276800179543108,-0.5820123346585349,0.947136563876652,0.9905866732265493,1.0,4/12,24.92%,CDK7;CDK4;MAPK1;CDK12
prerank,N-acetyltransferase activity (GO:0008080),0.205446310362305,0.5815580773724126,0.9765166340508806,1.0,1.0,10/19,36.97%,ATAT1;NAA50;NAT8L;GNPNAT1;KAT2B;NAA10;EP300;SAT2;NAA80;AANAT
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.18961408097240307,0.5786152717035284,0.9916107382550335,1.0,1.0,6/28,20.71%,POP1;RPP21;EXO1;ELAC2;NUDT16;RNASEH1
prerank,N-acyltransferase activity (GO:0016410),0.18291867055473804,0.5718626495573632,0.9888475836431226,1.0,1.0,12/32,32.89%,TGM2;CERS3;CERS2;NAA50;NAT8L;CERS4;GNPNAT1;NMT1;PLA2G4E;NAA10;EP300;SIRT7
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.1986803435662337,0.5692487282168545,0.9909747292418772,1.0,1.0,8/22,26.67%,DUSP29;DUSP18;DUSP5;DUSP6;PPM1F;DUSP12;DUSP19;DUSP23
prerank,peptidoglycan binding (GO:0042834),0.24449805799062851,0.5690079086492866,0.9640831758034026,1.0,1.0,2/10,20.07%,NLRP3;NOD2
prerank,"DNA binding, bending (GO:0008301)",-0.20948191266659405,-0.5626801619559975,0.9871794871794872,0.9938590483299676,1.0,3/14,19.30%,TOP2A;FOXC1;LEF1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.18429910919544124,0.5477022769077711,0.9878472222222222,1.0,1.0,3/26,12.94%,SLC16A6;MPC1;SLC16A7
prerank,acetyltransferase activity (GO:0016407),0.17569882286236896,0.5471552441377796,0.9875222816399287,1.0,1.0,15/31,35.67%,PAFAH2;NAA50;LCAT;DBT;KAT6B;ELP3;NAT8L;GNPNAT1;ACAT1;KAT2B;NAA10;EP300;CREBBP;SAT2;NAA80
prerank,nuclear localization sequence binding (GO:0008139),0.19344571951083053,0.5402445064740796,0.9792060491493384,1.0,1.0,5/18,24.22%,TNPO1;IPO4;KPNA3;NUP153;IPO5
prerank,MAP kinase phosphatase activity (GO:0033549),0.21900649567289643,0.5388346798045439,0.9760147601476015,0.9995938000805158,1.0,3/12,16.64%,DUSP29;DUSP5;DUSP6
prerank,tRNA methyltransferase activity (GO:0008175),0.20061500097436843,0.5278324011477795,0.9793621013133208,0.999272163421062,1.0,8/16,29.76%,BCDIN3D;THUMPD3;TRDMT1;FTSJ1;ALKBH8;TRMT9B;METTL2B;METTL2A
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.21581780007240983,-0.5222599277048002,0.98125,1.0,1.0,3/11,18.69%,RDH13;DHRS13;RDH12
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.20819733868943024,0.4958268863971529,0.9821782178217822,1.0,1.0,10/10,79.19%,ANKRD13B;FAN1;LAPTM5;ANKRD13D;FAAP20;DAXX;IDE;PML;ANKRD13A;DNAJB2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.15990639766939752,0.48717523834665577,1.0,1.0,1.0,2/26,10.10%,PPP1R9B;MGAT5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.18846386706400334,0.48182082824871686,0.9963833634719711,0.9981924714095082,1.0,4/13,24.42%,TRMT10B;THUMPD3;TRMT1L;FTSJ1
prerank,ribosomal large subunit binding (GO:0043023),-0.19882976479537331,-0.4799104908164805,0.9935483870967742,1.0,1.0,5/11,33.80%,NPM1;DHX33;MRRF;RBM3;NMD3
prerank,filamin binding (GO:0031005),-0.19604299923811622,-0.4791483784624557,0.9936842105263158,0.999150830282438,1.0,4/11,27.24%,NEBL;MICALL2;RFLNB;DPYSL4
prerank,hormone receptor binding (GO:0051427),0.18375687290933257,0.4624328496603189,0.9943502824858758,0.9972043327758943,1.0,4/14,24.81%,VIP;TYK2;PTHLH;NPPC
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.18098935242360786,-0.45067741061939276,0.9958419958419958,0.9981313060020032,1.0,4/11,28.96%,NUDT3;NUDT10;DCP2;NUDT11
